{"trialResultsOutput": {"Filters": {"@total": "37", "Filter": [{"@total": "100", "@label": "Inclusion Criteria Index", "@name": "trialInclusionCriteriaIndex", "FilterOption": [{"@id": "3900", "@count": "3170", "@label": "Lung tumor - Subjects with Non Small Cell Lung Cancer (NSCLC)"}, {"@id": "3976", "@count": "3156", "@label": "Lung tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/Zubrod/WHO performance score-0"}, {"@id": "3977", "@count": "3148", "@label": "Lung tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/Zubrod/WHO performance score-1"}, {"@id": "3957", "@count": "3101", "@label": "Lung tumor - Subjects Confirmed of Lung Cancer by Specific Modes - Subjects with cytologically/histologically confirmed diagnosis of lung cancer"}, {"@id": "4024", "@count": "2892", "@label": "Lung tumor - Subjects with Normal/Acceptable Clinical Assessments - Subjects with normal/acceptable liver functions"}, {"@id": "4032", "@count": "2858", "@label": "Lung tumor - Subjects with Normal/Acceptable Clinical Assessments - Subjects with normal/acceptable renal functions"}, {"@id": "4879", "@count": "2818", "@label": "Breast tumor - Subjects with Protocol Specified Performance Status - ECOG/Zubrod/WHO performance Score - 0"}, {"@id": "4880", "@count": "2806", "@label": "Breast tumor - Subjects with Protocol Specified Performance Status - ECOG/Zubrod/WHO performance Score - 1"}, {"@id": "4074", "@count": "2711", "@label": "Lung tumor - Protocol Specified Other Inclusion Criteria - Subjects able to provide informed consent and/or comply with Protocol"}, {"@id": "4840", "@count": "2703", "@label": "Breast tumor - Subjects with Advanced/Metastatic/TNM IV Breast Cancer"}, {"@id": "3936", "@count": "2616", "@label": "Lung tumor - Subjects with Protocol Specified Stages of Lung Cancer(TNM staging) - Subjects with stage IV lung cancer"}, {"@id": "13096", "@count": "2461", "@label": "Solid tumor - Subjects with Advanced/Metastatic Solid Tumors"}, {"@id": "3940", "@count": "2444", "@label": "Lung tumor - Lung Cancer Subjects with History of/Active Metastases"}, {"@id": "3938", "@count": "2289", "@label": "Lung tumor - Subjects with Protocol Specified Stages of Lung Cancer(TNM staging) - Subjects with advanced stage lung cancer"}, {"@id": "4483", "@count": "2256", "@label": "Colorectal tumor - Subjects with TNM Stage IV/Metastatic/Advanced Colorectal Cancer"}, {"@id": "4073", "@count": "2243", "@label": "Lung tumor - Protocol Specified Other Inclusion Criteria"}, {"@id": "3537", "@count": "2166", "@label": "Lymphoma - Subjects with Specific Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"}, {"@id": "3538", "@count": "2164", "@label": "Lymphoma - Subjects with Specific Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"}, {"@id": "13129", "@count": "2149", "@label": "Solid tumor - Subjects with Refractory Solid Tumors"}, {"@id": "4527", "@count": "2124", "@label": "Colorectal tumor - Subjects with Specified Performance Status - Subjects with ECOG [Eastern Cooperative Oncology Group]/Zubrod/WHO performance score - 0"}, {"@id": "4528", "@count": "2115", "@label": "Colorectal tumor - Subjects with Specified Performance Status - Subjects with ECOG [Eastern Cooperative Oncology Group]/Zubrod/WHO performance score - 1"}, {"@id": "3464", "@count": "2103", "@label": "Lymphoma - Subjects with B Cell Non Hodgkin's Lymphoma"}, {"@id": "3622", "@count": "2067", "@label": "Lymphoma - Subjects with Normal/Acceptable Organ Functions - Subjects with normal/acceptable hepatic functions"}, {"@id": "4509", "@count": "2048", "@label": "Colorectal tumor - Subjects with Histologically Confirmed Colorectal Cancer"}, {"@id": "5073", "@count": "2037", "@label": "Leukemia - Subjects with Normal/Adequate Organ Function - Subjects with normal/adequate liver function"}, {"@id": "3628", "@count": "2037", "@label": "Lymphoma - Subjects with Normal/Acceptable Organ Functions - Subjects with normal/acceptable renal functions"}, {"@id": "5087", "@count": "2009", "@label": "Leukemia - Subjects with Specific Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"}, {"@id": "5074", "@count": "2009", "@label": "Leukemia - Subjects with Normal/Adequate Organ Function - Subjects with normal/adequate renal function"}, {"@id": "5086", "@count": "2007", "@label": "Leukemia - Subjects with Specific Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"}, {"@id": "3548", "@count": "1970", "@label": "Lymphoma - Subjects Diagnosed Based on Histo-Pathological Examination"}, {"@id": "22381", "@count": "1947", "@label": "Lung tumor - Protocol Specified Other Inclusion Criteria - Protocol specified inclusion criteria for females"}, {"@id": "4569", "@count": "1913", "@label": "Colorectal tumor - Subjects with Normal/Acceptable Organ Function/Laboratory Parameters - Subjects with normal/acceptable hematopoetic/marrow function"}, {"@id": "13369", "@count": "1879", "@label": "Cancer supportive care - Other Inclusion Criteria"}, {"@id": "4564", "@count": "1855", "@label": "Colorectal tumor - Subjects with Normal/Acceptable Organ Function/Laboratory Parameters - Subjects with normal/acceptable liver function"}, {"@id": "4565", "@count": "1802", "@label": "Colorectal tumor - Subjects with Normal/Acceptable Organ Function/Laboratory Parameters - Subjects with normal/acceptable renal function"}, {"@id": "5088", "@count": "1799", "@label": "Leukemia - Subjects with Specific Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 2"}, {"@id": "3933", "@count": "1788", "@label": "Lung tumor - Subjects with Protocol Specified Stages of Lung Cancer(TNM staging) - Subjects with stage III lung cancer"}, {"@id": "3539", "@count": "1771", "@label": "Lymphoma - Subjects with Specific Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 2"}, {"@id": "3642", "@count": "1742", "@label": "Lymphoma - Subjects with Normal/Acceptable Organ Functions - Subjects with normal/acceptable hematological status"}, {"@id": "4973", "@count": "1738", "@label": "Leukemia - Subjects with Acute Leukemia Unspecified Type"}, {"@id": "3989", "@count": "1683", "@label": "Lung tumor - Subjects with History of/Scheduled for Anti-lung Cancer Therapy - Subjects with history of/scheduled for chemotherapy"}, {"@id": "13377", "@count": "1678", "@label": "Cancer supportive care - Other Inclusion Criteria - Subjects willing/able to provide informed consent/assent"}, {"@id": "3978", "@count": "1637", "@label": "Lung tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/Zubrod/WHO performance score-2"}, {"@id": "7091", "@count": "1609", "@label": "Prostate tumor - Subjects with Advanced/Metastatic Prostate Cancer"}, {"@id": "3695", "@count": "1604", "@label": "Prostate tumor - Subjects with Stage IV Prostate Cancer"}, {"@id": "4981", "@count": "1604", "@label": "Leukemia - Subjects with Acute Myeloid Leukemia (AML)"}, {"@id": "4893", "@count": "1578", "@label": "Breast tumor - Subjects with History of Breast Cancer Therapy"}, {"@id": "3935", "@count": "1566", "@label": "Lung tumor - Subjects with Protocol Specified Stages of Lung Cancer(TNM staging) - Subjects with stage IIIB lung cancer"}, {"@id": "4881", "@count": "1556", "@label": "Breast tumor - Subjects with Protocol Specified Performance Status - ECOG/Zubrod/WHO performance Score - 2"}, {"@id": "3738", "@count": "1514", "@label": "Prostate tumor - Subjects with Specified Performance Status - Subjects with ECOG/WHO/Zubrod status 0-2"}, {"@id": "3465", "@count": "1500", "@label": "Lymphoma - Subjects with T Cell Non Hodgkin's Lymphoma"}, {"@id": "3971", "@count": "1496", "@label": "Lung tumor - Subjects with Protocol Specified Life Expectancy - Subjects with at least 3 months life expectancy"}, {"@id": "4106", "@count": "1481", "@label": "Lung tumor - Protocol Specified Other Inclusion Criteria - Male subjects using acceptable means of contraception/infertile subjects"}, {"@id": "13120", "@count": "1473", "@label": "Solid tumor - Subjects with History/Scheduled of Treatment for Solid Tumors"}, {"@id": "4877", "@count": "1468", "@label": "Breast tumor - Subjects with Protocol Specified Life Expectancy"}, {"@id": "22417", "@count": "1438", "@label": "Breast tumor - Subjects with Locally Advanced Breast Cancer"}, {"@id": "3561", "@count": "1409", "@label": "Lymphoma - Subjects with History of Therapy for Lymphoma - Subject with history of chemotherapy for lymphoma"}, {"@id": "4545", "@count": "1366", "@label": "Colorectal tumor - Subjects with History of Colorectal Cancer Therapy - Subjects with history of/ scheduled to receive chemotherapy"}, {"@id": "3913", "@count": "1339", "@label": "Lung tumor - Subjects with Measurable Disease"}, {"@id": "4974", "@count": "1317", "@label": "Leukemia - Subjects with Chronic Leukemia Unspecified Type"}, {"@id": "5102", "@count": "1313", "@label": "Leukemia - Subjects with History of Anti Cancer Therapy for Leukemia - Subjects with history of chemotherapy for leukemia"}, {"@id": "3614", "@count": "1311", "@label": "Lymphoma - Subjects with Progressive/Treatment Refractory Lymphoma"}, {"@id": "3724", "@count": "1305", "@label": "Prostate tumor - Subjects with Acceptable Laboratory Values - Subjects with acceptable hematological value"}, {"@id": "4894", "@count": "1303", "@label": "Breast tumor - Subjects with History of Breast Cancer Therapy - Subjects with history of chemotherapy for breast cancer"}, {"@id": "3726", "@count": "1298", "@label": "Prostate tumor - Subjects with Acceptable Laboratory Values - Subjects with acceptable liver function"}, {"@id": "17850", "@count": "1293", "@label": "Stem cell transplantation - Subjects with History of/Indicated for Hematopoietic Stem Cell Transplantation(HSCT)"}, {"@id": "4126", "@count": "1291", "@label": "Melanoma - Subjects with Advanced Melanoma"}, {"@id": "3994", "@count": "1281", "@label": "Lung tumor - Subjects with History of/Scheduled for Anti-lung Cancer Therapy - Subjects with history of/scheduled for radiotherapy"}, {"@id": "4922", "@count": "1259", "@label": "Breast tumor - Subjects with Progressive/Refractory Breast Cancer"}, {"@id": "3727", "@count": "1255", "@label": "Prostate tumor - Subjects with Acceptable Laboratory Values - Subjects with acceptable renal function"}, {"@id": "3987", "@count": "1236", "@label": "Lung tumor - Specific Treatment Naive Subjects"}, {"@id": "4856", "@count": "1209", "@label": "Breast tumor - Subjects with Measurable Disease"}, {"@id": "4904", "@count": "1205", "@label": "Breast tumor - Subjects with History of Breast Cancer Therapy - Subjects with history of radiotherapy"}, {"@id": "13111", "@count": "1168", "@label": "Solid tumor - Subjects with Specific Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"}, {"@id": "13110", "@count": "1166", "@label": "Solid tumor - Subjects with Specific Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"}, {"@id": "4895", "@count": "1157", "@label": "Breast tumor - Subjects with History of Breast Cancer Therapy - Subjects with history of endocrine/hormonal therapy"}, {"@id": "22394", "@count": "1152", "@label": "Breast tumor - Subjects with History of Breast Cancer Therapy - Subjects with history of biologic therapy for breast cancer"}, {"@id": "3762", "@count": "1129", "@label": "Prostate tumor - Treatment Refractory Prostate Cancer Subjects"}, {"@id": "4139", "@count": "1112", "@label": "Melanoma - Subjects with Stage IV Melanoma"}, {"@id": "12981", "@count": "1097", "@label": "Central nervous system tumor - Subjects with Brain Tumors"}, {"@id": "4529", "@count": "1097", "@label": "Colorectal tumor - Subjects with Specified Performance Status - Subjects with ECOG [Eastern Cooperative Oncology Group]/Zubrod/WHO performance score-2"}, {"@id": "3609", "@count": "1082", "@label": "Lymphoma - Subjects with Relapse/Recurrent Lymphoma"}, {"@id": "13355", "@count": "1072", "@label": "Cancer supportive care - Subjects with History of Anti Cancer Therapy for Protocol Specified Cancer - Subjects with history of chemotherapy for protocol specified cancer"}, {"@id": "4398", "@count": "1072", "@label": "Head and neck tumor - Subjects with Specific Performance Status - Subjects with ECOG/WHO/Zubrod performance score - 1"}, {"@id": "4397", "@count": "1071", "@label": "Head and neck tumor - Subjects with Specific Performance Status - Subjects with ECOG/WHO/Zubrod performance score - 0"}, {"@id": "13131", "@count": "1070", "@label": "Solid tumor - Subjects with Normal/Acceptable Organ Functions - Subjects with normal/acceptable hematological status"}, {"@id": "4985", "@count": "1070", "@label": "Leukemia - Subjects with Acute Lymphocytic Leukemia (ALL)"}, {"@id": "22418", "@count": "1063", "@label": "Breast tumor - Subjects with Early Breast Cancer"}, {"@id": "13132", "@count": "1059", "@label": "Solid tumor - Subjects with Normal/Acceptable Organ Functions - Subjects with normal/acceptable hepatic functions"}, {"@id": "4169", "@count": "1059", "@label": "Melanoma - Subjects with Protocol Specified Performance Status - Subjects with ECOG/zubrod/WHO performance score - 0"}, {"@id": "8741", "@count": "1058", "@label": "Myeloproliferative disorder - Subjects with Chronic Myelogenous Leukemia"}, {"@id": "4870", "@count": "1057", "@label": "Breast tumor - Subjects History/Scheduled for Surgical Intervention"}, {"@id": "4004", "@count": "1052", "@label": "Lung tumor - Subjects with History/Co-existing Systemic Disorders - Subjects with History of/Active Cancers Other Than Lung Cancer"}, {"@id": "4170", "@count": "1052", "@label": "Melanoma - Subjects with Protocol Specified Performance Status - Subjects with ECOG/zubrod/WHO performance score - 1"}, {"@id": "13133", "@count": "1051", "@label": "Solid tumor - Subjects with Normal/Acceptable Organ Functions - Subjects with normal/acceptable renal functions"}, {"@id": "13347", "@count": "1043", "@label": "Cancer supportive care - Subjects with Specific Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"}, {"@id": "13346", "@count": "1042", "@label": "Cancer supportive care - Subjects with Specific Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"}, {"@id": "4416", "@count": "1040", "@label": "Head and neck tumor - Subjects with Normal/Acceptable Organ Functions - Subjects with normal/acceptable hematological status"}, {"@id": "4522", "@count": "1037", "@label": "Colorectal tumor - Subjects with Specified Life Expectancy - Subjects with life expectancy of three months or more"}, {"@id": "3914", "@count": "1023", "@label": "Lung tumor - Subjects with Measurable Disease - Subjects with measurable disease according to RECIST criteria"}]}, {"@total": "100", "@label": "Exclusion Criteria Index", "@name": "trialExclusionCriteriaIndex", "FilterOption": [{"@id": "4702", "@count": "3364", "@label": "Lymphoma - Subjects with Concurrent Systemic/Medical Illness"}, {"@id": "6554", "@count": "3362", "@label": "Leukemia - Subjects with Concurrent Systemic/Medical Illness"}, {"@id": "10704", "@count": "2877", "@label": "Solid tumor - Subjects with Concurrent Systemic/Medical Illness"}, {"@id": "5132", "@count": "2788", "@label": "Lung tumor - Subjects with Concurrent Systemic/Medical Illness - Subjects with cardiovascular diseases/disorders"}, {"@id": "20281", "@count": "2781", "@label": "Lung tumor - Subjects with Concurrent Systemic/Medical Illness"}, {"@id": "6328", "@count": "2763", "@label": "Breast tumor - Subjects with History of/Scheduled for Anti-neoplastic Therapy"}, {"@id": "6252", "@count": "2762", "@label": "Breast tumor - Subjects with Concurrent Systemic/Medical Illness"}, {"@id": "20282", "@count": "2601", "@label": "Lung tumor - Subjects with Concurrent Systemic/Medical Illness - Subjects with infectious/inflammatory/immunological diseases/disorders"}, {"@id": "6258", "@count": "2536", "@label": "Breast tumor - Subjects with Concurrent Systemic/Medical Illness - Subjects with cardiovascular diseases"}, {"@id": "10881", "@count": "2496", "@label": "Cancer supportive care - Subjects with Concurrent Systemic/Medical Illness"}, {"@id": "5193", "@count": "2483", "@label": "Lung tumor - Subjects with Malignancies other than Lung Cancer"}, {"@id": "5365", "@count": "2413", "@label": "Lung tumor - Protocol Specified Other Exclusion Criteria - Protocol specified exclusion criteria for females"}, {"@id": "5291", "@count": "2239", "@label": "Lung tumor - Subjects with History of/Scheduled for Other Interventions"}, {"@id": "6393", "@count": "2223", "@label": "Breast tumor - Subjects with History of Non-Anticancer Therapy"}, {"@id": "6294", "@count": "2216", "@label": "Breast tumor - Subjects with History of Cancer other than Breast Cancer"}, {"@id": "6272", "@count": "2206", "@label": "Breast tumor - Subjects with Concurrent Systemic/Medical Illness - Subjects with infectious/inflammatory/immunological diseases"}, {"@id": "5125", "@count": "2201", "@label": "Lung tumor - Lung Cancer Subjects with Evidence of Metastasis - Subjects with central nervous system metastases"}, {"@id": "5879", "@count": "2198", "@label": "Colorectal tumor - Subjects with Concurrent Systemic/Medical Illness"}, {"@id": "5270", "@count": "2120", "@label": "Lung tumor - Subjects with History of/Scheduled for Lung Cancer Therapy - Subjects with history of/scheduled for chemotherapy"}, {"@id": "6253", "@count": "2010", "@label": "Breast tumor - Subjects with Concurrent Systemic/Medical Illness - Subjects with central nervous system diseases"}, {"@id": "4918", "@count": "1998", "@label": "Prostate tumor - Subjects with Medical/Systemic Illness"}, {"@id": "5864", "@count": "1931", "@label": "Colorectal tumor - Subjects with cardiovascular diseases/disorders"}, {"@id": "6756", "@count": "1887", "@label": "Lung tumor - Subjects with History of/Scheduled for Other Cancer Therapies"}, {"@id": "4769", "@count": "1880", "@label": "Lymphoma - Subjects with History of Anti Cancer Therapy - Subject with history of chemotherapy"}, {"@id": "5282", "@count": "1876", "@label": "Lung tumor - Subjects with History of/Scheduled for Lung Cancer Therapy - Subjects with history of/scheduled for radiation therapy of lung cancer"}, {"@id": "5128", "@count": "1847", "@label": "Lung tumor - Subjects with Concurrent Systemic/Medical Illness - Subjects with central nervous system diseases/disorders"}, {"@id": "6247", "@count": "1806", "@label": "Breast tumor - Metastatic/TNM Stage IV Breast Cancer - Subjects with Brain/Leptomeningeal metastases"}, {"@id": "6377", "@count": "1797", "@label": "Breast tumor - Subjects with history of/planned radiotherapy"}, {"@id": "5856", "@count": "1768", "@label": "Colorectal tumor - Subjects with infectious/inflammatory/immunological diseases/disorders"}, {"@id": "5139", "@count": "1736", "@label": "Lung tumor - Subjects with Concurrent Systemic/Medical Illness - Subjects with pulmonary diseases/disorders"}, {"@id": "5349", "@count": "1729", "@label": "Lung tumor - Protocol Specified Other Exclusion Criteria - Subjects unable/unwilling to comply with protocol requirements"}, {"@id": "5962", "@count": "1695", "@label": "Colorectal tumor - Subjects with History of Other Therapies"}, {"@id": "5841", "@count": "1657", "@label": "Colorectal tumor - Subjects with History of /Active Cancers Other than Colorectal Cancer"}, {"@id": "10916", "@count": "1613", "@label": "Cancer supportive care - Subjects with History of Treatment with Non-chemotherapeutic Drugs"}, {"@id": "4692", "@count": "1609", "@label": "Lymphoma - Subjects with Malignancies Other than Lymphoma"}, {"@id": "6065", "@count": "1578", "@label": "Multiple myeloma - Subjects with Concurrent Systemic/Medical Illness"}, {"@id": "5344", "@count": "1453", "@label": "Lung tumor - Protocol Specified Other Exclusion Criteria"}, {"@id": "5826", "@count": "1441", "@label": "Colorectal tumor - Subjects with Metastatic Colorectal Cancer - Subjects with brain metastases or leptomeningeal carcinomatosis"}, {"@id": "4864", "@count": "1437", "@label": "Prostate tumor - Subjects with Medical/Systemic Illness - Subjects with Cardiovascular Diseases/Disorders"}, {"@id": "15723", "@count": "1432", "@label": "Stem cell transplantation - Subjects with Other Co-morbid Conditions - Subjects with history of infections"}, {"@id": "5744", "@count": "1416", "@label": "Head and neck tumor - Subjects with Concurrent Systemic/Medical Illness"}, {"@id": "6534", "@count": "1380", "@label": "Leukemia - Subjects with Malignancies Other Than Leukemia"}, {"@id": "10739", "@count": "1372", "@label": "Solid tumor - Subjects with History of Other Non Anti-cancer Drugs/Agents"}, {"@id": "5345", "@count": "1352", "@label": "Lung tumor - Protocol Specified Other Exclusion Criteria - Subjects with history of/concurrent use of investigational agents"}, {"@id": "10732", "@count": "1352", "@label": "Solid tumor - Subjects with History of Anti Cancer Therapy - Subjects with history of chemotherapy"}, {"@id": "5848", "@count": "1339", "@label": "Colorectal tumor - Subjects with gastrointestinal diseases/disorders"}, {"@id": "5269", "@count": "1331", "@label": "Lung tumor - Subjects with History of/Scheduled for Lung Cancer Therapy"}, {"@id": "5236", "@count": "1327", "@label": "Lung tumor - Subjects with Hypersensitivity/Contraindications to Drugs/Excipients"}, {"@id": "5949", "@count": "1325", "@label": "Colorectal tumor - Subjects with history of/scheduled to receive radiation therapy"}, {"@id": "5149", "@count": "1324", "@label": "Lung tumor - Subjects with Concurrent Systemic/Medical Illness - Subjects with gastrointestinal diseases/disorders"}, {"@id": "4975", "@count": "1310", "@label": "Prostate tumor - Subjects on Other Local/Systemic Therapy"}, {"@id": "4762", "@count": "1306", "@label": "Lymphoma - Subjects with History of Anti Cancer Therapy - Subject with history of radiotherapy"}, {"@id": "4909", "@count": "1304", "@label": "Prostate tumor - Subjects with Malignancies Other Than Prostate Cancer"}, {"@id": "20290", "@count": "1285", "@label": "Breast tumor - Subjects with History of/Scheduled for Anti-neoplastic Therapy - Subjects with history of/scheduled for surgery"}, {"@id": "9810", "@count": "1273", "@label": "Ovary tumor - Subjects with Concurrent Systemic/Medical Illness"}, {"@id": "6331", "@count": "1265", "@label": "Breast tumor - Subjects with History of/Scheduled for Anti-neoplastic Therapy - Subjects with history of/scheduled for chemotherapy"}, {"@id": "10761", "@count": "1248", "@label": "Solid tumor - Subjects with Advanced/Metastatic Solid Tumors - Subjects with brain/CNS metastasis"}, {"@id": "4810", "@count": "1244", "@label": "Lymphoma - Subjects with History of Treatment with Non-chemotherapeutic Drugs"}, {"@id": "10736", "@count": "1227", "@label": "Solid tumor - Subjects with History of Anti Cancer Therapy - Subjects with history of radiotherapy"}, {"@id": "4967", "@count": "1225", "@label": "Prostate tumor - Subjects on Prior/Concurrent Prostate Cancer Therapy - Subjects on prior/concurrent chemotherapy"}, {"@id": "4968", "@count": "1222", "@label": "Prostate tumor - Subjects on Prior/Concurrent Prostate Cancer Therapy - Subjects on prior/concurrent radiotherapy"}, {"@id": "10900", "@count": "1222", "@label": "Cancer supportive care - Subjects with Hypersensitivity/Contraindication to any Therapy"}, {"@id": "9412", "@count": "1220", "@label": "Hepatobiliary system tumor - Subjects with Concurrent Systemic/Medical Illness"}, {"@id": "10378", "@count": "1220", "@label": "Pancreas tumor - Subjects with Concurrent Systemic/Medical Illness"}, {"@id": "5934", "@count": "1201", "@label": "Colorectal tumor - Subjects with History of/Scheduled to Receive Colorectal Cancer Therapy - Subjects with history of/scheduled to receive chemotherapy"}, {"@id": "4783", "@count": "1164", "@label": "Lymphoma - Subjects with History of Anti Cancer Therapy - Subject with history of treatment with any investigational agent"}, {"@id": "20284", "@count": "1153", "@label": "Colorectal tumor - Subjects with History of/Scheduled to Receive Colorectal Cancer Therapy - Subjects with history of/scheduled to receive intervention/surgery"}, {"@id": "6660", "@count": "1141", "@label": "Leukemia - Subjects with History of Treatment with Non-chemotherapeutic Drugs"}, {"@id": "10738", "@count": "1137", "@label": "Solid tumor - Subjects with History of Anti Cancer Therapy - Patient with history of treatment with any investigational agent"}, {"@id": "6618", "@count": "1111", "@label": "Leukemia - Subjects with History of Anti Cancer Therapy - Subjects with history of chemotherapy"}, {"@id": "6302", "@count": "1107", "@label": "Breast tumor - Subjects with Contraindications to Drugs/Excipients - Subjects contraindicated to investigational agents"}, {"@id": "9161", "@count": "1105", "@label": "Myelodysplastic syndrome - Subjects with Concurrent Systemic/Medical Illness"}, {"@id": "5470", "@count": "1102", "@label": "Melanoma - Subjects with Concurrent Systemic/Medical Illness - Subjects with infectious/inflammatory/immunological diseases/disorders"}, {"@id": "20289", "@count": "1092", "@label": "Breast tumor - Subjects with History of/Scheduled for Anti-neoplastic Therapy - Subjects with history of biologic therapy"}, {"@id": "5954", "@count": "1080", "@label": "Colorectal tumor - Subjects with History of/Scheduled for Intervention/Surgery"}, {"@id": "6301", "@count": "1075", "@label": "Breast tumor - Subjects with Contraindications to Drugs/Excipients"}, {"@id": "10641", "@count": "1074", "@label": "Central nervous system tumor - Subjects with Concurrent Systemic/Medical Illness"}, {"@id": "4947", "@count": "1048", "@label": "Prostate tumor - Subjects with Hypersensitivity/Contraindication to any Therapy"}, {"@id": "9484", "@count": "1033", "@label": "Stomach tumor - Subjects with Concurrent Systemic/Medical Illness"}, {"@id": "5547", "@count": "1030", "@label": "Melanoma - Subjects with History of/Scheduled for Other Treatments"}, {"@id": "6260", "@count": "1024", "@label": "Breast tumor - Subjects with Concurrent Systemic/Medical Illness - Subjects with gastrointestinal diseases"}, {"@id": "6767", "@count": "1012", "@label": "Lymphoma - Lymphoma Subjects with Advanced Disease - Subjects with central nervous system involvement"}, {"@id": "6261", "@count": "1012", "@label": "Breast tumor - Subjects with Concurrent Systemic/Medical Illness - Subjects with hepato-biliary diseases"}, {"@id": "5751", "@count": "1011", "@label": "Head and neck tumor - Subjects with Malignancy Other than Head and Neck Cancer"}, {"@id": "5163", "@count": "995", "@label": "Lung tumor - Subjects with Concurrent Systemic/Medical Illness - Subjects with hepatobiliary diseases/disorders"}, {"@id": "5277", "@count": "980", "@label": "Lung tumor - Subjects with History of/Scheduled for Lung Cancer Therapy - Subjects with history of/scheduled for biological therapy"}, {"@id": "4847", "@count": "971", "@label": "Prostate tumor - Subjects with Advanced/Metastatic Prostate Cancer - Subjects with brain metastasis"}, {"@id": "5860", "@count": "962", "@label": "Colorectal tumor - Subjects with central nervous system diseases/disorders"}, {"@id": "4777", "@count": "957", "@label": "Lymphoma - Subjects with History of Anti Cancer Therapy - Subject with history of biologics therapy"}, {"@id": "10909", "@count": "932", "@label": "Cancer supportive care - Subjects with History of Anti Cancer Therapy - Subjects with history of chemotherapy"}, {"@id": "5430", "@count": "925", "@label": "Melanoma - Subjects with Concurrent Systemic/Medical Illness - Subjects with cardiovascular diseases/disorders"}, {"@id": "6246", "@count": "891", "@label": "Breast tumor - Metastatic/TNM Stage IV Breast Cancer"}, {"@id": "20280", "@count": "876", "@label": "Melanoma - Subjects with Concurrent Systemic/Medical Illness"}, {"@id": "5285", "@count": "875", "@label": "Lung tumor - Subjects with History of/Scheduled for Lung Cancer Therapy - Subjects with history of/scheduled for surgery"}, {"@id": "5779", "@count": "867", "@label": "Head and neck tumor - Subjects with History of Anti Cancer Therapy - Subjects with history of chemotherapy"}, {"@id": "5176", "@count": "865", "@label": "Lung tumor - Subjects with Concurrent Systemic/Medical Illness - Subjects with hematological diseases/disorders"}, {"@id": "10737", "@count": "862", "@label": "Solid tumor - Subjects with History of Anti Cancer Therapy - Patient with history of surgical interventions/procedure"}, {"@id": "9555", "@count": "860", "@label": "Glioblastoma - Subjects with Concurrent Systemic/Medical Illness"}, {"@id": "5168", "@count": "853", "@label": "Lung tumor - Subjects with Concurrent Systemic/Medical Illness - Subjects with endocrine/metabolic diseases/disorders"}, {"@id": "10311", "@count": "853", "@label": "Myeloproliferative disorder - Subjects with Concurrent Systemic/Medical Illness - Subjects with infectious/inflammatory/immunological diseases/disorders"}]}, {"@total": "100", "@label": "Trial Indications Adverse", "@name": "trialIndicationsAdverse", "FilterOption": [{"@id": "829", "@count": "4563", "@label": "Fatigue"}, {"@id": "1991", "@count": "4514", "@label": "Neutropenia"}, {"@id": "226", "@count": "4432", "@label": "Nausea"}, {"@id": "102", "@count": "4248", "@label": "Diarrhea"}, {"@id": "324", "@count": "3108", "@label": "Thrombocytopenia"}, {"@id": "110", "@count": "3014", "@label": "Emesis"}, {"@id": "17", "@count": "2708", "@label": "Anemia"}, {"@id": "3020", "@count": "1819", "@label": "Skin rash"}, {"@id": "3038", "@count": "1788", "@label": "Appetite loss"}, {"@id": "680", "@count": "1564", "@label": "Leukopenia"}, {"@id": "148", "@count": "1552", "@label": "Headache"}, {"@id": "1833", "@count": "1547", "@label": "Fever"}, {"@id": "404", "@count": "1137", "@label": "Constipation"}, {"@id": "20", "@count": "1035", "@label": "Pain"}, {"@id": "746", "@count": "1030", "@label": "Infectious disease"}, {"@id": "3062", "@count": "980", "@label": "Death"}, {"@id": "178", "@count": "959", "@label": "Hypertension"}, {"@id": "2400", "@count": "886", "@label": "Dyspnea"}, {"@id": "13", "@count": "793", "@label": "Alopecia"}, {"@id": "1263", "@count": "747", "@label": "Mucositis"}, {"@id": "360", "@count": "742", "@label": "Pneumonia"}, {"@id": "1016", "@count": "723", "@label": "Stomatitis"}, {"@id": "3795", "@count": "708", "@label": "Febrile neutropenia"}, {"@id": "402", "@count": "638", "@label": "Edema"}, {"@id": "678", "@count": "608", "@label": "Neuropathy"}, {"@id": "2439", "@count": "574", "@label": "Arthralgia"}, {"@id": "1039", "@count": "545", "@label": "Myalgia"}, {"@id": "1992", "@count": "543", "@label": "Lymphocytopenia"}, {"@id": "1821", "@count": "488", "@label": "Hyperglycemia"}, {"@id": "279", "@count": "464", "@label": "Pruritus"}, {"@id": "3472", "@count": "447", "@label": "Abdominal pain"}, {"@id": "82", "@count": "441", "@label": "Cough"}, {"@id": "259", "@count": "432", "@label": "Peripheral neuropathy"}, {"@id": "552", "@count": "411", "@label": "Bleeding"}, {"@id": "129", "@count": "410", "@label": "Gastrointestinal disease"}, {"@id": "181", "@count": "371", "@label": "Hypokalemia"}, {"@id": "408", "@count": "355", "@label": "Hypotension"}, {"@id": "3050", "@count": "351", "@label": "Chill"}, {"@id": "3221", "@count": "341", "@label": "Back pain"}, {"@id": "2274", "@count": "341", "@label": "Rhinopharyngitis"}, {"@id": "516", "@count": "341", "@label": "Upper respiratory tract infection"}, {"@id": "1256", "@count": "320", "@label": "Hyponatremia"}, {"@id": "114", "@count": "311", "@label": "Sepsis"}, {"@id": "2434", "@count": "281", "@label": "Vertigo"}, {"@id": "3454", "@count": "277", "@label": "Dizziness"}, {"@id": "277", "@count": "276", "@label": "Proteinuria"}, {"@id": "1280", "@count": "270", "@label": "Hypophosphatemia"}, {"@id": "1078", "@count": "263", "@label": "Lung embolism"}, {"@id": "201", "@count": "236", "@label": "Liver disease"}, {"@id": "750", "@count": "232", "@label": "Insomnia"}, {"@id": "2955", "@count": "230", "@label": "Weight loss"}, {"@id": "2024", "@count": "222", "@label": "Erythema"}, {"@id": "172", "@count": "221", "@label": "Hyperbilirubinemia"}, {"@id": "432", "@count": "221", "@label": "Dyspepsia"}, {"@id": "1009", "@count": "217", "@label": "Urinary tract infection"}, {"@id": "574", "@count": "201", "@label": "Deep vein thrombosis"}, {"@id": "95", "@count": "199", "@label": "Dermatological disease"}, {"@id": "69", "@count": "192", "@label": "Renal failure"}, {"@id": "505", "@count": "188", "@label": "Hypersensitivity"}, {"@id": "1076", "@count": "187", "@label": "Thrombosis"}, {"@id": "3073", "@count": "182", "@label": "Drowsiness"}, {"@id": "668", "@count": "182", "@label": "Muscle weakness"}, {"@id": "94", "@count": "172", "@label": "Dermatitis"}, {"@id": "2529", "@count": "169", "@label": "Hot flashes"}, {"@id": "735", "@count": "166", "@label": "Toxicity"}, {"@id": "325", "@count": "165", "@label": "Thromboembolism"}, {"@id": "142", "@count": "164", "@label": "Hematological disease"}, {"@id": "224", "@count": "162", "@label": "Myocardial infarction"}, {"@id": "2576", "@count": "154", "@label": "Dysgeusia"}, {"@id": "1063", "@count": "154", "@label": "Xerostomia"}, {"@id": "1835", "@count": "150", "@label": "Epistaxis"}, {"@id": "2184", "@count": "147", "@label": "Gastrointestinal bleeding"}, {"@id": "1987", "@count": "143", "@label": "Granulocytopenia"}, {"@id": "188", "@count": "139", "@label": "Inflammatory disease"}, {"@id": "810", "@count": "134", "@label": "Esophagitis"}, {"@id": "3826", "@count": "134", "@label": "Bone marrow depression"}, {"@id": "12", "@count": "133", "@label": "Allergy"}, {"@id": "2854", "@count": "127", "@label": "Ostealgia"}, {"@id": "1876", "@count": "124", "@label": "Syncope"}, {"@id": "191", "@count": "118", "@label": "Influenza virus infection"}, {"@id": "445", "@count": "118", "@label": "Hypoglycemia"}, {"@id": "2733", "@count": "116", "@label": "Hypomagnesemia"}, {"@id": "2469", "@count": "115", "@label": "Paresthesia"}, {"@id": "444", "@count": "114", "@label": "Hypocalcemia"}, {"@id": "1089", "@count": "111", "@label": "Neurotoxicity drug-induced"}, {"@id": "1053", "@count": "106", "@label": "Hypoxia"}, {"@id": "2085", "@count": "105", "@label": "Dysphagia"}, {"@id": "93", "@count": "102", "@label": "Depression"}, {"@id": "50", "@count": "102", "@label": "Bronchitis"}, {"@id": "250", "@count": "101", "@label": "Pancreatitis"}, {"@id": "1542", "@count": "99", "@label": "Atrial fibrillation"}, {"@id": "2291", "@count": "98", "@label": "Hematuria"}, {"@id": "3098", "@count": "94", "@label": "Hypoalbuminemia"}, {"@id": "3", "@count": "93", "@label": "Acne"}, {"@id": "1061", "@count": "91", "@label": "Sinusitis"}, {"@id": "555", "@count": "90", "@label": "Bone marrow disease"}, {"@id": "2525", "@count": "88", "@label": "Cellulitis"}, {"@id": "25", "@count": "86", "@label": "Anxiety disorder"}, {"@id": "286", "@count": "85", "@label": "Renal disease"}, {"@id": "2236", "@count": "85", "@label": "Hypertriglyceridemia"}]}, {"@total": "100", "@label": "Patient Segment Index", "@name": "trialPatientSegmentIndex", "FilterOption": [{"@id": "3617", "@count": "3174", "@label": "Lung tumor - Subjects with Non Small Cell Lung Cancer (NSCLC)"}, {"@id": "3634", "@count": "2894", "@label": "Lung tumor - Subjects with Advanced Stage Lung Cancer - Subjects with metastatic/stage IV lung cancer"}, {"@id": "3623", "@count": "2793", "@label": "Lung tumor - Subjects with Advanced Stage Lung Cancer"}, {"@id": "3954", "@count": "2705", "@label": "Breast tumor - Subjects with Advanced/Metastatic Breast Cancer/Stage IV Breast Cancer"}, {"@id": "7961", "@count": "2462", "@label": "Solid tumor - Subjects with Advanced/Metastatic Solid Tumors"}, {"@id": "3824", "@count": "2266", "@label": "Colorectal tumor - Subjects with TNM stage IV/Metastatic/Advanced Colorectal Cancer"}, {"@id": "7967", "@count": "2149", "@label": "Solid tumor - Subjects with Refractory Solid Tumors"}, {"@id": "10295", "@count": "2146", "@label": "Lung tumor - Subjects with Advanced Stage Lung Cancer - Subjects with locally advanced/stage III lung cancer"}, {"@id": "3489", "@count": "2137", "@label": "Lymphoma - Subjects with B Cell Non Hodgkin's Lymphoma"}, {"@id": "3975", "@count": "1722", "@label": "Leukemia - Subjects with Acute Leukemia Unspecified Type"}, {"@id": "9010", "@count": "1674", "@label": "Cancer supportive care - Others - Solid Tumor Subjects for Supportive Care"}, {"@id": "3977", "@count": "1640", "@label": "Leukemia - Subjects with Acute Myeloid Leukemia (AML)"}, {"@id": "3564", "@count": "1612", "@label": "Prostate tumor - Subjects with Advanced/Metastatic Prostate Cancer"}, {"@id": "3565", "@count": "1607", "@label": "Prostate tumor - Subjects with Stage IV Prostate Cancer"}, {"@id": "3530", "@count": "1569", "@label": "Lymphoma - Subjects with Progressive/Treatment Refractory Lymphoma"}, {"@id": "11487", "@count": "1535", "@label": "Stem cell transplantation - Subjects with H/O Hematological Malignancies Indicated for SCT"}, {"@id": "3490", "@count": "1514", "@label": "Lymphoma - Subjects with T Cell Non Hodgkin's Lymphoma"}, {"@id": "3525", "@count": "1448", "@label": "Lymphoma - Subjects with Relapse/Recurrent Lymphoma"}, {"@id": "3952", "@count": "1441", "@label": "Breast tumor - Subjects with Locally Advanced Breast Cancer"}, {"@id": "3502", "@count": "1318", "@label": "Lymphoma - Subjects with Aggressive (high grade) Lymphoma"}, {"@id": "3976", "@count": "1301", "@label": "Leukemia - Subjects with Chronic Leukemia Unspecified Type"}, {"@id": "3667", "@count": "1294", "@label": "Melanoma - Subjects with Advanced Melanoma"}, {"@id": "3965", "@count": "1259", "@label": "Breast tumor - Subjects with Treatment Refractory Breast Cancer"}, {"@id": "12053", "@count": "1233", "@label": "Lung tumor - Treatment Naive Subjects"}, {"@id": "3500", "@count": "1233", "@label": "Lymphoma - Subjects with Indolent (slow-growing, low grade) Lymphoma"}, {"@id": "10714", "@count": "1178", "@label": "Stem cell transplantation - Subjects with History of/Indicated for Hematopoietic Stem Cell Transplantation(HSCT)"}, {"@id": "3586", "@count": "1131", "@label": "Prostate tumor - Treatment Refractory Prostate Cancer Subjects"}, {"@id": "4003", "@count": "1121", "@label": "Leukemia - Subjects with Relapsed/Recurrent Leukemia"}, {"@id": "9624", "@count": "1097", "@label": "Central nervous system tumor - Subjects with Brain Tumors"}, {"@id": "3950", "@count": "1066", "@label": "Breast tumor - Subjects with Early Stage Breast Cancer"}, {"@id": "3650", "@count": "1063", "@label": "Lung tumor - Subjects with Recurrent/Relapsed Lung Cancer"}, {"@id": "3680", "@count": "1061", "@label": "Melanoma - Subjects with Stage IV Melanoma"}, {"@id": "8754", "@count": "1060", "@label": "Myeloproliferative disorder - Subjects with Chronic Myelogenous Leukemia"}, {"@id": "10713", "@count": "1053", "@label": "Stem cell transplantation - Subjects with History of/Indicated for Allogenic Stem Cell Transplantation(SCT)"}, {"@id": "3979", "@count": "1051", "@label": "Leukemia - Subjects with Acute Lymphocytic Leukemia (ALL)"}, {"@id": "3681", "@count": "1001", "@label": "Melanoma - Subjects with Evidence of Metastasis"}, {"@id": "3980", "@count": "979", "@label": "Leukemia - Subjects with Chronic Lymphocytic Leukemia (CLL)"}, {"@id": "3944", "@count": "973", "@label": "Breast tumor - Subjects with Stage II Breast Cancer"}, {"@id": "3999", "@count": "971", "@label": "Leukemia - Treatment Refractory/Resistant Leukemia Subjects"}, {"@id": "3978", "@count": "971", "@label": "Leukemia - Subjects with Chronic Myeloid Leukemia (CML)"}, {"@id": "12018", "@count": "963", "@label": "Prostate tumor - Subjects with adenocarcinoma of prostate"}, {"@id": "3501", "@count": "951", "@label": "Lymphoma - Subjects with Moderately Aggressive (intermediate grade) Lymphoma"}, {"@id": "3936", "@count": "907", "@label": "Breast tumor - Subjects with HER-2 Positive Breast Cancer"}, {"@id": "7411", "@count": "906", "@label": "Renal cell carcinoma - Subjects with TNM Stage IV Renal Cell Carcinoma"}, {"@id": "8073", "@count": "899", "@label": "Pancreas tumor - Subjects with Advanced/Metastatic Pancreatic Cancer"}, {"@id": "7415", "@count": "873", "@label": "Renal cell carcinoma - Subjects with Metastatic Renal Cell Carcinoma"}, {"@id": "3945", "@count": "871", "@label": "Breast tumor - Subjects with Stage III Breast Cancer"}, {"@id": "10712", "@count": "861", "@label": "Stem cell transplantation - Subjects with History of/Indicated for Autologous Stem Cell Transplantation(SCT)"}, {"@id": "3860", "@count": "861", "@label": "Colorectal tumor - Subjects Progressive/Refractory Colorectal Cancer"}, {"@id": "3583", "@count": "855", "@label": "Prostate tumor - Subjects with Castrate Resistant Prostate Cancer"}, {"@id": "3467", "@count": "854", "@label": "Lymphoma - Subjects with Hodgkin's Lymphoma"}, {"@id": "3778", "@count": "851", "@label": "Head and neck tumor - Subjects with Specific Histological Sub-type of HNC - Subjects with squamous cell carcinoma"}, {"@id": "9632", "@count": "835", "@label": "Central nervous system tumor - Subjects with Gliomas"}, {"@id": "3647", "@count": "784", "@label": "Lung tumor - Treatment Resistant/Refractory Lung Cancer Subjects"}, {"@id": "3774", "@count": "782", "@label": "Head and neck tumor - Subjects with Advanced/Metastatic Head and Neck Cancer"}, {"@id": "3931", "@count": "775", "@label": "Breast tumor - Subjects with Hormone Receptor Positive Breast Cancer - Estrogen receptor positive (ER+) breast cancer"}, {"@id": "3813", "@count": "773", "@label": "Colorectal tumor - Subjects with Rectal Cancer"}, {"@id": "8426", "@count": "764", "@label": "Pain - Subjects with Cancer Related Pain"}, {"@id": "3775", "@count": "757", "@label": "Head and neck tumor - Subjects with Locally Advanced Head and Neck Cancer"}, {"@id": "3966", "@count": "754", "@label": "Breast tumor - Subjects with Relapsed/Recurrent Breast cancer"}, {"@id": "3973", "@count": "736", "@label": "Leukemia - Subjects at Risk of Developing Leukemia"}, {"@id": "7879", "@count": "727", "@label": "Ovary tumor - Subjects with Ovarian Epithelial Tumor"}, {"@id": "3923", "@count": "727", "@label": "Multiple myeloma - Subjects with Progressive/Treatment Refractory Multiple Myeloma"}, {"@id": "7877", "@count": "719", "@label": "Lung tumor - Subjects with Non Small Cell Lung Cancer (NSCLC) - Subjects with non-squamous cell lung cancer"}, {"@id": "3637", "@count": "718", "@label": "Lung tumor - Subjects with Unresectable/In-operable Lung Cancer"}, {"@id": "3498", "@count": "717", "@label": "Lymphoma - Subjects with Ann Arbor Stage IV Lymphoma"}, {"@id": "3814", "@count": "717", "@label": "Colorectal tumor - Subjects with Colon Cancer"}, {"@id": "3937", "@count": "709", "@label": "Breast tumor - Subjects with HER-2 Negative Breast Cancer"}, {"@id": "8010", "@count": "690", "@label": "Stomach tumor - Subjects with Advanced/Metastatic Gastric Cancer"}, {"@id": "10289", "@count": "687", "@label": "Head and neck tumor - Subjects with TNM Stage III Head and Neck Cancer"}, {"@id": "7895", "@count": "673", "@label": "Ovary tumor - Platinum-Resistant/Refractory Ovarian Cancer Subjects"}, {"@id": "3926", "@count": "670", "@label": "Multiple myeloma - Subjects with Relapsed/Recurrent Multiple Myeloma"}, {"@id": "11612", "@count": "661", "@label": "Menopause - Menopausal Subjects - Postmenopausal Subjects"}, {"@id": "3473", "@count": "643", "@label": "Lymphoma - Subjects with B Cell Non Hodgkin's Lymphoma - Subjects with follicular lymphoma"}, {"@id": "3472", "@count": "643", "@label": "Lymphoma - Subjects with B Cell Non Hodgkin's Lymphoma - Subjects with diffuse large B cell lymphoma"}, {"@id": "11424", "@count": "628", "@label": "Pancreas tumor - Subjects with Adenocarcinoma of Pancreas"}, {"@id": "7988", "@count": "611", "@label": "Glioblastoma - Subjects with Relapse/Recurrent Glioblastoma Multiforme"}, {"@id": "3943", "@count": "610", "@label": "Breast tumor - Subjects with Stage I Breast Cancer"}, {"@id": "3497", "@count": "601", "@label": "Lymphoma - Subjects with Ann Arbor Stage III Lymphoma"}, {"@id": "7894", "@count": "599", "@label": "Ovary tumor - Subjects with Recurrent or Persistent Ovarian Cancer"}, {"@id": "8062", "@count": "564", "@label": "Hepatobiliary system tumor - Subjects with Unresectable Hepato-biliary Cancer"}, {"@id": "3559", "@count": "555", "@label": "Prostate tumor - Subjects with Early Stage/Localized Prostate Cancer"}, {"@id": "3799", "@count": "553", "@label": "Head and neck tumor - Subjects with Progressive/Treatment Refractory Head and Neck Cancer"}, {"@id": "9670", "@count": "552", "@label": "Central nervous system tumor - Subjects with High Grade CNS Tumors"}, {"@id": "8977", "@count": "550", "@label": "Cancer supportive care - Cancer/Treatment-related Pain"}, {"@id": "3560", "@count": "549", "@label": "Prostate tumor - Subjects with Stage I Prostate Cancer"}, {"@id": "7414", "@count": "546", "@label": "Renal cell carcinoma - Advanced Stage Renal Cell Carcinoma"}, {"@id": "9674", "@count": "544", "@label": "Central nervous system tumor - Subjects with Recurrent/Relapsed CNS Tumor"}, {"@id": "9672", "@count": "539", "@label": "Central nervous system tumor - Subjects with High Grade CNS Tumors - Subjects with WHO grade IV CNS tumors"}, {"@id": "8953", "@count": "536", "@label": "Soft tissue sarcoma - Subjects with Advanced/Metastatic Soft Tissue Sarcoma"}, {"@id": "9008", "@count": "534", "@label": "Cancer supportive care - Others - Subjects with General cancers"}, {"@id": "3496", "@count": "531", "@label": "Lymphoma - Subjects with Ann Arbor Stage II Lymphoma"}, {"@id": "8075", "@count": "529", "@label": "Pancreas tumor - Subjects with Unresectable Pancreatic Cancer"}, {"@id": "7918", "@count": "527", "@label": "Ovary tumor - Advanced Ovarian Cancer Subjects - Stage IV or metastatic ovarian cancer subjects"}, {"@id": "8998", "@count": "524", "@label": "Cancer supportive care - Other Chemotherapy Induced Adverse Events"}, {"@id": "7966", "@count": "523", "@label": "Solid tumor - Subjects with Relapsed/Recurrent Solid Tumors"}, {"@id": "3932", "@count": "522", "@label": "Breast tumor - Subjects with Hormone Receptor Positive Breast Cancer - Progesterone receptor positive (PR+) breast cancer"}, {"@id": "3569", "@count": "519", "@label": "Prostate tumor - Subjects with Progressive Prostate Cancer"}, {"@id": "9009", "@count": "515", "@label": "Cancer supportive care - Others - Hematological Cancer Subjects for Supportive Care"}, {"@id": "3823", "@count": "512", "@label": "Colorectal tumor - Subjects with TNM stage III/Dukes C Colorectal Cancer"}]}, {"@total": "100", "@label": "Endpoint Index", "@name": "trialEndpointIndex", "FilterOption": [{"@id": "8639", "@count": "3007", "@label": "Lung tumor - Safety/Toxicity and Tolerability Assessment"}, {"@id": "15312", "@count": "2201", "@label": "Solid tumor - Pharmacodynamics/Pharmacokinetics"}, {"@id": "8481", "@count": "2150", "@label": "Lung tumor - Assessment of Global/Overall Survival(OS)"}, {"@id": "7679", "@count": "1947", "@label": "Lymphoma - Assessment of Safety and Tolerability"}, {"@id": "15285", "@count": "1938", "@label": "Solid tumor - Assessment of Safety and Tolerability"}, {"@id": "8077", "@count": "1922", "@label": "Leukemia - Assessment of Safety and Tolerability"}, {"@id": "8489", "@count": "1807", "@label": "Lung tumor - Assessment of Progression Free Survival (PFS)"}, {"@id": "8996", "@count": "1717", "@label": "Breast tumor - Assessment of Safety/Tolerability"}, {"@id": "7879", "@count": "1516", "@label": "Leukemia - Assessment of Overall Survival (OS)"}, {"@id": "8712", "@count": "1478", "@label": "Breast tumor - Assessment of Overall Survival (OS)"}, {"@id": "8998", "@count": "1413", "@label": "Breast tumor - Assessment of Safety/Tolerability - Assessment of adverse events"}, {"@id": "9122", "@count": "1387", "@label": "Breast tumor - Others - Pharmacokinetic/pharmacodynamic Assessment"}, {"@id": "7538", "@count": "1367", "@label": "Lymphoma - Assessment of Overall Survival (OS)"}, {"@id": "8508", "@count": "1357", "@label": "Lung tumor - Assessment of Overall Response"}, {"@id": "8078", "@count": "1352", "@label": "Leukemia - Assessment of Safety and Tolerability - Assessment of adverse events/side effects"}, {"@id": "19282", "@count": "1334", "@label": "Cancer supportive care - Assessment of Patient Related Outcomes (PROs)/Quality of life"}, {"@id": "7189", "@count": "1327", "@label": "Prostate tumor - Assessment of Safety and Tolerability"}, {"@id": "19412", "@count": "1319", "@label": "Cancer supportive care - Assessment of Other Endpoints - Assessment of Other Treatment or Procedure Related Outcomes"}, {"@id": "8663", "@count": "1319", "@label": "Lung tumor - Assessment of Pharmacokinetic/ Pharmacodynamic Parameters"}, {"@id": "8430", "@count": "1286", "@label": "Colorectal tumor - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events(SAE)"}, {"@id": "19374", "@count": "1188", "@label": "Cancer supportive care - Assessment of Safety and Tolerability"}, {"@id": "8140", "@count": "1154", "@label": "Leukemia - Other Endpoints - Assessment of Clinical Efficacy"}, {"@id": "8719", "@count": "1137", "@label": "Breast tumor - Assessment of Response Rate (RR) - Assessment of Overall/Objective Response Rate (ORR)"}, {"@id": "8151", "@count": "1132", "@label": "Colorectal tumor - Assessment of Overall Survival (OS)"}, {"@id": "8429", "@count": "1125", "@label": "Colorectal tumor - Assessment of Safety and Tolerability"}, {"@id": "7906", "@count": "1106", "@label": "Leukemia - Assessment of Response Rate (RR)"}, {"@id": "7547", "@count": "1097", "@label": "Lymphoma - Assessment of Progression Free Survival (PFS)"}, {"@id": "8451", "@count": "1084", "@label": "Colorectal tumor - Assessment of Protocol Specified Other End Points - Pharmacokinetic/pharmacodynamic Assessments"}, {"@id": "7908", "@count": "1065", "@label": "Leukemia - Assessment of Response Rate (RR) - Assessment of complete response (CR)"}, {"@id": "7680", "@count": "1051", "@label": "Lymphoma - Assessment of Safety and Tolerability - Assessment of adverse events"}, {"@id": "15287", "@count": "1048", "@label": "Solid tumor - Assessment of Safety and Tolerability - Assessment of adverse events"}, {"@id": "7563", "@count": "1034", "@label": "Lymphoma - Assessment of Response Rate (RR) - Assessment of complete response (CR)"}, {"@id": "8187", "@count": "1017", "@label": "Colorectal tumor - Assessment of Response Rate (RR) - Assessment of Objective/Overall Response Rate (ORR)"}, {"@id": "7981", "@count": "999", "@label": "Leukemia - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"}, {"@id": "8713", "@count": "987", "@label": "Breast tumor - Assessment of Progression Free Survival (PFS)"}, {"@id": "8163", "@count": "967", "@label": "Colorectal tumor - Assessment of Progression Free Survival (PFS)"}, {"@id": "7868", "@count": "955", "@label": "Lymphoma - Other Endpoints - Assessment of Efficacy"}, {"@id": "15293", "@count": "923", "@label": "Solid tumor - Assessment of Safety and Tolerability - Assessment of dose limiting toxicity"}, {"@id": "8726", "@count": "876", "@label": "Breast tumor - Assessment of Response Rate (RR)"}, {"@id": "10900", "@count": "871", "@label": "Ovary tumor - Assessment of Safety and Tolerability"}, {"@id": "7217", "@count": "863", "@label": "Prostate tumor - Pharmacokinetic/Pharmacodynamic Assessments"}, {"@id": "8640", "@count": "850", "@label": "Lung tumor - Safety/Toxicity and Tolerability Assessment - Adverse events as graded by CTCAE/CTC"}, {"@id": "9152", "@count": "842", "@label": "Lung tumor - Assessment of Other/Unspecified Efficacy Parameters"}, {"@id": "7611", "@count": "829", "@label": "Lymphoma - Assessment of Response Rate (RR) - Assessment of tumor response rate (Duration of response)"}, {"@id": "13344", "@count": "798", "@label": "Pancreas tumor - Assessment of Overall Survival (OS)"}, {"@id": "7564", "@count": "795", "@label": "Lymphoma - Assessment of Response Rate (RR) - Assessment of partial response (PR)"}, {"@id": "8670", "@count": "781", "@label": "Lung tumor - Assessment of Pharmacokinetic/ Pharmacodynamic Parameters - Assessment of maximum tolerated dose (MTD)"}, {"@id": "12048", "@count": "772", "@label": "Hepatobiliary system tumor - Assessment of Overall Survival (OS)"}, {"@id": "8505", "@count": "763", "@label": "Lung tumor - Assessment of Objective Response - Assessment of objective response rate(ORR)"}, {"@id": "17405", "@count": "758", "@label": "Stem cell transplantation - Assessment of Overall Survival(OS)"}, {"@id": "1", "@count": "757", "@label": "Hypertension - Assessment of Blood Pressure (BP)"}, {"@id": "7775", "@count": "740", "@label": "Lymphoma - Pharmacokinetic and Pharmacodynamic Assessments"}, {"@id": "7569", "@count": "722", "@label": "Lymphoma - Assessment of Response Rate (RR) - Assessment of Overall/Objective Response Rate (ORR)"}, {"@id": "9012", "@count": "716", "@label": "Breast tumor - Assessment of Safety/Tolerability - Assessment of treatment induced toxicity"}, {"@id": "9147", "@count": "712", "@label": "Colorectal tumor - Assessment of Safety and Tolerability - Assessment of toxicities"}, {"@id": "13433", "@count": "711", "@label": "Pancreas tumor - Assessment of Safety and Tolerability"}, {"@id": "7987", "@count": "709", "@label": "Leukemia - Assessment of Pharmacokinetic/Pharmacodynamic Parameters - Assessment of maximum tolerated dose (MTD)"}, {"@id": "10650", "@count": "705", "@label": "Renal cell carcinoma - Assessment of Safety and Tolerability/Toxicity"}, {"@id": "7190", "@count": "704", "@label": "Prostate tumor - Assessment of Safety and Tolerability - Assessment of adverse event/serious adverse events"}, {"@id": "8513", "@count": "697", "@label": "Lung tumor - Assessment of Partial Response (PR)"}, {"@id": "6940", "@count": "691", "@label": "Melanoma - Assessment of Response Rate (RR) - Assessment of overall/objective response rate"}, {"@id": "9133", "@count": "690", "@label": "Lymphoma - Pharmacokinetic and Pharmacodynamic Assessments - Assessment of maximum tolerated dose"}, {"@id": "7311", "@count": "685", "@label": "Head and neck tumor - Assessment of Safety and Tolerability"}, {"@id": "17462", "@count": "676", "@label": "Stem cell transplantation - Assessment of Safety and Tolerability - Assessment of treatment toxicities"}, {"@id": "8563", "@count": "672", "@label": "Lung tumor - Assessment of Patient Reported Outcomes/Quality of Life"}, {"@id": "7026", "@count": "646", "@label": "Melanoma - Assessment of Safety/Tolerability - Assessment of toxicity profile"}, {"@id": "7025", "@count": "643", "@label": "Melanoma - Assessment of Safety/Tolerability"}, {"@id": "13551", "@count": "642", "@label": "Central nervous system tumor - Assessment of Safety and Tolerability"}, {"@id": "19407", "@count": "631", "@label": "Cancer supportive care - Assessment of Laboratory Measurements"}, {"@id": "2", "@count": "630", "@label": "Hypertension - Assessment of Blood Pressure (BP) - BP control rate"}, {"@id": "7312", "@count": "629", "@label": "Head and neck tumor - Assessment of Safety and Tolerability - Assessment of adverse events"}, {"@id": "8720", "@count": "627", "@label": "Breast tumor - Assessment of Response Rate (RR) - Assessment of Partial Response (PR)"}, {"@id": "7354", "@count": "625", "@label": "Multiple myeloma - Assessment of Overall Survival (OS)"}, {"@id": "7244", "@count": "624", "@label": "Head and neck tumor - Assessment of Overall Survival (OS)"}, {"@id": "8524", "@count": "621", "@label": "Lung tumor - Assessment of Disease Progression - Assessment of time to progression (TTP)"}, {"@id": "7014", "@count": "615", "@label": "Melanoma - Other Routine Lab Assessments - Pharmacokinetic assessments"}, {"@id": "8721", "@count": "614", "@label": "Breast tumor - Assessment of Response Rate (RR) - Assessment of Complete Response (CR)"}, {"@id": "7488", "@count": "613", "@label": "Multiple myeloma - Assessment of Safety and Tolerability"}, {"@id": "10939", "@count": "611", "@label": "Ovary tumor - Others - Pharmacokinetic/Pharmacodynamic Assessments"}, {"@id": "19376", "@count": "599", "@label": "Cancer supportive care - Assessment of Safety and Tolerability - Assessment of adverse events"}, {"@id": "15318", "@count": "599", "@label": "Solid tumor - Other Endpoints - Assessment of Anti-tumor Activity"}, {"@id": "12148", "@count": "592", "@label": "Stomach tumor - Assessment of Overall Survival (OS)"}, {"@id": "8745", "@count": "584", "@label": "Breast tumor - Assessment of Disease Progression - Assessment of Time to Tumor Progression (TTP)"}, {"@id": "8759", "@count": "583", "@label": "Breast tumor - Assessment of Patient Reported Outcome/Quality of Life"}, {"@id": "13208", "@count": "580", "@label": "Glioblastoma - Assessment of Safety and Tolerability"}, {"@id": "7891", "@count": "578", "@label": "Leukemia - Assessment of Progression Free Survival (PFS)"}, {"@id": "7916", "@count": "573", "@label": "Leukemia - Assessment of Response Rate (RR) - Assessment of hematologic/bone marrow response"}, {"@id": "8453", "@count": "570", "@label": "Colorectal tumor - Assessment of Protocol Specified Other End Points - Efficacy/feasibility Assessment"}, {"@id": "8514", "@count": "556", "@label": "Lung tumor - Assessment of Complete Response (CR)"}, {"@id": "7898", "@count": "556", "@label": "Leukemia - Assessment of Disease Free Survival (DFS) - Assessment of event free survival (EFS)"}, {"@id": "7230", "@count": "552", "@label": "Prostate tumor - Other Endpoint Analysis - Assessment of Other Efficacy Outcomes"}, {"@id": "11912", "@count": "548", "@label": "Myelodysplastic syndrome - Assessment of Safety and Tolerability"}, {"@id": "7885", "@count": "546", "@label": "Leukemia - Assessment of Disease Free Survival (DFS)"}, {"@id": "7374", "@count": "535", "@label": "Multiple myeloma - Assessment of Treatment Response"}, {"@id": "7340", "@count": "533", "@label": "Head and neck tumor - Pharmacokinetic and Pharmacodynamic Assessments"}, {"@id": "6919", "@count": "530", "@label": "Melanoma - Assessment of Overall Survival (OS)"}, {"@id": "7573", "@count": "529", "@label": "Lymphoma - Assessment of Response Rate (RR) - Assessment of therapeutic response"}, {"@id": "7489", "@count": "528", "@label": "Multiple myeloma - Assessment of Safety and Tolerability - Assessment of other adverse events"}, {"@id": "8714", "@count": "527", "@label": "Breast tumor - Assessment of Disease Free Survival (DFS)"}, {"@id": "8516", "@count": "522", "@label": "Lung tumor - Assessment of Other Measures of Response - Assessment of stable disease (SD)"}]}, {"@total": "100", "@label": "Trial Actions Secondary Interventions Primary", "@name": "trialActionsSecondaryInterventionsPrimary", "FilterOption": [{"@id": "1545", "@count": "24722", "@label": "Anticancer"}, {"@id": "62255", "@count": "9131", "@label": "Anticancer protein kinase inhibitor"}, {"@id": "2953", "@count": "7923", "@label": "Anti-inflammatory"}, {"@id": "55685", "@count": "7396", "@label": "Anticancer monoclonal antibody"}, {"@id": "140", "@count": "7127", "@label": "DNA synthesis inhibitor"}, {"@id": "1569", "@count": "6623", "@label": "Anticancer antimetabolite"}, {"@id": "50", "@count": "6574", "@label": "Anticancer alkylating agent"}, {"@id": "61", "@count": "6346", "@label": "Angiogenesis inhibitor"}, {"@id": "767", "@count": "4557", "@label": "Cell cycle inhibitor"}, {"@id": "1589", "@count": "4513", "@label": "Apoptosis stimulator"}, {"@id": "991", "@count": "3679", "@label": "Antiviral"}, {"@id": "2575", "@count": "3350", "@label": "Microtubule inhibitor"}, {"@id": "15184", "@count": "3155", "@label": "Systemic antipsoriatic product"}, {"@id": "2576", "@count": "2968", "@label": "Microtubule stabilizer"}, {"@id": "2660", "@count": "2786", "@label": "Vasoprotectant"}, {"@id": "396", "@count": "2048", "@label": "Immunosuppressant"}, {"@id": "1596", "@count": "1757", "@label": "Immunomodulator"}, {"@id": "59620", "@count": "1617", "@label": "Unspecified drug target"}, {"@id": "750", "@count": "1616", "@label": "DNA intercalator"}, {"@id": "12379", "@count": "1488", "@label": "Therapeutic vaccine"}, {"@id": "2946", "@count": "1389", "@label": "Analgesic"}, {"@id": "393", "@count": "1137", "@label": "Immunostimulant"}, {"@id": "7293", "@count": "1122", "@label": "Synergist"}, {"@id": "610", "@count": "1078", "@label": "Hematopoietic stimulant"}, {"@id": "399", "@count": "1063", "@label": "Hypoglycemic agent"}, {"@id": "2657", "@count": "963", "@label": "Antihypertensive"}, {"@id": "1615", "@count": "899", "@label": "Neuroprotectant"}, {"@id": "382", "@count": "884", "@label": "TNF alpha synthesis inhibitor"}, {"@id": "695", "@count": "825", "@label": "Metastasis inhibitor"}, {"@id": "12378", "@count": "807", "@label": "Prophylactic vaccine"}, {"@id": "1594", "@count": "785", "@label": "Antibacterial"}, {"@id": "664", "@count": "768", "@label": "Fibrosuppressant"}, {"@id": "70", "@count": "736", "@label": "Anticonvulsant agent"}, {"@id": "62253", "@count": "693", "@label": "Anticancer hormone"}, {"@id": "62254", "@count": "670", "@label": "Anticancer hormone antagonist"}, {"@id": "1332", "@count": "562", "@label": "Gastrointestinal system agent"}, {"@id": "7220", "@count": "557", "@label": "Neoplasm diagnostic agent"}, {"@id": "89", "@count": "552", "@label": "Bone resorption inhibitor"}, {"@id": "284", "@count": "493", "@label": "Nootropic agent"}, {"@id": "539", "@count": "486", "@label": "Immunotoxin"}, {"@id": "2970", "@count": "483", "@label": "Anti-emetic"}, {"@id": "2659", "@count": "482", "@label": "Cardioprotectant"}, {"@id": "2941", "@count": "482", "@label": "Antidepressant"}, {"@id": "1552", "@count": "459", "@label": "Radioimmunotherapeutic"}, {"@id": "339", "@count": "407", "@label": "Protein synthesis inhibitor"}, {"@id": "2955", "@count": "404", "@label": "Non-steroidal anti-inflammatory"}, {"@id": "1586", "@count": "392", "@label": "Anticancer chemosensitizer"}, {"@id": "12372", "@count": "385", "@label": "Protein subunit vaccine"}, {"@id": "12596", "@count": "381", "@label": "Osteoclast inhibitor"}, {"@id": "1748", "@count": "380", "@label": "Fungicide"}, {"@id": "7760", "@count": "369", "@label": "T-lymphocyte inhibitor"}, {"@id": "2942", "@count": "349", "@label": "Anxiolytic"}, {"@id": "12370", "@count": "304", "@label": "Recombinant viral vector vaccine"}, {"@id": "71", "@count": "296", "@label": "Antihypercholesterolemic agent"}, {"@id": "2667", "@count": "276", "@label": "Antiarteriosclerotic"}, {"@id": "1532", "@count": "262", "@label": "Viral replication inhibitor"}, {"@id": "646", "@count": "259", "@label": "Bronchodilator"}, {"@id": "721", "@count": "259", "@label": "TNF binding agent"}, {"@id": "72", "@count": "248", "@label": "Antihyperlipidemic agent"}, {"@id": "15187", "@count": "244", "@label": "Systemic dermatological antibacterial product"}, {"@id": "38206", "@count": "241", "@label": "Biguanide antidiabetic product"}, {"@id": "12367", "@count": "240", "@label": "Inactivated viral vaccine"}, {"@id": "524", "@count": "240", "@label": "Adjuvant"}, {"@id": "15128", "@count": "234", "@label": "Ophthalmological agent"}, {"@id": "7294", "@count": "232", "@label": "Antisense oligonucleotide inhibitor"}, {"@id": "1592", "@count": "219", "@label": "Reproductive system modulator"}, {"@id": "1919", "@count": "213", "@label": "Insulin sensitizer"}, {"@id": "55686", "@count": "207", "@label": "Anticancer polyclonal antibody"}, {"@id": "4780", "@count": "206", "@label": "Adenovirus based gene therapy"}, {"@id": "2943", "@count": "199", "@label": "Antipsychotic"}, {"@id": "4155", "@count": "198", "@label": "Imaging agent"}, {"@id": "3688", "@count": "197", "@label": "FGF3 receptor antagonist"}, {"@id": "5720", "@count": "193", "@label": "Radiodiagnostic"}, {"@id": "7212", "@count": "192", "@label": "Endocrine diagnostic agent"}, {"@id": "7213", "@count": "191", "@label": "Gastrointestinal diagnostic agent"}, {"@id": "2969", "@count": "190", "@label": "Vascular damaging agent"}, {"@id": "38200", "@count": "184", "@label": "Acid pump inhibitor antiulcerant product"}, {"@id": "388", "@count": "184", "@label": "Vasodilator"}, {"@id": "3", "@count": "179", "@label": "5-HT uptake inhibitor"}, {"@id": "15178", "@count": "178", "@label": "Systemic dermatological antifungal product"}, {"@id": "2638", "@count": "177", "@label": "Antiparasitic"}, {"@id": "439", "@count": "177", "@label": "RNA synthesis inhibitor"}, {"@id": "7210", "@count": "175", "@label": "Cardiovascular diagnostic agent"}, {"@id": "3189", "@count": "175", "@label": "Corticosteroid agonist"}, {"@id": "572", "@count": "173", "@label": "Radiochemosensitizer"}, {"@id": "1832", "@count": "173", "@label": "Nucleoside reverse transcriptase inhibitor"}, {"@id": "161", "@count": "173", "@label": "Ergosterol synthesis inhibitor"}, {"@id": "799", "@count": "173", "@label": "Photosensitizer"}, {"@id": "499", "@count": "172", "@label": "Tubulin binding agent"}, {"@id": "2954", "@count": "156", "@label": "Steroidal anti-inflammatory"}, {"@id": "959", "@count": "155", "@label": "Protectant"}, {"@id": "170", "@count": "154", "@label": "Free radical scavenger"}, {"@id": "3272", "@count": "152", "@label": "Growth hormone release inhibitor"}, {"@id": "1879", "@count": "150", "@label": "DNA vaccine"}, {"@id": "1669", "@count": "147", "@label": "Local anesthetic"}, {"@id": "2947", "@count": "146", "@label": "Antiparkinsonian"}, {"@id": "7211", "@count": "144", "@label": "CNS diagnostic agent"}, {"@id": "5555", "@count": "144", "@label": "PET contrast agent"}, {"@id": "1465", "@count": "143", "@label": "Radioprotectant"}, {"@id": "7761", "@count": "141", "@label": "T-lymphocyte stimulator"}]}, {"@total": "100", "@label": "Trial Actions Secondary Interventions Control", "@name": "trialActionsSecondaryInterventionsControl", "FilterOption": [{"@id": "1545", "@count": "1026", "@label": "Anticancer"}, {"@id": "140", "@count": "366", "@label": "DNA synthesis inhibitor"}, {"@id": "1569", "@count": "353", "@label": "Anticancer antimetabolite"}, {"@id": "2953", "@count": "300", "@label": "Anti-inflammatory"}, {"@id": "50", "@count": "275", "@label": "Anticancer alkylating agent"}, {"@id": "767", "@count": "239", "@label": "Cell cycle inhibitor"}, {"@id": "2575", "@count": "235", "@label": "Microtubule inhibitor"}, {"@id": "55685", "@count": "212", "@label": "Anticancer monoclonal antibody"}, {"@id": "2660", "@count": "199", "@label": "Vasoprotectant"}, {"@id": "62255", "@count": "182", "@label": "Anticancer protein kinase inhibitor"}, {"@id": "2576", "@count": "172", "@label": "Microtubule stabilizer"}, {"@id": "991", "@count": "144", "@label": "Antiviral"}, {"@id": "61", "@count": "129", "@label": "Angiogenesis inhibitor"}, {"@id": "399", "@count": "118", "@label": "Hypoglycemic agent"}, {"@id": "15184", "@count": "97", "@label": "Systemic antipsoriatic product"}, {"@id": "12378", "@count": "80", "@label": "Prophylactic vaccine"}, {"@id": "1594", "@count": "78", "@label": "Antibacterial"}, {"@id": "396", "@count": "77", "@label": "Immunosuppressant"}, {"@id": "750", "@count": "77", "@label": "DNA intercalator"}, {"@id": "646", "@count": "73", "@label": "Bronchodilator"}, {"@id": "2657", "@count": "62", "@label": "Antihypertensive"}, {"@id": "2970", "@count": "59", "@label": "Anti-emetic"}, {"@id": "15187", "@count": "58", "@label": "Systemic dermatological antibacterial product"}, {"@id": "1589", "@count": "55", "@label": "Apoptosis stimulator"}, {"@id": "2942", "@count": "54", "@label": "Anxiolytic"}, {"@id": "1615", "@count": "53", "@label": "Neuroprotectant"}, {"@id": "2946", "@count": "49", "@label": "Analgesic"}, {"@id": "62254", "@count": "48", "@label": "Anticancer hormone antagonist"}, {"@id": "610", "@count": "48", "@label": "Hematopoietic stimulant"}, {"@id": "59620", "@count": "43", "@label": "Unspecified drug target"}, {"@id": "1596", "@count": "42", "@label": "Immunomodulator"}, {"@id": "7760", "@count": "41", "@label": "T-lymphocyte inhibitor"}, {"@id": "89", "@count": "41", "@label": "Bone resorption inhibitor"}, {"@id": "12367", "@count": "36", "@label": "Inactivated viral vaccine"}, {"@id": "38206", "@count": "34", "@label": "Biguanide antidiabetic product"}, {"@id": "104", "@count": "34", "@label": "Bacterial cell wall synthesis inhibitor"}, {"@id": "633", "@count": "32", "@label": "Acetylcholine release stimulator"}, {"@id": "664", "@count": "31", "@label": "Fibrosuppressant"}, {"@id": "38215", "@count": "30", "@label": "Human insulin long acting product"}, {"@id": "3984", "@count": "30", "@label": "Bacterial nucleic acid synthesis inhibitor"}, {"@id": "71", "@count": "30", "@label": "Antihypercholesterolemic agent"}, {"@id": "12596", "@count": "29", "@label": "Osteoclast inhibitor"}, {"@id": "3189", "@count": "28", "@label": "Corticosteroid agonist"}, {"@id": "2954", "@count": "28", "@label": "Steroidal anti-inflammatory"}, {"@id": "38211", "@count": "24", "@label": "Human insulin fast acting product"}, {"@id": "1592", "@count": "23", "@label": "Reproductive system modulator"}, {"@id": "695", "@count": "21", "@label": "Metastasis inhibitor"}, {"@id": "1832", "@count": "21", "@label": "Nucleoside reverse transcriptase inhibitor"}, {"@id": "72", "@count": "21", "@label": "Antihyperlipidemic agent"}, {"@id": "284", "@count": "20", "@label": "Nootropic agent"}, {"@id": "393", "@count": "20", "@label": "Immunostimulant"}, {"@id": "2667", "@count": "20", "@label": "Antiarteriosclerotic"}, {"@id": "38200", "@count": "19", "@label": "Acid pump inhibitor antiulcerant product"}, {"@id": "62253", "@count": "19", "@label": "Anticancer hormone"}, {"@id": "2659", "@count": "19", "@label": "Cardioprotectant"}, {"@id": "2941", "@count": "18", "@label": "Antidepressant"}, {"@id": "38205", "@count": "18", "@label": "Sulphonylurea antidiabetic product"}, {"@id": "1748", "@count": "18", "@label": "Fungicide"}, {"@id": "3246", "@count": "18", "@label": "Insulin release stimulator"}, {"@id": "1332", "@count": "16", "@label": "Gastrointestinal system agent"}, {"@id": "3", "@count": "16", "@label": "5-HT uptake inhibitor"}, {"@id": "2955", "@count": "16", "@label": "Non-steroidal anti-inflammatory"}, {"@id": "12372", "@count": "16", "@label": "Protein subunit vaccine"}, {"@id": "15178", "@count": "15", "@label": "Systemic dermatological antifungal product"}, {"@id": "382", "@count": "15", "@label": "TNF alpha synthesis inhibitor"}, {"@id": "1535", "@count": "15", "@label": "Beta lactam antibiotic"}, {"@id": "1919", "@count": "15", "@label": "Insulin sensitizer"}, {"@id": "7220", "@count": "14", "@label": "Neoplasm diagnostic agent"}, {"@id": "484", "@count": "14", "@label": "Calcium metabolic inhibitor"}, {"@id": "70", "@count": "14", "@label": "Anticonvulsant agent"}, {"@id": "182", "@count": "13", "@label": "Gastric secretion inhibitor"}, {"@id": "12379", "@count": "13", "@label": "Therapeutic vaccine"}, {"@id": "659", "@count": "12", "@label": "Coagulation inhibitor"}, {"@id": "1537", "@count": "12", "@label": "Cephalosporin"}, {"@id": "1532", "@count": "12", "@label": "Viral replication inhibitor"}, {"@id": "388", "@count": "12", "@label": "Vasodilator"}, {"@id": "12364", "@count": "11", "@label": "Live attenuated viral vaccine"}, {"@id": "38439", "@count": "11", "@label": "DPP IV inhibitor antidiabetic product"}, {"@id": "1668", "@count": "11", "@label": "General anesthetic"}, {"@id": "15128", "@count": "10", "@label": "Ophthalmological agent"}, {"@id": "747", "@count": "10", "@label": "HIV replication inhibitor"}, {"@id": "2944", "@count": "10", "@label": "Hypnotic"}, {"@id": "1538", "@count": "10", "@label": "Bacterial protein synthesis inhibitor"}, {"@id": "721", "@count": "10", "@label": "TNF binding agent"}, {"@id": "1741", "@count": "9", "@label": "Low molecular weight heparin"}, {"@id": "285", "@count": "9", "@label": "Norepinephrine uptake inhibitor"}, {"@id": "12373", "@count": "9", "@label": "Polysaccharide subunit vaccine"}, {"@id": "15190", "@count": "9", "@label": "Systemic dermatological antiviral product"}, {"@id": "3313", "@count": "9", "@label": "Glucagon-like peptide 1 metabolism modulator"}, {"@id": "73547", "@count": "9", "@label": "Carbapenem"}, {"@id": "7210", "@count": "9", "@label": "Cardiovascular diagnostic agent"}, {"@id": "312", "@count": "8", "@label": "Platelet aggregation inhibitor"}, {"@id": "161", "@count": "8", "@label": "Ergosterol synthesis inhibitor"}, {"@id": "15189", "@count": "8", "@label": "Topical dermatological antiviral product"}, {"@id": "4158", "@count": "8", "@label": "MRI imaging agent"}, {"@id": "1540", "@count": "8", "@label": "Macrolide antibiotic"}, {"@id": "1833", "@count": "7", "@label": "Non-nucleoside reverse transcriptase inhibitor"}, {"@id": "4155", "@count": "7", "@label": "Imaging agent"}, {"@id": "536", "@count": "7", "@label": "Estradiol agonist"}, {"@id": "137", "@count": "7", "@label": "Diuretic agent"}]}, {"@total": "100", "@label": "Biomarker", "@name": "trialBiomarkerNames", "FilterOption": [{"@id": "38", "@count": "1142", "@label": "Prostate-specific antigen"}, {"@id": "3", "@count": "1060", "@label": "HER2"}, {"@id": "8", "@count": "899", "@label": "Epidermal growth factor receptor"}, {"@id": "1735", "@count": "818", "@label": "Glucose"}, {"@id": "46", "@count": "752", "@label": "C-reactive protein"}, {"@id": "213", "@count": "587", "@label": "Creatinine"}, {"@id": "176", "@count": "577", "@label": "Interleukin-6"}, {"@id": "289", "@count": "521", "@label": "Hemoglobin A, glycosylated"}, {"@id": "1236", "@count": "518", "@label": "Hemoglobin"}, {"@id": "2331", "@count": "499", "@label": "VEGF/SEMA ratio"}, {"@id": "2586", "@count": "493", "@label": "Blood pressure"}, {"@id": "52", "@count": "453", "@label": "GTPase KRas"}, {"@id": "1211", "@count": "448", "@label": "Alanine transaminase"}, {"@id": "1857", "@count": "438", "@label": "T-cell surface glycoprotein CD4"}, {"@id": "133", "@count": "434", "@label": "Total cholesterol"}, {"@id": "7", "@count": "432", "@label": "Antigen KI-67"}, {"@id": "153", "@count": "392", "@label": "High-density lipoprotein cholesterol"}, {"@id": "808", "@count": "390", "@label": "Insulin"}, {"@id": "274", "@count": "372", "@label": "Tumor necrosis factor"}, {"@id": "36136", "@count": "364", "@label": "Cytokines"}, {"@id": "2527", "@count": "358", "@label": "Aspartate aminotransferase"}, {"@id": "12058", "@count": "341", "@label": "Total body mass"}, {"@id": "1387", "@count": "331", "@label": "Testosterone"}, {"@id": "2054", "@count": "316", "@label": "Blood platelets"}, {"@id": "217", "@count": "304", "@label": "Triglycerides"}, {"@id": "71", "@count": "302", "@label": "CA-125 antigen"}, {"@id": "11580", "@count": "298", "@label": "T-lymphocytes"}, {"@id": "3447", "@count": "290", "@label": "T-cell surface glycoprotein CD8 alpha chain"}, {"@id": "152", "@count": "289", "@label": "Low-density lipoprotein cholesterol"}, {"@id": "2713", "@count": "284", "@label": "Forced expiratory volume"}, {"@id": "82", "@count": "271", "@label": "B-Raf proto-oncogene serine/threonine-protein kinase"}, {"@id": "1904", "@count": "271", "@label": "Heart rate"}, {"@id": "1925", "@count": "268", "@label": "Neutrophils"}, {"@id": "9", "@count": "266", "@label": "Cellular tumor antigen p53"}, {"@id": "118", "@count": "259", "@label": "Albumin"}, {"@id": "2387", "@count": "250", "@label": "Bilirubin"}, {"@id": "252", "@count": "242", "@label": "Interferon gamma"}, {"@id": "554", "@count": "238", "@label": "Interleukin-8"}, {"@id": "3614", "@count": "235", "@label": "RAC-alpha serine/threonine-protein kinase"}, {"@id": "883", "@count": "222", "@label": "Vascular endothelial growth factor receptor-2"}, {"@id": "113", "@count": "210", "@label": "Body Mass Index"}, {"@id": "10", "@count": "201", "@label": "Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN"}, {"@id": "64", "@count": "197", "@label": "Circulating Tumor Cells"}, {"@id": "28899", "@count": "197", "@label": "Alkaline phosphatase"}, {"@id": "14767", "@count": "195", "@label": "Lipids"}, {"@id": "175", "@count": "191", "@label": "Interleukin-10"}, {"@id": "5326", "@count": "188", "@label": "Estradiol"}, {"@id": "2706", "@count": "187", "@label": "Natural killer cells"}, {"@id": "3451", "@count": "178", "@label": "Immunoglobulin G"}, {"@id": "3374", "@count": "174", "@label": "Bone mineral density"}, {"@id": "70", "@count": "170", "@label": "Mucin-1"}, {"@id": "20", "@count": "169", "@label": "Apoptosis regulator Bcl-2"}, {"@id": "4", "@count": "167", "@label": "ER / PR ratio"}, {"@id": "379", "@count": "167", "@label": "Insulin-like growth factor 1"}, {"@id": "23", "@count": "163", "@label": "Carcinoembryonic antigen-related cell adhesion molecule 5"}, {"@id": "92", "@count": "161", "@label": "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform"}, {"@id": "2417", "@count": "158", "@label": "Calcium"}, {"@id": "5", "@count": "157", "@label": "Estrogen receptor"}, {"@id": "125", "@count": "149", "@label": "Leukocyte count"}, {"@id": "154", "@count": "144", "@label": "Lactate dehydrogenase"}, {"@id": "483", "@count": "141", "@label": "Collagen type I trimeric cross-linked peptide"}, {"@id": "67", "@count": "140", "@label": "Alpha-fetoprotein"}, {"@id": "172", "@count": "137", "@label": "Adiponectin"}, {"@id": "812", "@count": "134", "@label": "Interleukin-2"}, {"@id": "4806", "@count": "133", "@label": "Lymphocytes"}, {"@id": "855", "@count": "132", "@label": "Hematopoietic progenitor cell antigen CD34"}, {"@id": "1731", "@count": "131", "@label": "B-lymphocyte antigen CD20"}, {"@id": "245", "@count": "131", "@label": "CD8-Positive T-Lymphocytes"}, {"@id": "1688", "@count": "125", "@label": "Follicle-stimulating hormone"}, {"@id": "425", "@count": "123", "@label": "C-peptide"}, {"@id": "5093", "@count": "122", "@label": "P protein"}, {"@id": "330", "@count": "120", "@label": "Systolic blood pressure"}, {"@id": "1912", "@count": "115", "@label": "Forced Vital Capacity"}, {"@id": "44", "@count": "113", "@label": "Thymidylate synthase"}, {"@id": "235", "@count": "111", "@label": "Prostaglandin G/H synthase 2"}, {"@id": "495", "@count": "111", "@label": "Heparin-binding growth factor 2"}, {"@id": "6663", "@count": "109", "@label": "B-lymphocytes"}, {"@id": "35711", "@count": "108", "@label": "1-Pentadecanoyl-2-(octadecenoyl)-3-(octadecenoyl)-glycerol"}, {"@id": "288", "@count": "101", "@label": "Uric acid"}, {"@id": "2358", "@count": "99", "@label": "Urea nitrogen"}, {"@id": "332", "@count": "99", "@label": "Diastolic blood pressure"}, {"@id": "6", "@count": "97", "@label": "Progesterone receptor"}, {"@id": "74", "@count": "97", "@label": "Mast/stem cell growth factor receptor"}, {"@id": "2534", "@count": "96", "@label": "Hydrocortisone"}, {"@id": "126", "@count": "95", "@label": "BCR-ABL fusion protein"}, {"@id": "215", "@count": "93", "@label": "Apolipoprotein B-100"}, {"@id": "1371", "@count": "92", "@label": "Sex hormone-binding globulin"}, {"@id": "2098", "@count": "91", "@label": "Potassium"}, {"@id": "1051", "@count": "91", "@label": "Ferritin"}, {"@id": "11", "@count": "91", "@label": "G1/S-specific cyclin-D1"}, {"@id": "323", "@count": "91", "@label": "CD40 ligand"}, {"@id": "378", "@count": "90", "@label": "Insulin-like growth factor binding protein 3"}, {"@id": "59", "@count": "90", "@label": "Vascular endothelial growth factor A"}, {"@id": "1855", "@count": "90", "@label": "CD3 Antigens"}, {"@id": "418", "@count": "89", "@label": "Waist circumference"}, {"@id": "89", "@count": "88", "@label": "Hepatocyte growth factor receptor"}, {"@id": "303", "@count": "87", "@label": "Leptin"}, {"@id": "22", "@count": "85", "@label": "Breast cancer type 1 susceptibility protein"}, {"@id": "908", "@count": "84", "@label": "Cyclin-dependent kinase inhibitor 1"}, {"@id": "498", "@count": "83", "@label": "Vascular endothelial growth factor receptor-1"}]}, {"@total": "100", "@label": "Trial Actions Primary Interventions Primary", "@name": "trialActionsPrimaryInterventionsPrimary", "FilterOption": [{"@id": "141", "@count": "2788", "@label": "Topoisomerase I inhibitor"}, {"@id": "3808", "@count": "2699", "@label": "Kit tyrosine kinase inhibitor"}, {"@id": "740", "@count": "2499", "@label": "Epidermal growth factor antagonist"}, {"@id": "372", "@count": "2400", "@label": "Thymidylate synthase inhibitor"}, {"@id": "3848", "@count": "2243", "@label": "VEGF-2 receptor antagonist"}, {"@id": "142", "@count": "2023", "@label": "Topoisomerase II inhibitor"}, {"@id": "12521", "@count": "1768", "@label": "VEGF ligand inhibitor"}, {"@id": "3754", "@count": "1668", "@label": "EGFR family tyrosine kinase receptor inhibitor"}, {"@id": "5085", "@count": "1533", "@label": "B-lymphocyte antigen CD20 inhibitor"}, {"@id": "48492", "@count": "1522", "@label": "PDGF receptor beta antagonist"}, {"@id": "3846", "@count": "1485", "@label": "VEGF-1 receptor antagonist"}, {"@id": "3806", "@count": "1460", "@label": "Flt3 tyrosine kinase inhibitor"}, {"@id": "3850", "@count": "1436", "@label": "VEGF-3 receptor antagonist"}, {"@id": "3816", "@count": "1360", "@label": "RET tyrosine kinase receptor family inhibitor"}, {"@id": "3756", "@count": "1349", "@label": "Erbb2 tyrosine kinase receptor inhibitor"}, {"@id": "3151", "@count": "1068", "@label": "GCSF receptor agonist"}, {"@id": "948", "@count": "968", "@label": "PDGF receptor antagonist"}, {"@id": "3524", "@count": "952", "@label": "Abl tyrosine kinase inhibitor"}, {"@id": "6512", "@count": "946", "@label": "DNA methyltransferase inhibitor"}, {"@id": "346", "@count": "878", "@label": "Ribonucleotide reductase inhibitor"}, {"@id": "4917", "@count": "857", "@label": "Proteasome inhibitor"}, {"@id": "135", "@count": "855", "@label": "DHFR inhibitor"}, {"@id": "782", "@count": "835", "@label": "Dihydropyrimidine dehydrogenase inhibitor"}, {"@id": "51708", "@count": "827", "@label": "DNA polymerase alpha inhibitor"}, {"@id": "6830", "@count": "827", "@label": "DNA primase inhibitor"}, {"@id": "6661", "@count": "807", "@label": "Orotate phosphoribosyltransferase inhibitor"}, {"@id": "374", "@count": "777", "@label": "Transferase inhibitor"}, {"@id": "138", "@count": "769", "@label": "DNA polymerase inhibitor"}, {"@id": "4760", "@count": "733", "@label": "MEK protein kinase inhibitor"}, {"@id": "4542", "@count": "726", "@label": "Raf protein kinase inhibitor"}, {"@id": "76", "@count": "619", "@label": "Aromatase inhibitor"}, {"@id": "10240", "@count": "601", "@label": "mTOR inhibitor"}, {"@id": "76090", "@count": "572", "@label": "mTOR complex 1 inhibitor"}, {"@id": "629", "@count": "544", "@label": "Inosine monophosphate dehydrogenase inhibitor"}, {"@id": "286", "@count": "505", "@label": "Estrogen receptor antagonist"}, {"@id": "7025", "@count": "498", "@label": "Signal transduction inhibitor"}, {"@id": "4548", "@count": "489", "@label": "Raf B protein kinase inhibitor"}, {"@id": "4010", "@count": "455", "@label": "Calcineurin inhibitor"}, {"@id": "13571", "@count": "446", "@label": "Bcr protein inhibitor"}, {"@id": "12481", "@count": "444", "@label": "Interleukin-2 ligand"}, {"@id": "410", "@count": "420", "@label": "GM-CSF receptor agonist"}, {"@id": "7841", "@count": "397", "@label": "Histone deacetylase-1 inhibitor"}, {"@id": "7847", "@count": "392", "@label": "Histone deacetylase-3 inhibitor"}, {"@id": "3576", "@count": "362", "@label": "Src tyrosine kinase inhibitor"}, {"@id": "7844", "@count": "362", "@label": "Histone deacetylase-2 inhibitor"}, {"@id": "1001", "@count": "344", "@label": "Cyclooxygenase 2 inhibitor"}, {"@id": "7856", "@count": "339", "@label": "Histone deacetylase-6 inhibitor"}, {"@id": "420", "@count": "335", "@label": "CSF-1 agonist"}, {"@id": "1092", "@count": "331", "@label": "GNRH agonist"}, {"@id": "3592", "@count": "331", "@label": "Btk tyrosine kinase inhibitor"}, {"@id": "1513", "@count": "312", "@label": "Topoisomerase II modulator"}, {"@id": "48489", "@count": "312", "@label": "PDGF receptor alpha antagonist"}, {"@id": "15", "@count": "285", "@label": "5-HT 3 receptor antagonist"}, {"@id": "3762", "@count": "280", "@label": "EPH family tyrosine kinase inhibitor"}, {"@id": "214", "@count": "276", "@label": "Interferon alpha 2 ligand"}, {"@id": "60", "@count": "276", "@label": "Androgen receptor antagonist"}, {"@id": "431", "@count": "273", "@label": "DNA gyrase inhibitor"}, {"@id": "12162", "@count": "273", "@label": "Erythropoietin ligand"}, {"@id": "1722", "@count": "271", "@label": "VEGF receptor antagonist"}, {"@id": "3574", "@count": "265", "@label": "Fyn tyrosine kinase inhibitor"}, {"@id": "3584", "@count": "261", "@label": "Lck tyrosine kinase inhibitor"}, {"@id": "63083", "@count": "261", "@label": "DDR2 gene inhibitor"}, {"@id": "3596", "@count": "261", "@label": "Tec tyrosine kinase inhibitor"}, {"@id": "24539", "@count": "261", "@label": "PDGF-B ligand inhibitor"}, {"@id": "3760", "@count": "259", "@label": "Erbb4 tyrosine kinase receptor inhibitor"}, {"@id": "1575", "@count": "259", "@label": "Phosphoinositide 3-kinase inhibitor"}, {"@id": "675", "@count": "257", "@label": "Hepatocyte growth factor antagonist"}, {"@id": "8805", "@count": "249", "@label": "AMP activated protein kinase stimulator"}, {"@id": "2506", "@count": "247", "@label": "PARP modulator"}, {"@id": "5218", "@count": "245", "@label": "CD52 antagonist"}, {"@id": "14127", "@count": "245", "@label": "Clusterin stimulator"}, {"@id": "4762", "@count": "236", "@label": "MEK-1 protein kinase inhibitor"}, {"@id": "3252", "@count": "230", "@label": "Insulin-like growth factor 1 antagonist"}, {"@id": "4764", "@count": "227", "@label": "MEK-2 protein kinase inhibitor"}, {"@id": "205", "@count": "226", "@label": "HMG CoA reductase inhibitor"}, {"@id": "5482", "@count": "226", "@label": "Cytotoxic T-lymphocyte protein-4 inhibitor"}, {"@id": "5083", "@count": "224", "@label": "B-lymphocyte antigen CD20 modulator"}, {"@id": "2574", "@count": "219", "@label": "Histone deacetylase inhibitor"}, {"@id": "498", "@count": "217", "@label": "Sodium channel inhibitor"}, {"@id": "3755", "@count": "206", "@label": "Erbb2 tyrosine kinase receptor modulator"}, {"@id": "3154", "@count": "206", "@label": "CSF-1 antagonist"}, {"@id": "3682", "@count": "202", "@label": "FGF1 receptor antagonist"}, {"@id": "168", "@count": "196", "@label": "FGF receptor antagonist"}, {"@id": "208", "@count": "194", "@label": "H+ K+ ATPase inhibitor"}, {"@id": "541", "@count": "189", "@label": "Tubulin antagonist"}, {"@id": "10451", "@count": "188", "@label": "Ras GTPase inhibitor"}, {"@id": "381", "@count": "187", "@label": "TNF alpha ligand inhibitor"}, {"@id": "293", "@count": "186", "@label": "Opioid receptor mu agonist"}, {"@id": "3758", "@count": "183", "@label": "Erbb3 tyrosine kinase receptor inhibitor"}, {"@id": "8012", "@count": "183", "@label": "Hsp 90 inhibitor"}, {"@id": "3859", "@count": "180", "@label": "AKT protein kinase inhibitor"}, {"@id": "266", "@count": "176", "@label": "NK1 receptor antagonist"}, {"@id": "2480", "@count": "174", "@label": "PPAR gamma agonist"}, {"@id": "1875", "@count": "171", "@label": "Protein farnesyltransferase inhibitor"}, {"@id": "3685", "@count": "167", "@label": "FGF2 receptor antagonist"}, {"@id": "40", "@count": "167", "@label": "Beta 2 adrenoceptor agonist"}, {"@id": "814", "@count": "154", "@label": "Tubulin modulator"}, {"@id": "753", "@count": "154", "@label": "Retinoic acid receptor agonist"}, {"@id": "3748", "@count": "153", "@label": "DDR tyrosine kinase receptor inhibitor"}, {"@id": "347", "@count": "152", "@label": "RNA polymerase inhibitor"}]}, {"@total": "100", "@label": "Trial Actions Primary Interventions Control", "@name": "trialActionsPrimaryInterventionsControl", "FilterOption": [{"@id": "372", "@count": "150", "@label": "Thymidylate synthase inhibitor"}, {"@id": "141", "@count": "110", "@label": "Topoisomerase I inhibitor"}, {"@id": "3808", "@count": "75", "@label": "Kit tyrosine kinase inhibitor"}, {"@id": "740", "@count": "74", "@label": "Epidermal growth factor antagonist"}, {"@id": "5085", "@count": "70", "@label": "B-lymphocyte antigen CD20 inhibitor"}, {"@id": "142", "@count": "63", "@label": "Topoisomerase II inhibitor"}, {"@id": "3151", "@count": "55", "@label": "GCSF receptor agonist"}, {"@id": "76", "@count": "55", "@label": "Aromatase inhibitor"}, {"@id": "12521", "@count": "54", "@label": "VEGF ligand inhibitor"}, {"@id": "3756", "@count": "52", "@label": "Erbb2 tyrosine kinase receptor inhibitor"}, {"@id": "3848", "@count": "50", "@label": "VEGF-2 receptor antagonist"}, {"@id": "3754", "@count": "49", "@label": "EGFR family tyrosine kinase receptor inhibitor"}, {"@id": "15", "@count": "48", "@label": "5-HT 3 receptor antagonist"}, {"@id": "4010", "@count": "48", "@label": "Calcineurin inhibitor"}, {"@id": "48492", "@count": "47", "@label": "PDGF receptor beta antagonist"}, {"@id": "23014", "@count": "47", "@label": "Insulin ligand"}, {"@id": "400", "@count": "47", "@label": "Insulin receptor agonist"}, {"@id": "286", "@count": "47", "@label": "Estrogen receptor antagonist"}, {"@id": "374", "@count": "46", "@label": "Transferase inhibitor"}, {"@id": "629", "@count": "45", "@label": "Inosine monophosphate dehydrogenase inhibitor"}, {"@id": "135", "@count": "45", "@label": "DHFR inhibitor"}, {"@id": "138", "@count": "43", "@label": "DNA polymerase inhibitor"}, {"@id": "3816", "@count": "43", "@label": "RET tyrosine kinase receptor family inhibitor"}, {"@id": "3806", "@count": "42", "@label": "Flt3 tyrosine kinase inhibitor"}, {"@id": "6512", "@count": "41", "@label": "DNA methyltransferase inhibitor"}, {"@id": "3846", "@count": "39", "@label": "VEGF-1 receptor antagonist"}, {"@id": "40", "@count": "37", "@label": "Beta 2 adrenoceptor agonist"}, {"@id": "3850", "@count": "35", "@label": "VEGF-3 receptor antagonist"}, {"@id": "8805", "@count": "35", "@label": "AMP activated protein kinase stimulator"}, {"@id": "1092", "@count": "34", "@label": "GNRH agonist"}, {"@id": "431", "@count": "31", "@label": "DNA gyrase inhibitor"}, {"@id": "3524", "@count": "30", "@label": "Abl tyrosine kinase inhibitor"}, {"@id": "9320", "@count": "30", "@label": "Topoisomerase IV inhibitor"}, {"@id": "948", "@count": "30", "@label": "PDGF receptor antagonist"}, {"@id": "4542", "@count": "27", "@label": "Raf protein kinase inhibitor"}, {"@id": "205", "@count": "27", "@label": "HMG CoA reductase inhibitor"}, {"@id": "4760", "@count": "27", "@label": "MEK protein kinase inhibitor"}, {"@id": "7025", "@count": "26", "@label": "Signal transduction inhibitor"}, {"@id": "262", "@count": "26", "@label": "Muscarinic M3 receptor antagonist"}, {"@id": "51708", "@count": "25", "@label": "DNA polymerase alpha inhibitor"}, {"@id": "6830", "@count": "25", "@label": "DNA primase inhibitor"}, {"@id": "346", "@count": "25", "@label": "Ribonucleotide reductase inhibitor"}, {"@id": "261", "@count": "24", "@label": "Muscarinic M1 receptor antagonist"}, {"@id": "214", "@count": "21", "@label": "Interferon alpha 2 ligand"}, {"@id": "12162", "@count": "20", "@label": "Erythropoietin ligand"}, {"@id": "208", "@count": "19", "@label": "H+ K+ ATPase inhibitor"}, {"@id": "782", "@count": "17", "@label": "Dihydropyrimidine dehydrogenase inhibitor"}, {"@id": "6661", "@count": "17", "@label": "Orotate phosphoribosyltransferase inhibitor"}, {"@id": "37", "@count": "17", "@label": "Beta adrenoceptor agonist"}, {"@id": "1513", "@count": "16", "@label": "Topoisomerase II modulator"}, {"@id": "2480", "@count": "15", "@label": "PPAR gamma agonist"}, {"@id": "4917", "@count": "15", "@label": "Proteasome inhibitor"}, {"@id": "60", "@count": "14", "@label": "Androgen receptor antagonist"}, {"@id": "66340", "@count": "12", "@label": "Penicillin binding protein inhibitor"}, {"@id": "624", "@count": "12", "@label": "Progesterone receptor agonist"}, {"@id": "1001", "@count": "12", "@label": "Cyclooxygenase 2 inhibitor"}, {"@id": "777", "@count": "12", "@label": "Lanosterol-14 demethylase inhibitor"}, {"@id": "5537", "@count": "11", "@label": "Dipeptidyl peptidase IV inhibitor"}, {"@id": "1016", "@count": "11", "@label": "HIV-1 reverse transcriptase inhibitor"}, {"@id": "2585", "@count": "11", "@label": "Glucagon-like peptide 1 agonist"}, {"@id": "259", "@count": "10", "@label": "Muscarinic receptor antagonist"}, {"@id": "6909", "@count": "10", "@label": "Alpha 1A adrenoceptor antagonist"}, {"@id": "753", "@count": "10", "@label": "Retinoic acid receptor agonist"}, {"@id": "10583", "@count": "10", "@label": "Vitamin K epoxide reductase inhibitor"}, {"@id": "551", "@count": "9", "@label": "RNA DNA polymerase inhibitor"}, {"@id": "917", "@count": "9", "@label": "Interferon alpha ligand modulator"}, {"@id": "2506", "@count": "9", "@label": "PARP modulator"}, {"@id": "76090", "@count": "9", "@label": "mTOR complex 1 inhibitor"}, {"@id": "293", "@count": "9", "@label": "Opioid receptor mu agonist"}, {"@id": "59", "@count": "9", "@label": "Androgen receptor agonist"}, {"@id": "64", "@count": "9", "@label": "Angiotensin II receptor antagonist"}, {"@id": "12481", "@count": "8", "@label": "Interleukin-2 ligand"}, {"@id": "18", "@count": "8", "@label": "ACE inhibitor"}, {"@id": "8", "@count": "7", "@label": "5-HT 1b receptor agonist"}, {"@id": "10", "@count": "7", "@label": "5-HT 1d receptor agonist"}, {"@id": "410", "@count": "7", "@label": "GM-CSF receptor agonist"}, {"@id": "401", "@count": "7", "@label": "Estrogen receptor agonist"}, {"@id": "52970", "@count": "7", "@label": "GCSF ligand"}, {"@id": "4548", "@count": "7", "@label": "Raf B protein kinase inhibitor"}, {"@id": "7821", "@count": "7", "@label": "TLR-7 agonist"}, {"@id": "420", "@count": "7", "@label": "CSF-1 agonist"}, {"@id": "81", "@count": "7", "@label": "Benzodiazepine receptor agonist"}, {"@id": "57003", "@count": "7", "@label": "Peptidoglycan recognition protein inhibitor"}, {"@id": "381", "@count": "7", "@label": "TNF alpha ligand inhibitor"}, {"@id": "5100", "@count": "6", "@label": "IL-2 receptor alpha subunit inhibitor"}, {"@id": "5482", "@count": "6", "@label": "Cytotoxic T-lymphocyte protein-4 inhibitor"}, {"@id": "788", "@count": "6", "@label": "Angiotensin II AT-1 receptor antagonist"}, {"@id": "4913", "@count": "6", "@label": "P2Y12 purinoceptor antagonist"}, {"@id": "204", "@count": "6", "@label": "HIV protease inhibitor"}, {"@id": "778", "@count": "6", "@label": "PDE 5 inhibitor"}, {"@id": "846", "@count": "6", "@label": "Estrogen receptor modulator"}, {"@id": "266", "@count": "5", "@label": "NK1 receptor antagonist"}, {"@id": "48489", "@count": "5", "@label": "PDGF receptor alpha antagonist"}, {"@id": "41", "@count": "5", "@label": "Beta 2 adrenoceptor antagonist"}, {"@id": "481", "@count": "5", "@label": "Interferon beta ligand"}, {"@id": "5218", "@count": "4", "@label": "CD52 antagonist"}, {"@id": "458", "@count": "4", "@label": "5-Alpha-reductase inhibitor"}, {"@id": "173", "@count": "4", "@label": "GABA receptor agonist"}, {"@id": "14127", "@count": "4", "@label": "Clusterin stimulator"}, {"@id": "701", "@count": "4", "@label": "Parathyroid hormone receptor agonist"}]}, {"@total": "100", "@label": "Trial Interventions Primary In Regimen Name Display", "@name": "trialInterventionsPrimaryInRegimenNameDisplay", "FilterOption": [{"@id": "44383", "@count": "2157", "@label": "carboplatin"}, {"@id": "3199", "@count": "2058", "@label": "gemcitabine"}, {"@id": "3803", "@count": "2055", "@label": "paclitaxel"}, {"@id": "2953", "@count": "1989", "@label": "docetaxel"}, {"@id": "3792", "@count": "1515", "@label": "oxaliplatin"}, {"@id": "8047", "@count": "1479", "@label": "bevacizumab"}, {"@id": "2871", "@count": "1286", "@label": "irinotecan"}, {"@id": "12205", "@count": "1284", "@label": "capecitabine"}, {"@id": "3072", "@count": "1210", "@label": "etoposide phosphate"}, {"@id": "6736", "@count": "1051", "@label": "rituximab"}, {"@id": "3130", "@count": "686", "@label": "filgrastim"}, {"@id": "6156", "@count": "680", "@label": "fludarabine"}, {"@id": "10388", "@count": "650", "@label": "cetuximab"}, {"@id": "3536", "@count": "603", "@label": "pemetrexed disodium"}, {"@id": "10084", "@count": "596", "@label": "tegafur + gimeracil + oteracil potassium"}, {"@id": "15954", "@count": "580", "@label": "bortezomib"}, {"@id": "6386", "@count": "560", "@label": "trastuzumab"}, {"@id": "11961", "@count": "534", "@label": "erlotinib"}, {"@id": "13022", "@count": "533", "@label": "epirubicin"}, {"@id": "6408", "@count": "462", "@label": "vinorelbine"}, {"@id": "4529", "@count": "441", "@label": "temozolomide"}, {"@id": "27572", "@count": "431", "@label": "lenalidomide"}, {"@id": "29831", "@count": "380", "@label": "sorafenib"}, {"@id": "13340", "@count": "321", "@label": "everolimus"}, {"@id": "4577", "@count": "284", "@label": "topotecan"}, {"@id": "11519", "@count": "280", "@label": "mitoxantrone"}, {"@id": "29016", "@count": "262", "@label": "paclitaxel (albumin-bound nanoparticle, intravenous), Abraxis/Taiho"}, {"@id": "3669", "@count": "257", "@label": "mycophenolate mofetil"}, {"@id": "4510", "@count": "256", "@label": "tacrolimus"}, {"@id": "7121", "@count": "246", "@label": "sargramostim"}, {"@id": "6306", "@count": "232", "@label": "aldesleukin"}, {"@id": "7934", "@count": "231", "@label": "doxorubicin (liposomal, STEALTH), Alza"}, {"@id": "33591", "@count": "212", "@label": "lapatinib"}, {"@id": "11460", "@count": "206", "@label": "imatinib"}, {"@id": "47000", "@count": "198", "@label": "bendamustine"}, {"@id": "11603", "@count": "182", "@label": "gefitinib"}, {"@id": "44314", "@count": "167", "@label": "tamoxifen"}, {"@id": "4200", "@count": "167", "@label": "sirolimus"}, {"@id": "12135", "@count": "166", "@label": "celecoxib"}, {"@id": "12646", "@count": "164", "@label": "panitumumab"}, {"@id": "12973", "@count": "156", "@label": "sunitinib"}, {"@id": "21374", "@count": "154", "@label": "pegfilgrastim"}, {"@id": "9298", "@count": "150", "@label": "Thymoglobulin"}, {"@id": "2716", "@count": "148", "@label": "alemtuzumab"}, {"@id": "17625", "@count": "146", "@label": "vorinostat (oral), Merck & Co"}, {"@id": "37370", "@count": "143", "@label": "azacitidine"}, {"@id": "8050", "@count": "141", "@label": "thalidomide, Celgene"}, {"@id": "2784", "@count": "136", "@label": "letrozole"}, {"@id": "6050", "@count": "132", "@label": "metformin hydrochloride"}, {"@id": "22965", "@count": "127", "@label": "temsirolimus"}, {"@id": "7286", "@count": "126", "@label": "goserelin"}, {"@id": "5369", "@count": "121", "@label": "ribavirin"}, {"@id": "3081", "@count": "112", "@label": "exemestane"}, {"@id": "3321", "@count": "108", "@label": "anastrozole"}, {"@id": "24142", "@count": "106", "@label": "mesna"}, {"@id": "12210", "@count": "102", "@label": "UFT"}, {"@id": "3311", "@count": "100", "@label": "bicalutamide"}, {"@id": "48946", "@count": "99", "@label": "dasatinib"}, {"@id": "36630", "@count": "97", "@label": "ipilimumab"}, {"@id": "23624", "@count": "97", "@label": "clofarabine"}, {"@id": "2765", "@count": "93", "@label": "zoledronic acid"}, {"@id": "43738", "@count": "91", "@label": "pazopanib"}, {"@id": "5267", "@count": "88", "@label": "leuprolide acetate"}, {"@id": "4705", "@count": "87", "@label": "ibritumomab tiuxetan"}, {"@id": "16748", "@count": "85", "@label": "aprepitant"}, {"@id": "10309", "@count": "82", "@label": "abiraterone"}, {"@id": "45998", "@count": "78", "@label": "interferon alfa-2b"}, {"@id": "5202", "@count": "75", "@label": "gemtuzumab"}, {"@id": "13239", "@count": "72", "@label": "decitabine (intravenous, myelodysplastic syndromes), Eisai"}, {"@id": "23625", "@count": "72", "@label": "peginterferon alfa-2a"}, {"@id": "3313", "@count": "70", "@label": "fulvestrant"}, {"@id": "44299", "@count": "69", "@label": "ketoconazole"}, {"@id": "28532", "@count": "69", "@label": "pertuzumab"}, {"@id": "42299", "@count": "68", "@label": "ofatumumab"}, {"@id": "2573", "@count": "68", "@label": "pegaspargase"}, {"@id": "2495", "@count": "67", "@label": "amifostine"}, {"@id": "3688", "@count": "66", "@label": "nedaplatin"}, {"@id": "54601", "@count": "66", "@label": "carfilzomib"}, {"@id": "54226", "@count": "65", "@label": "panobinostat (oral), Novartis"}, {"@id": "9754", "@count": "64", "@label": "palonosetron"}, {"@id": "3364", "@count": "64", "@label": "peginterferon alfa-2b"}, {"@id": "16758", "@count": "63", "@label": "plerixafor"}, {"@id": "26495", "@count": "62", "@label": "vandetanib"}, {"@id": "56368", "@count": "62", "@label": "veliparib"}, {"@id": "5999", "@count": "59", "@label": "ciclosporin, Novartis"}, {"@id": "3750", "@count": "56", "@label": "ondansetron"}, {"@id": "55288", "@count": "55", "@label": "trametinib DMSO"}, {"@id": "9829", "@count": "55", "@label": "Busulfex"}, {"@id": "15541", "@count": "55", "@label": "ixabepilone"}, {"@id": "44318", "@count": "51", "@label": "isotretinoin"}, {"@id": "2829", "@count": "51", "@label": "clarithromycin"}, {"@id": "5265", "@count": "50", "@label": "valproic acid"}, {"@id": "44316", "@count": "50", "@label": "zidovudine"}, {"@id": "4563", "@count": "49", "@label": "doxorubicin (liposome formulation), Cephalon"}, {"@id": "2606", "@count": "49", "@label": "oblimersen"}, {"@id": "2959", "@count": "49", "@label": "DaunoXome"}, {"@id": "35340", "@count": "48", "@label": "cediranib"}, {"@id": "17113", "@count": "47", "@label": "tipifarnib"}, {"@id": "61901", "@count": "46", "@label": "buparlisib"}, {"@id": "53252", "@count": "45", "@label": "recombinant human endostatin (cancer), Shandong Simcere Medgenn"}]}, {"@total": "100", "@label": "Trial Interventions Control In Regimen Name Display", "@name": "trialInterventionsControlInRegimenNameDisplay", "FilterOption": [{"@id": "44383", "@count": "122", "@label": "carboplatin"}, {"@id": "3803", "@count": "120", "@label": "paclitaxel"}, {"@id": "2953", "@count": "83", "@label": "docetaxel"}, {"@id": "3199", "@count": "77", "@label": "gemcitabine"}, {"@id": "3792", "@count": "64", "@label": "oxaliplatin"}, {"@id": "12205", "@count": "52", "@label": "capecitabine"}, {"@id": "8047", "@count": "43", "@label": "bevacizumab"}, {"@id": "13022", "@count": "40", "@label": "epirubicin"}, {"@id": "6736", "@count": "39", "@label": "rituximab"}, {"@id": "3072", "@count": "35", "@label": "etoposide phosphate"}, {"@id": "2871", "@count": "35", "@label": "irinotecan"}, {"@id": "6386", "@count": "29", "@label": "trastuzumab"}, {"@id": "6156", "@count": "23", "@label": "fludarabine"}, {"@id": "6408", "@count": "23", "@label": "vinorelbine"}, {"@id": "3669", "@count": "23", "@label": "mycophenolate mofetil"}, {"@id": "3536", "@count": "19", "@label": "pemetrexed disodium"}, {"@id": "4510", "@count": "18", "@label": "tacrolimus"}, {"@id": "6050", "@count": "16", "@label": "metformin hydrochloride"}, {"@id": "3750", "@count": "13", "@label": "ondansetron"}, {"@id": "10252", "@count": "13", "@label": "insulin glargine"}, {"@id": "10388", "@count": "11", "@label": "cetuximab"}, {"@id": "11519", "@count": "11", "@label": "mitoxantrone"}, {"@id": "5369", "@count": "11", "@label": "ribavirin"}, {"@id": "11961", "@count": "10", "@label": "erlotinib"}, {"@id": "3130", "@count": "9", "@label": "filgrastim"}, {"@id": "10084", "@count": "9", "@label": "tegafur + gimeracil + oteracil potassium"}, {"@id": "15954", "@count": "8", "@label": "bortezomib"}, {"@id": "33591", "@count": "8", "@label": "lapatinib"}, {"@id": "8832", "@count": "7", "@label": "glimepiride"}, {"@id": "4577", "@count": "7", "@label": "topotecan"}, {"@id": "23625", "@count": "7", "@label": "peginterferon alfa-2a"}, {"@id": "47000", "@count": "7", "@label": "bendamustine"}, {"@id": "7286", "@count": "6", "@label": "goserelin"}, {"@id": "29016", "@count": "6", "@label": "paclitaxel (albumin-bound nanoparticle, intravenous), Abraxis/Taiho"}, {"@id": "3364", "@count": "6", "@label": "peginterferon alfa-2b"}, {"@id": "3311", "@count": "6", "@label": "bicalutamide"}, {"@id": "10411", "@count": "6", "@label": "insulin aspart"}, {"@id": "2807", "@count": "6", "@label": "atorvastatin"}, {"@id": "27572", "@count": "6", "@label": "lenalidomide"}, {"@id": "7934", "@count": "5", "@label": "doxorubicin (liposomal, STEALTH), Alza"}, {"@id": "3353", "@count": "5", "@label": "insulin lispro"}, {"@id": "44499", "@count": "5", "@label": "sitagliptin"}, {"@id": "8050", "@count": "5", "@label": "thalidomide, Celgene"}, {"@id": "2836", "@count": "4", "@label": "clopidogrel"}, {"@id": "10172", "@count": "4", "@label": "efavirenz"}, {"@id": "3474", "@count": "4", "@label": "lamivudine"}, {"@id": "4529", "@count": "4", "@label": "temozolomide"}, {"@id": "5999", "@count": "4", "@label": "ciclosporin, Novartis"}, {"@id": "3081", "@count": "4", "@label": "exemestane"}, {"@id": "44314", "@count": "4", "@label": "tamoxifen"}, {"@id": "7121", "@count": "3", "@label": "sargramostim"}, {"@id": "44316", "@count": "3", "@label": "zidovudine"}, {"@id": "12210", "@count": "3", "@label": "UFT"}, {"@id": "3241", "@count": "3", "@label": "granisetron"}, {"@id": "44308", "@count": "3", "@label": "propofol, AstraZeneca"}, {"@id": "5267", "@count": "3", "@label": "leuprolide acetate"}, {"@id": "3492", "@count": "3", "@label": "levofloxacin"}, {"@id": "44303", "@count": "3", "@label": "midazolam"}, {"@id": "21374", "@count": "3", "@label": "pegfilgrastim"}, {"@id": "9298", "@count": "3", "@label": "Thymoglobulin"}, {"@id": "9754", "@count": "3", "@label": "palonosetron"}, {"@id": "25880", "@count": "3", "@label": "enteric-coated mycophenolate sodium, Novartis"}, {"@id": "16915", "@count": "3", "@label": "calcium levofolinate"}, {"@id": "11141", "@count": "3", "@label": "basiliximab"}, {"@id": "13928", "@count": "3", "@label": "enoxaparin sodium"}, {"@id": "37370", "@count": "3", "@label": "azacitidine"}, {"@id": "12135", "@count": "3", "@label": "celecoxib"}, {"@id": "16748", "@count": "3", "@label": "aprepitant"}, {"@id": "23624", "@count": "3", "@label": "clofarabine"}, {"@id": "49219", "@count": "2", "@label": "tenofovir disoproxil fumarate + emtricitabine (fixed dose), Gilead Sciences"}, {"@id": "44284", "@count": "2", "@label": "amoxicillin + clavulanate potassium, GSK"}, {"@id": "45998", "@count": "2", "@label": "interferon alfa-2b"}, {"@id": "36630", "@count": "2", "@label": "ipilimumab"}, {"@id": "10096", "@count": "2", "@label": "telaprevir"}, {"@id": "44279", "@count": "2", "@label": "amoxicillin"}, {"@id": "44318", "@count": "2", "@label": "isotretinoin"}, {"@id": "15541", "@count": "2", "@label": "ixabepilone"}, {"@id": "4481", "@count": "2", "@label": "stavudine"}, {"@id": "2829", "@count": "2", "@label": "clarithromycin"}, {"@id": "24142", "@count": "2", "@label": "mesna"}, {"@id": "44312", "@count": "2", "@label": "salmeterol"}, {"@id": "7310", "@count": "2", "@label": "ritonavir"}, {"@id": "4208", "@count": "2", "@label": "remifentanil"}, {"@id": "20524", "@count": "2", "@label": "paclitaxel poliglumex"}, {"@id": "9829", "@count": "2", "@label": "Busulfex"}, {"@id": "5957", "@count": "2", "@label": "budesonide (inhaled formulations), AstraZeneca"}, {"@id": "4126", "@count": "2", "@label": "pioglitazone"}, {"@id": "3159", "@count": "2", "@label": "fluticasone propionate"}, {"@id": "44375", "@count": "2", "@label": "warfarin"}, {"@id": "46890", "@count": "2", "@label": "glibenclamide"}, {"@id": "11295", "@count": "2", "@label": "valrubicin"}, {"@id": "6306", "@count": "2", "@label": "aldesleukin"}, {"@id": "17426", "@count": "2", "@label": "insulin detemir"}, {"@id": "2716", "@count": "2", "@label": "alemtuzumab"}, {"@id": "14493", "@count": "2", "@label": "tenofovir disoproxil fumarate"}, {"@id": "78947", "@count": "1", "@label": "rituximab biosimilar, Celltrion/EGIS"}, {"@id": "4645", "@count": "1", "@label": "varicella-zoster vaccine (Varivax/Zostavax)"}, {"@id": "14232", "@count": "1", "@label": "Veldona"}, {"@id": "53258", "@count": "1", "@label": "ridaforolimus"}, {"@id": "71923", "@count": "1", "@label": "rituximab biosimilar, Merck & Co"}]}, {"@total": "100", "@label": "Trial Country", "@name": "trialCountries", "FilterOption": [{"@id": "US", "@count": "22505", "@label": "US"}, {"@id": "JP", "@count": "5126", "@label": "Japan"}, {"@id": "GB", "@count": "4017", "@label": "UK"}, {"@id": "DE", "@count": "3901", "@label": "Germany"}, {"@id": "CA", "@count": "3572", "@label": "Canada"}, {"@id": "FR", "@count": "3455", "@label": "France"}, {"@id": "IT", "@count": "3180", "@label": "Italy"}, {"@id": "ES", "@count": "2650", "@label": "Spain"}, {"@id": "CN", "@count": "2425", "@label": "China"}, {"@id": "AU", "@count": "2282", "@label": "Australia"}, {"@id": "NL", "@count": "2134", "@label": "Netherlands"}, {"@id": "BE", "@count": "1952", "@label": "Belgium"}, {"@id": "KR", "@count": "1779", "@label": "South Korea"}, {"@id": "PL", "@count": "1433", "@label": "Poland"}, {"@id": "RU", "@count": "1334", "@label": "Russian Federation"}, {"@id": "AT", "@count": "1186", "@label": "Austria"}, {"@id": "SE", "@count": "1085", "@label": "Sweden"}, {"@id": "CH", "@count": "1055", "@label": "Switzerland"}, {"@id": "HU", "@count": "1033", "@label": "Hungary"}, {"@id": "CZ", "@count": "1031", "@label": "Czech Republic"}, {"@id": "IN", "@count": "994", "@label": "India"}, {"@id": "DK", "@count": "982", "@label": "Denmark"}, {"@id": "TW", "@count": "962", "@label": "Taiwan"}, {"@id": "IL", "@count": "921", "@label": "Israel"}, {"@id": "BR", "@count": "914", "@label": "Brazil"}, {"@id": "MX", "@count": "744", "@label": "Mexico"}, {"@id": "AR", "@count": "718", "@label": "Argentina"}, {"@id": "ZA", "@count": "681", "@label": "South Africa"}, {"@id": "GR", "@count": "675", "@label": "Greece"}, {"@id": "RO", "@count": "595", "@label": "Romania"}, {"@id": "NZ", "@count": "579", "@label": "New Zealand"}, {"@id": "FI", "@count": "575", "@label": "Finland"}, {"@id": "NO", "@count": "556", "@label": "Norway"}, {"@id": "SG", "@count": "538", "@label": "Singapore"}, {"@id": "HK", "@count": "518", "@label": "Hong Kong"}, {"@id": "PR", "@count": "515", "@label": "Puerto Rico"}, {"@id": "UA", "@count": "463", "@label": "Ukraine"}, {"@id": "TR", "@count": "457", "@label": "Turkey"}, {"@id": "PT", "@count": "450", "@label": "Portugal"}, {"@id": "SK", "@count": "424", "@label": "Slovakia"}, {"@id": "BG", "@count": "424", "@label": "Bulgaria"}, {"@id": "IE", "@count": "416", "@label": "Ireland"}, {"@id": "TH", "@count": "396", "@label": "Thailand"}, {"@id": "CL", "@count": "336", "@label": "Chile"}, {"@id": "PE", "@count": "336", "@label": "Peru"}, {"@id": "LT", "@count": "240", "@label": "Lithuania"}, {"@id": "CO", "@count": "237", "@label": "Colombia"}, {"@id": "IR", "@count": "237", "@label": "Iran"}, {"@id": "HR", "@count": "232", "@label": "Croatia"}, {"@id": "PH", "@count": "228", "@label": "Philippines"}, {"@id": "MY", "@count": "225", "@label": "Malaysia"}, {"@id": "EE", "@count": "220", "@label": "Estonia"}, {"@id": "RS", "@count": "217", "@label": "Serbia"}, {"@id": "X5", "@count": "215", "@label": "Europe"}, {"@id": "LV", "@count": "205", "@label": "Latvia"}, {"@id": "SI", "@count": "156", "@label": "Slovenia"}, {"@id": "EG", "@count": "155", "@label": "Egypt"}, {"@id": "CU", "@count": "81", "@label": "Cuba"}, {"@id": "SA", "@count": "79", "@label": "Saudi Arabia"}, {"@id": "LB", "@count": "69", "@label": "Lebanon"}, {"@id": "BA", "@count": "66", "@label": "Bosnia and Herzegovina"}, {"@id": "GT", "@count": "61", "@label": "Guatemala"}, {"@id": "PA", "@count": "60", "@label": "Panama"}, {"@id": "GE", "@count": "58", "@label": "Georgia"}, {"@id": "BY", "@count": "57", "@label": "Belarus"}, {"@id": "ID", "@count": "54", "@label": "Indonesia"}, {"@id": "VE", "@count": "54", "@label": "Venezuela"}, {"@id": "XD", "@count": "52", "@label": "North America"}, {"@id": "PK", "@count": "51", "@label": "Pakistan"}, {"@id": "TN", "@count": "44", "@label": "Tunisia"}, {"@id": "IS", "@count": "38", "@label": "Iceland"}, {"@id": "CR", "@count": "37", "@label": "Costa Rica"}, {"@id": "VN", "@count": "33", "@label": "Vietnam"}, {"@id": "X2", "@count": "32", "@label": "Asia"}, {"@id": "LU", "@count": "30", "@label": "Luxembourg"}, {"@id": "MK", "@count": "29", "@label": "Macedonia, The Former Yugoslav Republic of"}, {"@id": "EC", "@count": "27", "@label": "Ecuador"}, {"@id": "MA", "@count": "26", "@label": "Morocco"}, {"@id": "AE", "@count": "26", "@label": "United Arab Emirates"}, {"@id": "EU", "@count": "25", "@label": "EU"}, {"@id": "KP", "@count": "25", "@label": "North Korea"}, {"@id": "UY", "@count": "24", "@label": "Uruguay"}, {"@id": "JO", "@count": "21", "@label": "Jordan"}, {"@id": "UG", "@count": "21", "@label": "Uganda"}, {"@id": "XE", "@count": "20", "@label": "South America"}, {"@id": "XA", "@count": "18", "@label": "Not assigned"}, {"@id": "MT", "@count": "18", "@label": "Malta"}, {"@id": "DO", "@count": "18", "@label": "Dominican Republic"}, {"@id": "CY", "@count": "17", "@label": "Cyprus"}, {"@id": "DZ", "@count": "17", "@label": "Algeria"}, {"@id": "TZ", "@count": "16", "@label": "Tanzania"}, {"@id": "LK", "@count": "14", "@label": "Sri Lanka"}, {"@id": "KE", "@count": "14", "@label": "Kenya"}, {"@id": "BD", "@count": "13", "@label": "Bangladesh"}, {"@id": "MD", "@count": "13", "@label": "Moldova, Republic of"}, {"@id": "XW", "@count": "12", "@label": "Western Europe"}, {"@id": "MW", "@count": "10", "@label": "Malawi"}, {"@id": "ME", "@count": "10", "@label": "Montenegro"}, {"@id": "KW", "@count": "10", "@label": "Kuwait"}, {"@id": "KZ", "@count": "9", "@label": "Kazakhstan"}]}, {"@total": "100", "@label": "Trial Indications Pioneer", "@name": "trialIndicationsPioneer", "FilterOption": [{"@id": "725", "@count": "861", "@label": "Solid tumor"}, {"@id": "3713", "@count": "682", "@label": "Advanced solid tumor"}, {"@id": "651", "@count": "608", "@label": "Cancer"}, {"@id": "49", "@count": "571", "@label": "Breast tumor"}, {"@id": "1262", "@count": "433", "@label": "Non-small-cell lung cancer"}, {"@id": "799", "@count": "389", "@label": "Ovary tumor"}, {"@id": "205", "@count": "356", "@label": "Melanoma"}, {"@id": "989", "@count": "354", "@label": "Colorectal tumor"}, {"@id": "1069", "@count": "352", "@label": "Metastasis"}, {"@id": "3246", "@count": "334", "@label": "Hormone refractory prostate cancer"}, {"@id": "319", "@count": "331", "@label": "Non-Hodgkin lymphoma"}, {"@id": "203", "@count": "328", "@label": "Lymphoma"}, {"@id": "3657", "@count": "323", "@label": "Metastatic breast cancer"}, {"@id": "276", "@count": "301", "@label": "Prostate tumor"}, {"@id": "1731", "@count": "290", "@label": "Acute myelogenous leukemia"}, {"@id": "1828", "@count": "288", "@label": "Multiple myeloma"}, {"@id": "3665", "@count": "286", "@label": "Metastatic non small cell lung cancer"}, {"@id": "249", "@count": "275", "@label": "Pancreas tumor"}, {"@id": "623", "@count": "244", "@label": "Head and neck tumor"}, {"@id": "1767", "@count": "226", "@label": "Hepatocellular carcinoma"}, {"@id": "1766", "@count": "225", "@label": "Renal cell carcinoma"}, {"@id": "1272", "@count": "214", "@label": "Myelodysplastic syndrome"}, {"@id": "2454", "@count": "210", "@label": "Glioblastoma"}, {"@id": "3658", "@count": "207", "@label": "Metastatic colorectal cancer"}, {"@id": "3257", "@count": "204", "@label": "Stage IV melanoma"}, {"@id": "1734", "@count": "200", "@label": "Chronic lymphocytic leukemia"}, {"@id": "1108", "@count": "198", "@label": "Glioma"}, {"@id": "755", "@count": "192", "@label": "Lung tumor"}, {"@id": "199", "@count": "184", "@label": "Leukemia"}, {"@id": "3669", "@count": "181", "@label": "Metastatic pancreas cancer"}, {"@id": "3083", "@count": "171", "@label": "Peritoneal tumor"}, {"@id": "1261", "@count": "167", "@label": "Small-cell lung cancer"}, {"@id": "230", "@count": "163", "@label": "Neoplasm"}, {"@id": "194", "@count": "162", "@label": "Sarcoma"}, {"@id": "127", "@count": "161", "@label": "Stomach tumor"}, {"@id": "760", "@count": "158", "@label": "Brain tumor"}, {"@id": "2054", "@count": "158", "@label": "Hematological neoplasm"}, {"@id": "1728", "@count": "157", "@label": "Acute lymphoblastic leukemia"}, {"@id": "307", "@count": "155", "@label": "Squamous cell carcinoma"}, {"@id": "1735", "@count": "148", "@label": "Chronic myelocytic leukemia"}, {"@id": "1011", "@count": "131", "@label": "Esophagus tumor"}, {"@id": "427", "@count": "131", "@label": "Uterine cervix tumor"}, {"@id": "2243", "@count": "130", "@label": "Fallopian tube cancer"}, {"@id": "161", "@count": "123", "@label": "Hodgkins disease"}, {"@id": "2380", "@count": "116", "@label": "Bladder cancer"}, {"@id": "316", "@count": "116", "@label": "B-cell lymphoma"}, {"@id": "2399", "@count": "115", "@label": "Adenocarcinoma"}, {"@id": "999", "@count": "115", "@label": "Renal tumor"}, {"@id": "759", "@count": "112", "@label": "Central nervous system tumor"}, {"@id": "54", "@count": "105", "@label": "Carcinoma"}, {"@id": "3666", "@count": "103", "@label": "Metastatic stomach cancer"}, {"@id": "158", "@count": "99", "@label": "HIV infection"}, {"@id": "2726", "@count": "99", "@label": "Neuroblastoma"}, {"@id": "767", "@count": "97", "@label": "Colon tumor"}, {"@id": "1240", "@count": "96", "@label": "Mesothelioma"}, {"@id": "1705", "@count": "93", "@label": "Endometrioid carcinoma"}, {"@id": "202", "@count": "93", "@label": "Liver tumor"}, {"@id": "1749", "@count": "88", "@label": "Diffuse large B-cell lymphoma"}, {"@id": "3673", "@count": "80", "@label": "Metastatic head and neck cancer"}, {"@id": "1745", "@count": "78", "@label": "Follicle center lymphoma"}, {"@id": "20", "@count": "77", "@label": "Pain"}, {"@id": "3664", "@count": "76", "@label": "Metastatic prostate cancer"}, {"@id": "1744", "@count": "75", "@label": "Mantle cell lymphoma"}, {"@id": "3866", "@count": "74", "@label": "Metastatic ovary cancer"}, {"@id": "936", "@count": "73", "@label": "Kaposis sarcoma"}, {"@id": "3378", "@count": "73", "@label": "Soft tissue sarcoma"}, {"@id": "3247", "@count": "73", "@label": "Hormone dependent prostate cancer"}, {"@id": "291", "@count": "70", "@label": "Rheumatoid arthritis"}, {"@id": "837", "@count": "68", "@label": "Non-insulin dependent diabetes"}, {"@id": "3211", "@count": "68", "@label": "Cancer pain"}, {"@id": "616", "@count": "62", "@label": "Graft versus host disease"}, {"@id": "1991", "@count": "62", "@label": "Neutropenia"}, {"@id": "131", "@count": "62", "@label": "Gastrointestinal tumor"}, {"@id": "1771", "@count": "61", "@label": "Transitional cell carcinoma"}, {"@id": "3667", "@count": "61", "@label": "Metastatic esophageal cancer"}, {"@id": "273", "@count": "61", "@label": "Myeloproliferative disorder"}, {"@id": "1727", "@count": "59", "@label": "Acute leukemia"}, {"@id": "3467", "@count": "58", "@label": "Metastatic renal cancer"}, {"@id": "3256", "@count": "57", "@label": "Stage III melanoma"}, {"@id": "1134", "@count": "56", "@label": "Thyroid tumor"}, {"@id": "1768", "@count": "53", "@label": "Nasopharyngeal carcinoma"}, {"@id": "311", "@count": "53", "@label": "T-cell lymphoma"}, {"@id": "1128", "@count": "51", "@label": "Neuroendocrine tumor"}, {"@id": "153", "@count": "51", "@label": "Hepatitis C virus infection"}, {"@id": "1754", "@count": "51", "@label": "Cutaneous T-cell lymphoma"}, {"@id": "17", "@count": "49", "@label": "Anemia"}, {"@id": "3462", "@count": "48", "@label": "Metastatic liver cancer"}, {"@id": "1055", "@count": "47", "@label": "Rectal tumor"}, {"@id": "1772", "@count": "45", "@label": "Osteosarcoma"}, {"@id": "281", "@count": "45", "@label": "Psoriasis"}, {"@id": "2436", "@count": "45", "@label": "Myelofibrosis"}, {"@id": "1765", "@count": "45", "@label": "Cholangiocarcinoma"}, {"@id": "3205", "@count": "43", "@label": "Gastrointestinal stromal tumor"}, {"@id": "1516", "@count": "41", "@label": "Biliary cancer"}, {"@id": "1829", "@count": "41", "@label": "Bone metastases"}, {"@id": "3471", "@count": "39", "@label": "Metastatic brain cancer"}, {"@id": "2567", "@count": "39", "@label": "Anaplastic astrocytoma"}, {"@id": "3146", "@count": "38", "@label": "Gallbladder tumor"}, {"@id": "3668", "@count": "37", "@label": "Metastatic lung cancer"}, {"@id": "191", "@count": "36", "@label": "Influenza virus infection"}]}, {"@total": "100", "@label": "Indications", "@name": "indications", "FilterOption": [{"@id": "49", "@count": "3375", "@label": "Breast tumor"}, {"@id": "1262", "@count": "2283", "@label": "Non-small-cell lung cancer"}, {"@id": "725", "@count": "2110", "@label": "Solid tumor"}, {"@id": "3657", "@count": "1516", "@label": "Metastatic breast cancer"}, {"@id": "3665", "@count": "1495", "@label": "Metastatic non small cell lung cancer"}, {"@id": "3713", "@count": "1361", "@label": "Advanced solid tumor"}, {"@id": "1828", "@count": "1351", "@label": "Multiple myeloma"}, {"@id": "989", "@count": "1349", "@label": "Colorectal tumor"}, {"@id": "799", "@count": "1339", "@label": "Ovary tumor"}, {"@id": "319", "@count": "1311", "@label": "Non-Hodgkin lymphoma"}, {"@id": "1731", "@count": "1307", "@label": "Acute myelogenous leukemia"}, {"@id": "276", "@count": "1206", "@label": "Prostate tumor"}, {"@id": "651", "@count": "1194", "@label": "Cancer"}, {"@id": "3658", "@count": "1172", "@label": "Metastatic colorectal cancer"}, {"@id": "1767", "@count": "1032", "@label": "Hepatocellular carcinoma"}, {"@id": "3246", "@count": "969", "@label": "Hormone refractory prostate cancer"}, {"@id": "623", "@count": "940", "@label": "Head and neck tumor"}, {"@id": "249", "@count": "912", "@label": "Pancreas tumor"}, {"@id": "1272", "@count": "903", "@label": "Myelodysplastic syndrome"}, {"@id": "205", "@count": "882", "@label": "Melanoma"}, {"@id": "203", "@count": "841", "@label": "Lymphoma"}, {"@id": "1766", "@count": "753", "@label": "Renal cell carcinoma"}, {"@id": "1069", "@count": "749", "@label": "Metastasis"}, {"@id": "1734", "@count": "718", "@label": "Chronic lymphocytic leukemia"}, {"@id": "127", "@count": "711", "@label": "Stomach tumor"}, {"@id": "2454", "@count": "703", "@label": "Glioblastoma"}, {"@id": "1735", "@count": "671", "@label": "Chronic myelocytic leukemia"}, {"@id": "3257", "@count": "619", "@label": "Stage IV melanoma"}, {"@id": "1728", "@count": "575", "@label": "Acute lymphoblastic leukemia"}, {"@id": "3669", "@count": "568", "@label": "Metastatic pancreas cancer"}, {"@id": "1011", "@count": "567", "@label": "Esophagus tumor"}, {"@id": "1108", "@count": "553", "@label": "Glioma"}, {"@id": "3666", "@count": "530", "@label": "Metastatic stomach cancer"}, {"@id": "427", "@count": "523", "@label": "Uterine cervix tumor"}, {"@id": "199", "@count": "523", "@label": "Leukemia"}, {"@id": "1261", "@count": "522", "@label": "Small-cell lung cancer"}, {"@id": "837", "@count": "519", "@label": "Non-insulin dependent diabetes"}, {"@id": "20", "@count": "518", "@label": "Pain"}, {"@id": "307", "@count": "495", "@label": "Squamous cell carcinoma"}, {"@id": "3083", "@count": "494", "@label": "Peritoneal tumor"}, {"@id": "755", "@count": "485", "@label": "Lung tumor"}, {"@id": "760", "@count": "468", "@label": "Brain tumor"}, {"@id": "161", "@count": "431", "@label": "Hodgkins disease"}, {"@id": "2380", "@count": "417", "@label": "Bladder cancer"}, {"@id": "158", "@count": "389", "@label": "HIV infection"}, {"@id": "17", "@count": "374", "@label": "Anemia"}, {"@id": "2054", "@count": "339", "@label": "Hematological neoplasm"}, {"@id": "2243", "@count": "338", "@label": "Fallopian tube cancer"}, {"@id": "230", "@count": "337", "@label": "Neoplasm"}, {"@id": "194", "@count": "325", "@label": "Sarcoma"}, {"@id": "1749", "@count": "310", "@label": "Diffuse large B-cell lymphoma"}, {"@id": "759", "@count": "305", "@label": "Central nervous system tumor"}, {"@id": "291", "@count": "299", "@label": "Rheumatoid arthritis"}, {"@id": "616", "@count": "293", "@label": "Graft versus host disease"}, {"@id": "316", "@count": "291", "@label": "B-cell lymphoma"}, {"@id": "1185", "@count": "287", "@label": "Chronic obstructive pulmonary disease"}, {"@id": "1705", "@count": "286", "@label": "Endometrioid carcinoma"}, {"@id": "2726", "@count": "270", "@label": "Neuroblastoma"}, {"@id": "1744", "@count": "253", "@label": "Mantle cell lymphoma"}, {"@id": "153", "@count": "249", "@label": "Hepatitis C virus infection"}, {"@id": "3211", "@count": "246", "@label": "Cancer pain"}, {"@id": "3673", "@count": "245", "@label": "Metastatic head and neck cancer"}, {"@id": "1745", "@count": "238", "@label": "Follicle center lymphoma"}, {"@id": "202", "@count": "238", "@label": "Liver tumor"}, {"@id": "2399", "@count": "231", "@label": "Adenocarcinoma"}, {"@id": "767", "@count": "228", "@label": "Colon tumor"}, {"@id": "3664", "@count": "226", "@label": "Metastatic prostate cancer"}, {"@id": "1240", "@count": "224", "@label": "Mesothelioma"}, {"@id": "1055", "@count": "221", "@label": "Rectal tumor"}, {"@id": "1768", "@count": "201", "@label": "Nasopharyngeal carcinoma"}, {"@id": "191", "@count": "196", "@label": "Influenza virus infection"}, {"@id": "999", "@count": "195", "@label": "Renal tumor"}, {"@id": "31", "@count": "190", "@label": "Asthma"}, {"@id": "1241", "@count": "186", "@label": "Prostate hyperplasia"}, {"@id": "3378", "@count": "182", "@label": "Soft tissue sarcoma"}, {"@id": "3667", "@count": "181", "@label": "Metastatic esophageal cancer"}, {"@id": "281", "@count": "180", "@label": "Psoriasis"}, {"@id": "1829", "@count": "176", "@label": "Bone metastases"}, {"@id": "1128", "@count": "174", "@label": "Neuroendocrine tumor"}, {"@id": "54", "@count": "170", "@label": "Carcinoma"}, {"@id": "2984", "@count": "167", "@label": "Kidney transplantation"}, {"@id": "3247", "@count": "166", "@label": "Hormone dependent prostate cancer"}, {"@id": "1771", "@count": "160", "@label": "Transitional cell carcinoma"}, {"@id": "1134", "@count": "160", "@label": "Thyroid tumor"}, {"@id": "1516", "@count": "158", "@label": "Biliary cancer"}, {"@id": "3467", "@count": "154", "@label": "Metastatic renal cancer"}, {"@id": "3205", "@count": "150", "@label": "Gastrointestinal stromal tumor"}, {"@id": "273", "@count": "147", "@label": "Myeloproliferative disorder"}, {"@id": "3866", "@count": "147", "@label": "Metastatic ovary cancer"}, {"@id": "1765", "@count": "141", "@label": "Cholangiocarcinoma"}, {"@id": "1991", "@count": "138", "@label": "Neutropenia"}, {"@id": "3462", "@count": "133", "@label": "Metastatic liver cancer"}, {"@id": "14", "@count": "133", "@label": "Alzheimers disease"}, {"@id": "404", "@count": "129", "@label": "Constipation"}, {"@id": "238", "@count": "128", "@label": "Obesity"}, {"@id": "3671", "@count": "126", "@label": "Metastatic rectal cancer"}, {"@id": "178", "@count": "123", "@label": "Hypertension"}, {"@id": "1727", "@count": "123", "@label": "Acute leukemia"}, {"@id": "3256", "@count": "123", "@label": "Stage III melanoma"}, {"@id": "131", "@count": "122", "@label": "Gastrointestinal tumor"}]}, {"@total": "100", "@label": "Active Controls", "@name": "trialActiveControls", "FilterOption": [{"@id": "2953", "@count": "189", "@label": "docetaxel"}, {"@id": "3803", "@count": "167", "@label": "paclitaxel"}, {"@id": "3199", "@count": "163", "@label": "gemcitabine"}, {"@id": "44383", "@count": "130", "@label": "carboplatin"}, {"@id": "12205", "@count": "102", "@label": "capecitabine"}, {"@id": "3792", "@count": "68", "@label": "oxaliplatin"}, {"@id": "6736", "@count": "66", "@label": "rituximab"}, {"@id": "8047", "@count": "54", "@label": "bevacizumab"}, {"@id": "2871", "@count": "48", "@label": "irinotecan"}, {"@id": "3536", "@count": "45", "@label": "pemetrexed disodium"}, {"@id": "13022", "@count": "42", "@label": "epirubicin"}, {"@id": "6408", "@count": "41", "@label": "vinorelbine"}, {"@id": "3072", "@count": "41", "@label": "etoposide phosphate"}, {"@id": "6386", "@count": "40", "@label": "trastuzumab"}, {"@id": "44314", "@count": "40", "@label": "tamoxifen"}, {"@id": "4510", "@count": "40", "@label": "tacrolimus"}, {"@id": "3130", "@count": "37", "@label": "filgrastim"}, {"@id": "11961", "@count": "36", "@label": "erlotinib"}, {"@id": "4529", "@count": "35", "@label": "temozolomide"}, {"@id": "6050", "@count": "32", "@label": "metformin hydrochloride"}, {"@id": "3750", "@count": "32", "@label": "ondansetron"}, {"@id": "10252", "@count": "30", "@label": "insulin glargine"}, {"@id": "3669", "@count": "29", "@label": "mycophenolate mofetil"}, {"@id": "29831", "@count": "27", "@label": "sorafenib"}, {"@id": "11460", "@count": "26", "@label": "imatinib"}, {"@id": "6156", "@count": "25", "@label": "fludarabine"}, {"@id": "8165", "@count": "24", "@label": "tiotropium bromide"}, {"@id": "10388", "@count": "24", "@label": "cetuximab"}, {"@id": "3321", "@count": "23", "@label": "anastrozole"}, {"@id": "4577", "@count": "21", "@label": "topotecan"}, {"@id": "5267", "@count": "21", "@label": "leuprolide acetate"}, {"@id": "44409", "@count": "20", "@label": "Fluzone"}, {"@id": "2765", "@count": "20", "@label": "zoledronic acid"}, {"@id": "3081", "@count": "18", "@label": "exemestane"}, {"@id": "7934", "@count": "18", "@label": "doxorubicin (liposomal, STEALTH), Alza"}, {"@id": "21374", "@count": "18", "@label": "pegfilgrastim"}, {"@id": "44312", "@count": "17", "@label": "salmeterol"}, {"@id": "10084", "@count": "17", "@label": "tegafur + gimeracil + oteracil potassium"}, {"@id": "12978", "@count": "17", "@label": "moxifloxacin"}, {"@id": "2784", "@count": "16", "@label": "letrozole"}, {"@id": "11519", "@count": "16", "@label": "mitoxantrone"}, {"@id": "7286", "@count": "16", "@label": "goserelin"}, {"@id": "6140", "@count": "15", "@label": "formoterol"}, {"@id": "15954", "@count": "15", "@label": "bortezomib"}, {"@id": "8832", "@count": "15", "@label": "glimepiride"}, {"@id": "2807", "@count": "15", "@label": "atorvastatin"}, {"@id": "12973", "@count": "15", "@label": "sunitinib"}, {"@id": "33591", "@count": "14", "@label": "lapatinib"}, {"@id": "23625", "@count": "13", "@label": "peginterferon alfa-2a"}, {"@id": "3311", "@count": "13", "@label": "bicalutamide"}, {"@id": "4126", "@count": "13", "@label": "pioglitazone"}, {"@id": "29016", "@count": "13", "@label": "paclitaxel (albumin-bound nanoparticle, intravenous), Abraxis/Taiho"}, {"@id": "14336", "@count": "12", "@label": "fluticasone propionate + salmeterol (asthma and COPD), GlaxoSmithKline"}, {"@id": "3353", "@count": "12", "@label": "insulin lispro"}, {"@id": "10411", "@count": "12", "@label": "insulin aspart"}, {"@id": "12135", "@count": "11", "@label": "celecoxib"}, {"@id": "5369", "@count": "11", "@label": "ribavirin"}, {"@id": "5999", "@count": "11", "@label": "ciclosporin, Novartis"}, {"@id": "3241", "@count": "11", "@label": "granisetron"}, {"@id": "44375", "@count": "10", "@label": "warfarin"}, {"@id": "11603", "@count": "10", "@label": "gefitinib"}, {"@id": "4513", "@count": "10", "@label": "tamsulosin"}, {"@id": "45998", "@count": "9", "@label": "interferon alfa-2b"}, {"@id": "12210", "@count": "9", "@label": "UFT"}, {"@id": "5800", "@count": "9", "@label": "pantoprazole"}, {"@id": "13340", "@count": "9", "@label": "everolimus"}, {"@id": "3474", "@count": "9", "@label": "lamivudine"}, {"@id": "27572", "@count": "9", "@label": "lenalidomide"}, {"@id": "47000", "@count": "9", "@label": "bendamustine"}, {"@id": "44313", "@count": "9", "@label": "simvastatin"}, {"@id": "44292", "@count": "8", "@label": "fluconazole"}, {"@id": "3492", "@count": "8", "@label": "levofloxacin"}, {"@id": "3268", "@count": "8", "@label": "Engerix B"}, {"@id": "13928", "@count": "8", "@label": "enoxaparin sodium"}, {"@id": "44499", "@count": "8", "@label": "sitagliptin"}, {"@id": "7413", "@count": "8", "@label": "darbepoetin alfa"}, {"@id": "3364", "@count": "7", "@label": "peginterferon alfa-2b"}, {"@id": "67892", "@count": "7", "@label": "epoetin alfa (Procrit/Eprex, Johnson & Johnson)"}, {"@id": "37370", "@count": "7", "@label": "azacitidine"}, {"@id": "6306", "@count": "7", "@label": "aldesleukin"}, {"@id": "7067", "@count": "7", "@label": "imiquimod"}, {"@id": "44401", "@count": "7", "@label": "vancomycin"}, {"@id": "8050", "@count": "7", "@label": "thalidomide, Celgene"}, {"@id": "6342", "@count": "7", "@label": "rabies vaccine, Aventis Pasteur"}, {"@id": "7121", "@count": "6", "@label": "sargramostim"}, {"@id": "2472", "@count": "6", "@label": "alendronic acid"}, {"@id": "3313", "@count": "6", "@label": "fulvestrant"}, {"@id": "2836", "@count": "6", "@label": "clopidogrel"}, {"@id": "44303", "@count": "6", "@label": "midazolam"}, {"@id": "36630", "@count": "6", "@label": "ipilimumab"}, {"@id": "7080", "@count": "6", "@label": "Pneumovax 23"}, {"@id": "5957", "@count": "6", "@label": "budesonide (inhaled formulations), AstraZeneca"}, {"@id": "44316", "@count": "5", "@label": "zidovudine"}, {"@id": "17837", "@count": "5", "@label": "testosterone gel, Solvay/Bayer"}, {"@id": "2944", "@count": "5", "@label": "pamidronate disodium"}, {"@id": "3411", "@count": "5", "@label": "itraconazole"}, {"@id": "44384", "@count": "5", "@label": "ceftriaxone"}, {"@id": "2736", "@count": "5", "@label": "cefepime"}, {"@id": "5148", "@count": "5", "@label": "liraglutide"}, {"@id": "9247", "@count": "5", "@label": "tretinoin"}]}, {"@total": "29", "@label": "Trial Terms Design", "@name": "trialTermsDesign", "FilterOption": [{"@id": "SSTINV", "@count": "52482", "@label": "Interventional"}, {"@id": "SIPTRE", "@count": "48420", "@label": "Treatment"}, {"@id": "SIMOPN", "@count": "31453", "@label": "Open Label"}, {"@id": "SIARND", "@count": "19891", "@label": "Randomized"}, {"@id": "SISSNG", "@count": "18423", "@label": "Single Group Assignment"}, {"@id": "SISPRL", "@count": "14970", "@label": "Parallel Assignment"}, {"@id": "SIANON", "@count": "12815", "@label": "Non-Randomized"}, {"@id": "SIMMBD", "@count": "8081", "@label": "Multiple Blind"}, {"@id": "SICPLC", "@count": "7283", "@label": "Placebo Control"}, {"@id": "SICACT", "@count": "5326", "@label": "Active Control"}, {"@id": "SICNOC", "@count": "5161", "@label": "No Control"}, {"@id": "SIPPRE", "@count": "2555", "@label": "Prevention"}, {"@id": "SSTOBS", "@count": "2371", "@label": "Observational"}, {"@id": "SOTPRO", "@count": "1543", "@label": "Prospective"}, {"@id": "SISXOV", "@count": "1416", "@label": "Crossover Assignment"}, {"@id": "SOSCOH", "@count": "1029", "@label": "Cohort"}, {"@id": "SIMSBD", "@count": "973", "@label": "Single Blind"}, {"@id": "SICHST", "@count": "879", "@label": "Historical Control"}, {"@id": "SIPDIA", "@count": "876", "@label": "Diagnosis"}, {"@id": "SICDSC", "@count": "704", "@label": "Dose Comparison"}, {"@id": "SOSCSC", "@count": "534", "@label": "Case Control"}, {"@id": "SOTRET", "@count": "521", "@label": "Retrospective"}, {"@id": "SISFCT", "@count": "359", "@label": "Factorial Assignment"}, {"@id": "SODXSC", "@count": "130", "@label": "Cross-sectional"}, {"@id": "SODLNG", "@count": "102", "@label": "Longitudinal"}, {"@id": "SOSDEF", "@count": "69", "@label": "Defined Population"}, {"@id": "SISEAA", "@count": "28", "@label": "Expanded Access Assignment"}, {"@id": "SOSCON", "@count": "6", "@label": "Convenience Sample"}, {"@id": "SOSRND", "@count": "6", "@label": "Random Sample"}]}, {"@total": "100", "@label": "Interventions", "@name": "trialInterventions", "FilterOption": [{"@id": "3199", "@count": "2394", "@label": "gemcitabine"}, {"@id": "2953", "@count": "2323", "@label": "docetaxel"}, {"@id": "3803", "@count": "2316", "@label": "paclitaxel"}, {"@id": "44383", "@count": "2297", "@label": "carboplatin"}, {"@id": "8047", "@count": "1760", "@label": "bevacizumab"}, {"@id": "3792", "@count": "1625", "@label": "oxaliplatin"}, {"@id": "12205", "@count": "1519", "@label": "capecitabine"}, {"@id": "2871", "@count": "1462", "@label": "irinotecan"}, {"@id": "6736", "@count": "1354", "@label": "rituximab"}, {"@id": "3072", "@count": "1306", "@label": "etoposide phosphate"}, {"@id": "11961", "@count": "868", "@label": "erlotinib"}, {"@id": "3130", "@count": "843", "@label": "filgrastim"}, {"@id": "6156", "@count": "827", "@label": "fludarabine"}, {"@id": "10388", "@count": "811", "@label": "cetuximab"}, {"@id": "10084", "@count": "805", "@label": "tegafur + gimeracil + oteracil potassium"}, {"@id": "3536", "@count": "750", "@label": "pemetrexed disodium"}, {"@id": "15954", "@count": "730", "@label": "bortezomib"}, {"@id": "29831", "@count": "718", "@label": "sorafenib"}, {"@id": "6386", "@count": "715", "@label": "trastuzumab"}, {"@id": "4529", "@count": "693", "@label": "temozolomide"}, {"@id": "27572", "@count": "599", "@label": "lenalidomide"}, {"@id": "13022", "@count": "583", "@label": "epirubicin"}, {"@id": "6408", "@count": "545", "@label": "vinorelbine"}, {"@id": "13340", "@count": "511", "@label": "everolimus"}, {"@id": "11460", "@count": "494", "@label": "imatinib"}, {"@id": "12973", "@count": "449", "@label": "sunitinib"}, {"@id": "4577", "@count": "426", "@label": "topotecan"}, {"@id": "11603", "@count": "405", "@label": "gefitinib"}, {"@id": "29016", "@count": "371", "@label": "paclitaxel (albumin-bound nanoparticle, intravenous), Abraxis/Taiho"}, {"@id": "44314", "@count": "351", "@label": "tamoxifen"}, {"@id": "3669", "@count": "342", "@label": "mycophenolate mofetil"}, {"@id": "4510", "@count": "341", "@label": "tacrolimus"}, {"@id": "6306", "@count": "334", "@label": "aldesleukin"}, {"@id": "7121", "@count": "322", "@label": "sargramostim"}, {"@id": "7934", "@count": "317", "@label": "doxorubicin (liposomal, STEALTH), Alza"}, {"@id": "33591", "@count": "315", "@label": "lapatinib"}, {"@id": "11519", "@count": "312", "@label": "mitoxantrone"}, {"@id": "2765", "@count": "289", "@label": "zoledronic acid"}, {"@id": "2784", "@count": "278", "@label": "letrozole"}, {"@id": "12135", "@count": "266", "@label": "celecoxib"}, {"@id": "48946", "@count": "261", "@label": "dasatinib"}, {"@id": "4200", "@count": "255", "@label": "sirolimus"}, {"@id": "47000", "@count": "247", "@label": "bendamustine"}, {"@id": "2716", "@count": "244", "@label": "alemtuzumab"}, {"@id": "6050", "@count": "232", "@label": "metformin hydrochloride"}, {"@id": "37370", "@count": "230", "@label": "azacitidine"}, {"@id": "21374", "@count": "228", "@label": "pegfilgrastim"}, {"@id": "43738", "@count": "223", "@label": "pazopanib"}, {"@id": "12646", "@count": "220", "@label": "panitumumab"}, {"@id": "17625", "@count": "218", "@label": "vorinostat (oral), Merck & Co"}, {"@id": "8050", "@count": "216", "@label": "thalidomide, Celgene"}, {"@id": "3321", "@count": "213", "@label": "anastrozole"}, {"@id": "3081", "@count": "211", "@label": "exemestane"}, {"@id": "22965", "@count": "208", "@label": "temsirolimus"}, {"@id": "9298", "@count": "199", "@label": "Thymoglobulin"}, {"@id": "36630", "@count": "183", "@label": "ipilimumab"}, {"@id": "7286", "@count": "169", "@label": "goserelin"}, {"@id": "51388", "@count": "153", "@label": "nilotinib"}, {"@id": "4705", "@count": "145", "@label": "ibritumomab tiuxetan"}, {"@id": "3311", "@count": "144", "@label": "bicalutamide"}, {"@id": "5267", "@count": "144", "@label": "leuprolide acetate"}, {"@id": "12210", "@count": "140", "@label": "UFT"}, {"@id": "23624", "@count": "139", "@label": "clofarabine"}, {"@id": "5369", "@count": "137", "@label": "ribavirin"}, {"@id": "3313", "@count": "133", "@label": "fulvestrant"}, {"@id": "13239", "@count": "131", "@label": "decitabine (intravenous, myelodysplastic syndromes), Eisai"}, {"@id": "24142", "@count": "126", "@label": "mesna"}, {"@id": "16748", "@count": "120", "@label": "aprepitant"}, {"@id": "10309", "@count": "117", "@label": "abiraterone"}, {"@id": "15541", "@count": "117", "@label": "ixabepilone"}, {"@id": "54226", "@count": "116", "@label": "panobinostat (oral), Novartis"}, {"@id": "45998", "@count": "115", "@label": "interferon alfa-2b"}, {"@id": "42299", "@count": "112", "@label": "ofatumumab"}, {"@id": "26495", "@count": "110", "@label": "vandetanib"}, {"@id": "23625", "@count": "109", "@label": "peginterferon alfa-2a"}, {"@id": "17113", "@count": "108", "@label": "tipifarnib"}, {"@id": "28773", "@count": "107", "@label": "eribulin mesylate"}, {"@id": "5202", "@count": "105", "@label": "gemtuzumab"}, {"@id": "9754", "@count": "104", "@label": "palonosetron"}, {"@id": "4567", "@count": "104", "@label": "etanercept"}, {"@id": "2495", "@count": "100", "@label": "amifostine"}, {"@id": "54449", "@count": "98", "@label": "afatinib"}, {"@id": "39209", "@count": "98", "@label": "axitinib"}, {"@id": "67892", "@count": "97", "@label": "epoetin alfa (Procrit/Eprex, Johnson & Johnson)"}, {"@id": "14163", "@count": "96", "@label": "adalimumab"}, {"@id": "3364", "@count": "96", "@label": "peginterferon alfa-2b"}, {"@id": "9112", "@count": "96", "@label": "trabectedin"}, {"@id": "5933", "@count": "95", "@label": "amrubicin"}, {"@id": "15860", "@count": "94", "@label": "nimotuzumab"}, {"@id": "7413", "@count": "93", "@label": "darbepoetin alfa"}, {"@id": "16758", "@count": "93", "@label": "plerixafor"}, {"@id": "35340", "@count": "91", "@label": "cediranib"}, {"@id": "54601", "@count": "89", "@label": "carfilzomib"}, {"@id": "54469", "@count": "89", "@label": "vemurafenib"}, {"@id": "3750", "@count": "88", "@label": "ondansetron"}, {"@id": "4126", "@count": "83", "@label": "pioglitazone"}, {"@id": "28035", "@count": "83", "@label": "cabazitaxel"}, {"@id": "28532", "@count": "83", "@label": "pertuzumab"}, {"@id": "44299", "@count": "81", "@label": "ketoconazole"}, {"@id": "2573", "@count": "81", "@label": "pegaspargase"}]}, {"@total": "100", "@label": "Trial Interventions Control Alone Name Display", "@name": "trialInterventionsControlAloneNameDisplay", "FilterOption": [{"@id": "2953", "@count": "106", "@label": "docetaxel"}, {"@id": "3199", "@count": "86", "@label": "gemcitabine"}, {"@id": "12205", "@count": "50", "@label": "capecitabine"}, {"@id": "3803", "@count": "47", "@label": "paclitaxel"}, {"@id": "44314", "@count": "36", "@label": "tamoxifen"}, {"@id": "4529", "@count": "31", "@label": "temozolomide"}, {"@id": "3130", "@count": "28", "@label": "filgrastim"}, {"@id": "6736", "@count": "27", "@label": "rituximab"}, {"@id": "3536", "@count": "26", "@label": "pemetrexed disodium"}, {"@id": "29831", "@count": "26", "@label": "sorafenib"}, {"@id": "11961", "@count": "26", "@label": "erlotinib"}, {"@id": "11460", "@count": "26", "@label": "imatinib"}, {"@id": "8165", "@count": "24", "@label": "tiotropium bromide"}, {"@id": "3321", "@count": "22", "@label": "anastrozole"}, {"@id": "4510", "@count": "22", "@label": "tacrolimus"}, {"@id": "44409", "@count": "20", "@label": "Fluzone"}, {"@id": "2765", "@count": "20", "@label": "zoledronic acid"}, {"@id": "3750", "@count": "19", "@label": "ondansetron"}, {"@id": "5267", "@count": "18", "@label": "leuprolide acetate"}, {"@id": "6408", "@count": "18", "@label": "vinorelbine"}, {"@id": "10252", "@count": "17", "@label": "insulin glargine"}, {"@id": "12978", "@count": "17", "@label": "moxifloxacin"}, {"@id": "6050", "@count": "16", "@label": "metformin hydrochloride"}, {"@id": "21374", "@count": "15", "@label": "pegfilgrastim"}, {"@id": "2784", "@count": "15", "@label": "letrozole"}, {"@id": "12973", "@count": "15", "@label": "sunitinib"}, {"@id": "44312", "@count": "15", "@label": "salmeterol"}, {"@id": "6140", "@count": "14", "@label": "formoterol"}, {"@id": "4577", "@count": "14", "@label": "topotecan"}, {"@id": "3081", "@count": "14", "@label": "exemestane"}, {"@id": "7934", "@count": "13", "@label": "doxorubicin (liposomal, STEALTH), Alza"}, {"@id": "10388", "@count": "13", "@label": "cetuximab"}, {"@id": "2871", "@count": "13", "@label": "irinotecan"}, {"@id": "14336", "@count": "12", "@label": "fluticasone propionate + salmeterol (asthma and COPD), GlaxoSmithKline"}, {"@id": "4126", "@count": "11", "@label": "pioglitazone"}, {"@id": "8047", "@count": "11", "@label": "bevacizumab"}, {"@id": "6386", "@count": "11", "@label": "trastuzumab"}, {"@id": "4513", "@count": "10", "@label": "tamsulosin"}, {"@id": "7286", "@count": "10", "@label": "goserelin"}, {"@id": "5800", "@count": "9", "@label": "pantoprazole"}, {"@id": "2807", "@count": "9", "@label": "atorvastatin"}, {"@id": "11603", "@count": "9", "@label": "gefitinib"}, {"@id": "3241", "@count": "8", "@label": "granisetron"}, {"@id": "13340", "@count": "8", "@label": "everolimus"}, {"@id": "8832", "@count": "8", "@label": "glimepiride"}, {"@id": "10084", "@count": "8", "@label": "tegafur + gimeracil + oteracil potassium"}, {"@id": "12135", "@count": "8", "@label": "celecoxib"}, {"@id": "44383", "@count": "8", "@label": "carboplatin"}, {"@id": "44313", "@count": "8", "@label": "simvastatin"}, {"@id": "3268", "@count": "8", "@label": "Engerix B"}, {"@id": "44375", "@count": "8", "@label": "warfarin"}, {"@id": "44292", "@count": "8", "@label": "fluconazole"}, {"@id": "5999", "@count": "7", "@label": "ciclosporin, Novartis"}, {"@id": "7067", "@count": "7", "@label": "imiquimod"}, {"@id": "3311", "@count": "7", "@label": "bicalutamide"}, {"@id": "6342", "@count": "7", "@label": "rabies vaccine, Aventis Pasteur"}, {"@id": "67892", "@count": "7", "@label": "epoetin alfa (Procrit/Eprex, Johnson & Johnson)"}, {"@id": "7413", "@count": "7", "@label": "darbepoetin alfa"}, {"@id": "15954", "@count": "7", "@label": "bortezomib"}, {"@id": "45998", "@count": "7", "@label": "interferon alfa-2b"}, {"@id": "3353", "@count": "7", "@label": "insulin lispro"}, {"@id": "29016", "@count": "7", "@label": "paclitaxel (albumin-bound nanoparticle, intravenous), Abraxis/Taiho"}, {"@id": "44401", "@count": "6", "@label": "vancomycin"}, {"@id": "3669", "@count": "6", "@label": "mycophenolate mofetil"}, {"@id": "2472", "@count": "6", "@label": "alendronic acid"}, {"@id": "33591", "@count": "6", "@label": "lapatinib"}, {"@id": "3313", "@count": "6", "@label": "fulvestrant"}, {"@id": "7080", "@count": "6", "@label": "Pneumovax 23"}, {"@id": "3072", "@count": "6", "@label": "etoposide phosphate"}, {"@id": "23625", "@count": "6", "@label": "peginterferon alfa-2a"}, {"@id": "12210", "@count": "6", "@label": "UFT"}, {"@id": "10411", "@count": "6", "@label": "insulin aspart"}, {"@id": "44297", "@count": "5", "@label": "ipratropium bromide"}, {"@id": "6681", "@count": "5", "@label": "raloxifene"}, {"@id": "11519", "@count": "5", "@label": "mitoxantrone"}, {"@id": "2944", "@count": "5", "@label": "pamidronate disodium"}, {"@id": "17837", "@count": "5", "@label": "testosterone gel, Solvay/Bayer"}, {"@id": "3411", "@count": "5", "@label": "itraconazole"}, {"@id": "3350", "@count": "5", "@label": "Fluarix"}, {"@id": "3474", "@count": "5", "@label": "lamivudine"}, {"@id": "6306", "@count": "5", "@label": "aldesleukin"}, {"@id": "13928", "@count": "5", "@label": "enoxaparin sodium"}, {"@id": "14163", "@count": "5", "@label": "adalimumab"}, {"@id": "5148", "@count": "5", "@label": "liraglutide"}, {"@id": "3492", "@count": "5", "@label": "levofloxacin"}, {"@id": "9247", "@count": "5", "@label": "tretinoin"}, {"@id": "2736", "@count": "5", "@label": "cefepime"}, {"@id": "22395", "@count": "4", "@label": "ranibizumab"}, {"@id": "46939", "@count": "4", "@label": "olmesartan medoxomil + hydrochlorothiazide (hypertension), Sankyo"}, {"@id": "13572", "@count": "4", "@label": "exenatide"}, {"@id": "10412", "@count": "4", "@label": "estradiol + norethisterone acetate, Novo Nordisk"}, {"@id": "5907", "@count": "4", "@label": "duloxetine"}, {"@id": "16026", "@count": "4", "@label": "esomeprazole"}, {"@id": "3792", "@count": "4", "@label": "oxaliplatin"}, {"@id": "15518", "@count": "4", "@label": "teriparatide (osteoporosis), Lilly"}, {"@id": "37370", "@count": "4", "@label": "azacitidine"}, {"@id": "5957", "@count": "4", "@label": "budesonide (inhaled formulations), AstraZeneca"}, {"@id": "43738", "@count": "4", "@label": "pazopanib"}, {"@id": "44384", "@count": "4", "@label": "ceftriaxone"}, {"@id": "36630", "@count": "4", "@label": "ipilimumab"}]}, {"@total": "100", "@label": "Trial Date End By Month", "@name": "trialDateEndByMonth", "FilterOption": [{"@count": "912", "@label": "201412"}, {"@count": "861", "@label": "201312"}, {"@count": "668", "@label": "201512"}, {"@count": "559", "@label": "201212"}, {"@count": "460", "@label": "201406"}, {"@count": "405", "@label": "201112"}, {"@count": "399", "@label": "201306"}, {"@count": "398", "@label": "201012"}, {"@count": "386", "@label": "201506"}, {"@count": "382", "@label": "201403"}, {"@count": "372", "@label": "201409"}, {"@count": "365", "@label": "200912"}, {"@count": "339", "@label": "201612"}, {"@count": "323", "@label": "201501"}, {"@count": "321", "@label": "201408"}, {"@count": "316", "@label": "201407"}, {"@count": "306", "@label": "201309"}, {"@count": "300", "@label": "201401"}, {"@count": "299", "@label": "201303"}, {"@count": "298", "@label": "201410"}, {"@count": "296", "@label": "201503"}, {"@count": "293", "@label": "201404"}, {"@count": "287", "@label": "201206"}, {"@count": "283", "@label": "201210"}, {"@count": "280", "@label": "201405"}, {"@count": "279", "@label": "201310"}, {"@count": "276", "@label": "201307"}, {"@count": "270", "@label": "201203"}, {"@count": "261", "@label": "201106"}, {"@count": "259", "@label": "201509"}, {"@count": "252", "@label": "200812"}, {"@count": "248", "@label": "201109"}, {"@count": "247", "@label": "201003"}, {"@count": "246", "@label": "201308"}, {"@count": "245", "@label": "201305"}, {"@count": "244", "@label": "201301"}, {"@count": "243", "@label": "201006"}, {"@count": "242", "@label": "201311"}, {"@count": "241", "@label": "201508"}, {"@count": "240", "@label": "201208"}, {"@count": "239", "@label": "201504"}, {"@count": "238", "@label": "201207"}, {"@count": "237", "@label": "201304"}, {"@count": "237", "@label": "201505"}, {"@count": "236", "@label": "201107"}, {"@count": "236", "@label": "201201"}, {"@count": "235", "@label": "201502"}, {"@count": "233", "@label": "201103"}, {"@count": "231", "@label": "201105"}, {"@count": "230", "@label": "201204"}, {"@count": "229", "@label": "201507"}, {"@count": "228", "@label": "201606"}, {"@count": "227", "@label": "201209"}, {"@count": "227", "@label": "200903"}, {"@count": "226", "@label": "201402"}, {"@count": "225", "@label": "201302"}, {"@count": "224", "@label": "201110"}, {"@count": "224", "@label": "201211"}, {"@count": "223", "@label": "201411"}, {"@count": "219", "@label": "201601"}, {"@count": "218", "@label": "201011"}, {"@count": "213", "@label": "200907"}, {"@count": "211", "@label": "201712"}, {"@count": "209", "@label": "201205"}, {"@count": "209", "@label": "201104"}, {"@count": "209", "@label": "201603"}, {"@count": "205", "@label": "200904"}, {"@count": "204", "@label": "201101"}, {"@count": "204", "@label": "201001"}, {"@count": "204", "@label": "200906"}, {"@count": "202", "@label": "200712"}, {"@count": "200", "@label": "201004"}, {"@count": "198", "@label": "201202"}, {"@count": "198", "@label": "200901"}, {"@count": "198", "@label": "201010"}, {"@count": "197", "@label": "201007"}, {"@count": "195", "@label": "201005"}, {"@count": "194", "@label": "201009"}, {"@count": "193", "@label": "200910"}, {"@count": "193", "@label": "201108"}, {"@count": "190", "@label": "201008"}, {"@count": "188", "@label": "201102"}, {"@count": "187", "@label": "201111"}, {"@count": "186", "@label": "200809"}, {"@count": "183", "@label": "200806"}, {"@count": "183", "@label": "201510"}, {"@count": "182", "@label": "201511"}, {"@count": "181", "@label": "200909"}, {"@count": "178", "@label": "200911"}, {"@count": "175", "@label": "200902"}, {"@count": "173", "@label": "200810"}, {"@count": "173", "@label": "200908"}, {"@count": "170", "@label": "200803"}, {"@count": "167", "@label": "200710"}, {"@count": "167", "@label": "201609"}, {"@count": "167", "@label": "200905"}, {"@count": "166", "@label": "200807"}, {"@count": "165", "@label": "200707"}, {"@count": "161", "@label": "200808"}, {"@count": "159", "@label": "200709"}]}, {"@total": "100", "@label": "Trial Date Start By Month", "@name": "trialDateStartByMonth", "FilterOption": [{"@count": "439", "@label": "201101"}, {"@count": "437", "@label": "201207"}, {"@count": "435", "@label": "201201"}, {"@count": "433", "@label": "201401"}, {"@count": "430", "@label": "201301"}, {"@count": "429", "@label": "201309"}, {"@count": "426", "@label": "201210"}, {"@count": "424", "@label": "201103"}, {"@count": "422", "@label": "201109"}, {"@count": "412", "@label": "201001"}, {"@count": "406", "@label": "200909"}, {"@count": "405", "@label": "201212"}, {"@count": "404", "@label": "201305"}, {"@count": "400", "@label": "201206"}, {"@count": "396", "@label": "201312"}, {"@count": "396", "@label": "201209"}, {"@count": "395", "@label": "201106"}, {"@count": "394", "@label": "201304"}, {"@count": "394", "@label": "201306"}, {"@count": "391", "@label": "201006"}, {"@count": "390", "@label": "201203"}, {"@count": "389", "@label": "201208"}, {"@count": "388", "@label": "201311"}, {"@count": "383", "@label": "200806"}, {"@count": "379", "@label": "200906"}, {"@count": "379", "@label": "201310"}, {"@count": "377", "@label": "200903"}, {"@count": "377", "@label": "200606"}, {"@count": "376", "@label": "201303"}, {"@count": "375", "@label": "201009"}, {"@count": "374", "@label": "201204"}, {"@count": "373", "@label": "200801"}, {"@count": "372", "@label": "200901"}, {"@count": "372", "@label": "201107"}, {"@count": "371", "@label": "201111"}, {"@count": "371", "@label": "201308"}, {"@count": "370", "@label": "201211"}, {"@count": "367", "@label": "201112"}, {"@count": "366", "@label": "200710"}, {"@count": "365", "@label": "201110"}, {"@count": "363", "@label": "201307"}, {"@count": "363", "@label": "201010"}, {"@count": "361", "@label": "201012"}, {"@count": "360", "@label": "200706"}, {"@count": "358", "@label": "201004"}, {"@count": "356", "@label": "201105"}, {"@count": "356", "@label": "201104"}, {"@count": "356", "@label": "201005"}, {"@count": "356", "@label": "201007"}, {"@count": "354", "@label": "201108"}, {"@count": "354", "@label": "200904"}, {"@count": "353", "@label": "201205"}, {"@count": "351", "@label": "201011"}, {"@count": "349", "@label": "200810"}, {"@count": "346", "@label": "201003"}, {"@count": "344", "@label": "200907"}, {"@count": "341", "@label": "200612"}, {"@count": "340", "@label": "200601"}, {"@count": "337", "@label": "201302"}, {"@count": "337", "@label": "200902"}, {"@count": "334", "@label": "201403"}, {"@count": "333", "@label": "200812"}, {"@count": "331", "@label": "201008"}, {"@count": "331", "@label": "201404"}, {"@count": "331", "@label": "200701"}, {"@count": "331", "@label": "200910"}, {"@count": "331", "@label": "200911"}, {"@count": "330", "@label": "200905"}, {"@count": "329", "@label": "200807"}, {"@count": "329", "@label": "200509"}, {"@count": "327", "@label": "200505"}, {"@count": "326", "@label": "201402"}, {"@count": "326", "@label": "200707"}, {"@count": "321", "@label": "201202"}, {"@count": "321", "@label": "200709"}, {"@count": "320", "@label": "200705"}, {"@count": "318", "@label": "200804"}, {"@count": "317", "@label": "200703"}, {"@count": "315", "@label": "200908"}, {"@count": "314", "@label": "200809"}, {"@count": "313", "@label": "200611"}, {"@count": "309", "@label": "200803"}, {"@count": "308", "@label": "200406"}, {"@count": "307", "@label": "200912"}, {"@count": "306", "@label": "200805"}, {"@count": "300", "@label": "200711"}, {"@count": "299", "@label": "200802"}, {"@count": "298", "@label": "201002"}, {"@count": "298", "@label": "200712"}, {"@count": "298", "@label": "200603"}, {"@count": "297", "@label": "200512"}, {"@count": "293", "@label": "201102"}, {"@count": "293", "@label": "200605"}, {"@count": "291", "@label": "200306"}, {"@count": "288", "@label": "200808"}, {"@count": "282", "@label": "200708"}, {"@count": "280", "@label": "200510"}, {"@count": "276", "@label": "200511"}, {"@count": "275", "@label": "200205"}, {"@count": "274", "@label": "200501"}]}, {"@total": "21", "@label": "Primary Completion Filter by Month", "@name": "trialPrimaryCompletionDateByMonth", "FilterOption": [{"@count": "2", "@label": "201601"}, {"@count": "2", "@label": "201012"}, {"@count": "1", "@label": "201809"}, {"@count": "1", "@label": "201708"}, {"@count": "1", "@label": "201610"}, {"@count": "1", "@label": "201503"}, {"@count": "1", "@label": "201409"}, {"@count": "1", "@label": "201401"}, {"@count": "1", "@label": "201212"}, {"@count": "1", "@label": "201112"}, {"@count": "1", "@label": "201101"}, {"@count": "1", "@label": "200904"}, {"@count": "1", "@label": "200805"}, {"@count": "1", "@label": "200708"}, {"@count": "1", "@label": "200706"}, {"@count": "1", "@label": "200705"}, {"@count": "1", "@label": "200501"}, {"@count": "1", "@label": "200412"}, {"@count": "1", "@label": "200410"}, {"@count": "1", "@label": "200404"}, {"@count": "1", "@label": "200301"}]}, {"@total": "100", "@label": "Sponsors/Collaborators", "@name": "trialCompanies", "FilterOption": [{"@id": "20519", "@count": "8263", "@label": "National Cancer Institute"}, {"@id": "23137", "@count": "1510", "@label": "Novartis AG"}, {"@id": "28355", "@count": "1307", "@label": "GlaxoSmithKline plc"}, {"@id": "23382", "@count": "1126", "@label": "MD Anderson Cancer Center"}, {"@id": "18767", "@count": "1031", "@label": "Pfizer Inc"}, {"@id": "1009547", "@count": "973", "@label": "Sanofi"}, {"@id": "17810", "@count": "893", "@label": "Eli Lilly & Co"}, {"@id": "19446", "@count": "862", "@label": "Roche Holding AG"}, {"@id": "15065", "@count": "833", "@label": "Bristol-Myers Squibb Co"}, {"@id": "14190", "@count": "817", "@label": "AstraZeneca plc"}, {"@id": "22122", "@count": "777", "@label": "Memorial Sloan-Kettering Cancer Center"}, {"@id": "19453", "@count": "772", "@label": "Genentech Inc"}, {"@id": "20518", "@count": "605", "@label": "National Institutes of Health"}, {"@id": "18077", "@count": "568", "@label": "Merck & Co Inc"}, {"@id": "15331", "@count": "552", "@label": "Celgene Corp"}, {"@id": "14109", "@count": "537", "@label": "Amgen Inc"}, {"@id": "14455", "@count": "520", "@label": "Bayer AG"}, {"@id": "15615", "@count": "519", "@label": "Dana-Farber Cancer Institute Inc"}, {"@id": "20520", "@count": "428", "@label": "National Institute of Allergy and Infectious Diseases"}, {"@id": "1069368", "@count": "379", "@label": "National Institutes of Health Clinical Center"}, {"@id": "21569", "@count": "357", "@label": "Massachusetts General Hospital"}, {"@id": "24771", "@count": "331", "@label": "Eastern Cooperative Oncology Group"}, {"@id": "29469", "@count": "327", "@label": "Cancer Research UK"}, {"@id": "1028858", "@count": "318", "@label": "SWOG"}, {"@id": "21111", "@count": "293", "@label": "Mayo Foundation"}, {"@id": "21991", "@count": "283", "@label": "Millennium Pharmaceuticals Inc"}, {"@id": "20567", "@count": "260", "@label": "Duke University"}, {"@id": "1042135", "@count": "258", "@label": "Sidney Kimmel Comprehensive Cancer Center"}, {"@id": "16218", "@count": "253", "@label": "Fred Hutchinson Cancer Research Center"}, {"@id": "23119", "@count": "248", "@label": "European Organisation for Research and Treatment of Cancer (EORTC)"}, {"@id": "13601", "@count": "243", "@label": "Abbott Laboratories"}, {"@id": "1041378", "@count": "241", "@label": "Children's Oncology Group"}, {"@id": "1037951", "@count": "240", "@label": "North Central Cancer Treatment Group"}, {"@id": "21048", "@count": "237", "@label": "Brigham & Women's Hospital"}, {"@id": "1040381", "@count": "217", "@label": "Cancer and Leukemia Group B"}, {"@id": "1003240", "@count": "212", "@label": "National Heart Lung and Blood Institute"}, {"@id": "19461", "@count": "207", "@label": "Hoffmann-La Roche Inc"}, {"@id": "1013295", "@count": "205", "@label": "Astellas Pharma Inc"}, {"@id": "29603", "@count": "199", "@label": "H Lee Moffitt Cancer Center and Research Institute"}, {"@id": "18720", "@count": "199", "@label": "Taiho Pharmaceutical Co Ltd"}, {"@id": "1041702", "@count": "197", "@label": "Gynecologic Oncology Group"}, {"@id": "DOL1000375", "@count": "192", "@label": "Fudan University"}, {"@id": "20679", "@count": "191", "@label": "Stanford University"}, {"@id": "24877", "@count": "191", "@label": "Beth Israel Deaconess Medical Center"}, {"@id": "21099", "@count": "189", "@label": "Roswell Park Cancer Institute"}, {"@id": "1039242", "@count": "187", "@label": "Case Comprehensive Cancer Center"}, {"@id": "1040921", "@count": "186", "@label": "Ministry of Health, Labour and Welfare, Japan"}, {"@id": "24773", "@count": "185", "@label": "University of California San Francisco"}, {"@id": "16299", "@count": "182", "@label": "Genzyme Corp"}, {"@id": "20300", "@count": "181", "@label": "Takeda Pharmaceutical Co Ltd"}, {"@id": "18101", "@count": "179", "@label": "Merck KGaA"}, {"@id": "26013", "@count": "179", "@label": "University of Chicago"}, {"@id": "17332", "@count": "179", "@label": "Johnson & Johnson"}, {"@id": "1004360", "@count": "172", "@label": "Sun Yat-Sen University"}, {"@id": "20659", "@count": "171", "@label": "University of Pittsburgh"}, {"@id": "26113", "@count": "170", "@label": "Washington University in St Louis"}, {"@id": "20645", "@count": "168", "@label": "Northwestern University"}, {"@id": "26109", "@count": "167", "@label": "Jonsson Comprehensive Cancer Center"}, {"@id": "1059823", "@count": "166", "@label": "Merck Sharp & Dohme Corp"}, {"@id": "1032972", "@count": "164", "@label": "Sarah Cannon Research Institute"}, {"@id": "29481", "@count": "161", "@label": "Johnson & Johnson Pharmaceutical Research & Development LLC"}, {"@id": "1051922", "@count": "157", "@label": "City of Hope Medical Center"}, {"@id": "18438", "@count": "154", "@label": "Medical Research Council (MRC)"}, {"@id": "1004334", "@count": "150", "@label": "Samsung Medical Center (SMC)"}, {"@id": "1039398", "@count": "148", "@label": "Radiation Therapy Oncology Group"}, {"@id": "19620", "@count": "147", "@label": "Eisai Inc"}, {"@id": "20701", "@count": "147", "@label": "University of Washington"}, {"@id": "1036320", "@count": "147", "@label": "Asan Medical Center"}, {"@id": "14881", "@count": "143", "@label": "Boehringer Ingelheim Corp"}, {"@id": "28443", "@count": "143", "@label": "The University Health Network"}, {"@id": "20534", "@count": "142", "@label": "Baylor College of Medicine"}, {"@id": "20658", "@count": "137", "@label": "University of Pennsylvania"}, {"@id": "20573", "@count": "137", "@label": "Emory University"}, {"@id": "14112", "@count": "135", "@label": "Wyeth"}, {"@id": "1038961", "@count": "135", "@label": "National Taiwan University Hospital"}, {"@id": "16450", "@count": "131", "@label": "Gilead Sciences Inc"}, {"@id": "19711", "@count": "131", "@label": "Schering-Plough Corp"}, {"@id": "18683", "@count": "131", "@label": "Onyx Pharmaceuticals Inc"}, {"@id": "1042263", "@count": "127", "@label": "Ohio State University Comprehensive Cancer Center"}, {"@id": "DOL1000742", "@count": "127", "@label": "University of Wisconsin-Madison"}, {"@id": "1039386", "@count": "126", "@label": "National Cancer Institute of Canada"}, {"@id": "1035000", "@count": "124", "@label": "Takeda Global Research & Development Center Inc"}, {"@id": "17193", "@count": "122", "@label": "ImClone Systems Inc"}, {"@id": "18676", "@count": "119", "@label": "OSI Pharmaceuticals Inc"}, {"@id": "1040998", "@count": "115", "@label": "Masonic Cancer Center"}, {"@id": "20699", "@count": "114", "@label": "Wake Forest University"}, {"@id": "1040917", "@count": "114", "@label": "Weill Medical College of Cornell University"}, {"@id": "1060642", "@count": "111", "@label": "National Cancer Center Hospital"}, {"@id": "20524", "@count": "110", "@label": "University of Alabama at Birmingham"}, {"@id": "14383", "@count": "110", "@label": "Barbara Ann Karmanos Cancer Institute"}, {"@id": "20348", "@count": "108", "@label": "Teva Pharmaceutical Industries Ltd"}, {"@id": "1003017", "@count": "108", "@label": "Seoul National University Hospital"}, {"@id": "1005775", "@count": "108", "@label": "National Cancer Center of Korea"}, {"@id": "21081", "@count": "106", "@label": "Institut Gustave Roussy"}, {"@id": "20686", "@count": "106", "@label": "Tokyo University"}, {"@id": "26178", "@count": "105", "@label": "F Hoffmann-La Roche AG"}, {"@id": "18008", "@count": "104", "@label": "MedImmune LLC"}, {"@id": "15358", "@count": "103", "@label": "Cephalon Inc"}, {"@id": "1003379", "@count": "102", "@label": "Sichuan University"}, {"@id": "20559", "@count": "101", "@label": "Columbia University"}]}, {"@total": "100", "@label": "Trial Company Collaborator", "@name": "trialCompaniesCollaborator", "FilterOption": [{"@id": "20519", "@count": "6397", "@label": "National Cancer Institute"}, {"@id": "23137", "@count": "569", "@label": "Novartis AG"}, {"@id": "20518", "@count": "500", "@label": "National Institutes of Health"}, {"@id": "19453", "@count": "485", "@label": "Genentech Inc"}, {"@id": "28355", "@count": "366", "@label": "GlaxoSmithKline plc"}, {"@id": "1009547", "@count": "360", "@label": "Sanofi"}, {"@id": "1069368", "@count": "346", "@label": "National Institutes of Health Clinical Center"}, {"@id": "18767", "@count": "343", "@label": "Pfizer Inc"}, {"@id": "15331", "@count": "328", "@label": "Celgene Corp"}, {"@id": "19446", "@count": "297", "@label": "Roche Holding AG"}, {"@id": "15065", "@count": "271", "@label": "Bristol-Myers Squibb Co"}, {"@id": "14455", "@count": "235", "@label": "Bayer AG"}, {"@id": "14190", "@count": "212", "@label": "AstraZeneca plc"}, {"@id": "21048", "@count": "197", "@label": "Brigham & Women's Hospital"}, {"@id": "14109", "@count": "196", "@label": "Amgen Inc"}, {"@id": "18077", "@count": "195", "@label": "Merck & Co Inc"}, {"@id": "17810", "@count": "194", "@label": "Eli Lilly & Co"}, {"@id": "29469", "@count": "182", "@label": "Cancer Research UK"}, {"@id": "21569", "@count": "146", "@label": "Massachusetts General Hospital"}, {"@id": "1040921", "@count": "137", "@label": "Ministry of Health, Labour and Welfare, Japan"}, {"@id": "15615", "@count": "136", "@label": "Dana-Farber Cancer Institute Inc"}, {"@id": "21991", "@count": "133", "@label": "Millennium Pharmaceuticals Inc"}, {"@id": "24877", "@count": "133", "@label": "Beth Israel Deaconess Medical Center"}, {"@id": "1003240", "@count": "106", "@label": "National Heart Lung and Blood Institute"}, {"@id": "24771", "@count": "92", "@label": "Eastern Cooperative Oncology Group"}, {"@id": "1065861", "@count": "84", "@label": "Ministry of Education, Culture, Sports, Science and Technology of Japan"}, {"@id": "16299", "@count": "82", "@label": "Genzyme Corp"}, {"@id": "17332", "@count": "80", "@label": "Johnson & Johnson"}, {"@id": "1028858", "@count": "79", "@label": "SWOG"}, {"@id": "1040381", "@count": "76", "@label": "Cancer and Leukemia Group B"}, {"@id": "23382", "@count": "75", "@label": "MD Anderson Cancer Center"}, {"@id": "1013295", "@count": "71", "@label": "Astellas Pharma Inc"}, {"@id": "1041750", "@count": "69", "@label": "National Comprehensive Cancer Network"}, {"@id": "20348", "@count": "69", "@label": "Teva Pharmaceutical Industries Ltd"}, {"@id": "19711", "@count": "68", "@label": "Schering-Plough Corp"}, {"@id": "13601", "@count": "67", "@label": "Abbott Laboratories"}, {"@id": "20520", "@count": "66", "@label": "National Institute of Allergy and Infectious Diseases"}, {"@id": "19461", "@count": "66", "@label": "Hoffmann-La Roche Inc"}, {"@id": "1041243", "@count": "63", "@label": "US Department of Defense"}, {"@id": "18676", "@count": "62", "@label": "OSI Pharmaceuticals Inc"}, {"@id": "18683", "@count": "61", "@label": "Onyx Pharmaceuticals Inc"}, {"@id": "19620", "@count": "59", "@label": "Eisai Inc"}, {"@id": "20300", "@count": "58", "@label": "Takeda Pharmaceutical Co Ltd"}, {"@id": "18438", "@count": "54", "@label": "Medical Research Council (MRC)"}, {"@id": "DOL1000129", "@count": "53", "@label": "Texas Children's Hospital"}, {"@id": "15358", "@count": "53", "@label": "Cephalon Inc"}, {"@id": "1037951", "@count": "53", "@label": "North Central Cancer Treatment Group"}, {"@id": "26178", "@count": "52", "@label": "F Hoffmann-La Roche AG"}, {"@id": "18101", "@count": "50", "@label": "Merck KGaA"}, {"@id": "14112", "@count": "48", "@label": "Wyeth"}, {"@id": "22122", "@count": "47", "@label": "Memorial Sloan-Kettering Cancer Center"}, {"@id": "1039386", "@count": "45", "@label": "National Cancer Institute of Canada"}, {"@id": "1041928", "@count": "45", "@label": "National Institute on Aging"}, {"@id": "1038146", "@count": "44", "@label": "National Health and Medical Research Council"}, {"@id": "27251", "@count": "43", "@label": "Aventis Pharmaceuticals Inc"}, {"@id": "18720", "@count": "42", "@label": "Taiho Pharmaceutical Co Ltd"}, {"@id": "1005244", "@count": "41", "@label": "Biogen Idec Inc"}, {"@id": "1059823", "@count": "39", "@label": "Merck Sharp & Dohme Corp"}, {"@id": "26334", "@count": "38", "@label": "National Institute of Diabetes, Digestive and Kidney Diseases"}, {"@id": "1053488", "@count": "37", "@label": "NCIC Clinical Trials Group"}, {"@id": "17570", "@count": "37", "@label": "Ortho Biotech Products LP"}, {"@id": "20686", "@count": "37", "@label": "Tokyo University"}, {"@id": "1043628", "@count": "36", "@label": "University Hospital of Crete"}, {"@id": "1046733", "@count": "36", "@label": "Dutch Cancer Society"}, {"@id": "17193", "@count": "35", "@label": "ImClone Systems Inc"}, {"@id": "1038741", "@count": "34", "@label": "The Leukemia & Lymphoma Society"}, {"@id": "1081469", "@count": "34", "@label": "NPO Osaka Clinical Study Supporting Organization"}, {"@id": "1041701", "@count": "34", "@label": "Japanese Ministry of Health, Labor and Welfare"}, {"@id": "DOL1000375", "@count": "33", "@label": "Fudan University"}, {"@id": "1061499", "@count": "33", "@label": "Human Genome Center"}, {"@id": "1003755", "@count": "32", "@label": "Japan Society for the Promotion of Science (JSPS)"}, {"@id": "1017433", "@count": "32", "@label": "Celgro Corporation"}, {"@id": "20567", "@count": "31", "@label": "Duke University"}, {"@id": "1041623", "@count": "31", "@label": "The Methodist Hospital System"}, {"@id": "23119", "@count": "31", "@label": "European Organisation for Research and Treatment of Cancer (EORTC)"}, {"@id": "1039740", "@count": "30", "@label": "National Natural Science Foundation of China"}, {"@id": "1038961", "@count": "30", "@label": "National Taiwan University Hospital"}, {"@id": "17392", "@count": "29", "@label": "Janssen-Cilag Ltd"}, {"@id": "1081068", "@count": "27", "@label": "Clinical Research Support Center Kyushu"}, {"@id": "1004360", "@count": "27", "@label": "Sun Yat-Sen University"}, {"@id": "1034426", "@count": "27", "@label": "Canadian Institutes of Health Research"}, {"@id": "26494", "@count": "27", "@label": "Sanofi-Synthelabo"}, {"@id": "1036410", "@count": "27", "@label": "National Center for Complementary and Alternative Medicine"}, {"@id": "21246", "@count": "26", "@label": "University of Louisville"}, {"@id": "19214", "@count": "26", "@label": "Regeneron Pharmaceuticals Inc"}, {"@id": "1005970", "@count": "26", "@label": "Medinet Co Ltd"}, {"@id": "1043352", "@count": "26", "@label": "Ministry of Health, France"}, {"@id": "DOL1000591", "@count": "25", "@label": "Quintiles Transnational Corp"}, {"@id": "1036320", "@count": "25", "@label": "Asan Medical Center"}, {"@id": "14337", "@count": "25", "@label": "Australian Government"}, {"@id": "15414", "@count": "25", "@label": "Chugai Pharmaceutical Co Ltd"}, {"@id": "20596", "@count": "24", "@label": "Johns Hopkins University"}, {"@id": "20645", "@count": "24", "@label": "Northwestern University"}, {"@id": "19601", "@count": "24", "@label": "National Institute on Drug Abuse"}, {"@id": "24773", "@count": "24", "@label": "University of California San Francisco"}, {"@id": "1082887", "@count": "23", "@label": "Clinical Trials Awards and Advisory Committee"}, {"@id": "19063", "@count": "23", "@label": "Pharmacyclics Inc"}, {"@id": "25554", "@count": "23", "@label": "Seattle Genetics Inc"}, {"@id": "1004334", "@count": "23", "@label": "Samsung Medical Center (SMC)"}, {"@id": "1045208", "@count": "23", "@label": "Koningin Wilhelmina Fonds (Dutch Cancer Fund)"}]}, {"@total": "100", "@label": "Trial Interventions Primary Alone Name Display", "@name": "trialInterventionsPrimaryAloneNameDisplay", "FilterOption": [{"@id": "3199", "@count": "423", "@label": "gemcitabine"}, {"@id": "2953", "@count": "417", "@label": "docetaxel"}, {"@id": "11961", "@count": "380", "@label": "erlotinib"}, {"@id": "29831", "@count": "362", "@label": "sorafenib"}, {"@id": "8047", "@count": "329", "@label": "bevacizumab"}, {"@id": "6736", "@count": "327", "@label": "rituximab"}, {"@id": "3803", "@count": "316", "@label": "paclitaxel"}, {"@id": "12973", "@count": "303", "@label": "sunitinib"}, {"@id": "11460", "@count": "299", "@label": "imatinib"}, {"@id": "12205", "@count": "286", "@label": "capecitabine"}, {"@id": "4529", "@count": "268", "@label": "temozolomide"}, {"@id": "11603", "@count": "239", "@label": "gefitinib"}, {"@id": "10084", "@count": "230", "@label": "tegafur + gimeracil + oteracil potassium"}, {"@id": "44314", "@count": "219", "@label": "tamoxifen"}, {"@id": "13340", "@count": "209", "@label": "everolimus"}, {"@id": "2765", "@count": "206", "@label": "zoledronic acid"}, {"@id": "2871", "@count": "196", "@label": "irinotecan"}, {"@id": "27572", "@count": "194", "@label": "lenalidomide"}, {"@id": "10388", "@count": "188", "@label": "cetuximab"}, {"@id": "3536", "@count": "180", "@label": "pemetrexed disodium"}, {"@id": "15954", "@count": "171", "@label": "bortezomib"}, {"@id": "6386", "@count": "166", "@label": "trastuzumab"}, {"@id": "2784", "@count": "166", "@label": "letrozole"}, {"@id": "48946", "@count": "166", "@label": "dasatinib"}, {"@id": "3130", "@count": "162", "@label": "filgrastim"}, {"@id": "44383", "@count": "160", "@label": "carboplatin"}, {"@id": "6156", "@count": "152", "@label": "fludarabine"}, {"@id": "4577", "@count": "144", "@label": "topotecan"}, {"@id": "43738", "@count": "143", "@label": "pazopanib"}, {"@id": "3321", "@count": "125", "@label": "anastrozole"}, {"@id": "51388", "@count": "121", "@label": "nilotinib"}, {"@id": "3792", "@count": "117", "@label": "oxaliplatin"}, {"@id": "3081", "@count": "115", "@label": "exemestane"}, {"@id": "33591", "@count": "111", "@label": "lapatinib"}, {"@id": "6306", "@count": "111", "@label": "aldesleukin"}, {"@id": "29016", "@count": "111", "@label": "paclitaxel (albumin-bound nanoparticle, intravenous), Abraxis/Taiho"}, {"@id": "6050", "@count": "110", "@label": "metformin hydrochloride"}, {"@id": "12135", "@count": "104", "@label": "celecoxib"}, {"@id": "3072", "@count": "103", "@label": "etoposide phosphate"}, {"@id": "37370", "@count": "99", "@label": "azacitidine"}, {"@id": "2716", "@count": "98", "@label": "alemtuzumab"}, {"@id": "36630", "@count": "97", "@label": "ipilimumab"}, {"@id": "6408", "@count": "93", "@label": "vinorelbine"}, {"@id": "7934", "@count": "92", "@label": "doxorubicin (liposomal, STEALTH), Alza"}, {"@id": "67892", "@count": "90", "@label": "epoetin alfa (Procrit/Eprex, Johnson & Johnson)"}, {"@id": "4200", "@count": "88", "@label": "sirolimus"}, {"@id": "4510", "@count": "87", "@label": "tacrolimus"}, {"@id": "22965", "@count": "86", "@label": "temsirolimus"}, {"@id": "3669", "@count": "86", "@label": "mycophenolate mofetil"}, {"@id": "14163", "@count": "84", "@label": "adalimumab"}, {"@id": "3313", "@count": "84", "@label": "fulvestrant"}, {"@id": "8050", "@count": "78", "@label": "thalidomide, Celgene"}, {"@id": "4567", "@count": "78", "@label": "etanercept"}, {"@id": "7121", "@count": "76", "@label": "sargramostim"}, {"@id": "7413", "@count": "75", "@label": "darbepoetin alfa"}, {"@id": "21374", "@count": "75", "@label": "pegfilgrastim"}, {"@id": "17625", "@count": "75", "@label": "vorinostat (oral), Merck & Co"}, {"@id": "39209", "@count": "69", "@label": "axitinib"}, {"@id": "28773", "@count": "68", "@label": "eribulin mesylate"}, {"@id": "15541", "@count": "66", "@label": "ixabepilone"}, {"@id": "54449", "@count": "65", "@label": "afatinib"}, {"@id": "4126", "@count": "65", "@label": "pioglitazone"}, {"@id": "13239", "@count": "65", "@label": "decitabine (intravenous, myelodysplastic syndromes), Eisai"}, {"@id": "9112", "@count": "63", "@label": "trabectedin"}, {"@id": "5267", "@count": "62", "@label": "leuprolide acetate"}, {"@id": "17113", "@count": "61", "@label": "tipifarnib"}, {"@id": "5933", "@count": "59", "@label": "amrubicin"}, {"@id": "12646", "@count": "58", "@label": "panitumumab"}, {"@id": "4705", "@count": "58", "@label": "ibritumomab tiuxetan"}, {"@id": "13022", "@count": "57", "@label": "epirubicin"}, {"@id": "7352", "@count": "57", "@label": "dutasteride"}, {"@id": "28453", "@count": "57", "@label": "degarelix"}, {"@id": "54226", "@count": "57", "@label": "panobinostat (oral), Novartis"}, {"@id": "7067", "@count": "57", "@label": "imiquimod"}, {"@id": "3311", "@count": "56", "@label": "bicalutamide"}, {"@id": "26495", "@count": "54", "@label": "vandetanib"}, {"@id": "8752", "@count": "54", "@label": "Cervarix"}, {"@id": "47000", "@count": "54", "@label": "bendamustine"}, {"@id": "54469", "@count": "53", "@label": "vemurafenib"}, {"@id": "9028", "@count": "52", "@label": "tositumomab"}, {"@id": "7286", "@count": "52", "@label": "goserelin"}, {"@id": "15860", "@count": "50", "@label": "nimotuzumab"}, {"@id": "40735", "@count": "49", "@label": "dovitinib"}, {"@id": "35340", "@count": "49", "@label": "cediranib"}, {"@id": "9298", "@count": "49", "@label": "Thymoglobulin"}, {"@id": "44403", "@count": "49", "@label": "lidocaine"}, {"@id": "28035", "@count": "48", "@label": "cabazitaxel"}, {"@id": "42299", "@count": "48", "@label": "ofatumumab"}, {"@id": "2539", "@count": "48", "@label": "antineoplaston A-10, Burzynski Institute"}, {"@id": "2540", "@count": "47", "@label": "antineoplaston AS2-1, Burzynski Institute"}, {"@id": "54624", "@count": "47", "@label": "regorafenib"}, {"@id": "2807", "@count": "46", "@label": "atorvastatin"}, {"@id": "44409", "@count": "45", "@label": "Fluzone"}, {"@id": "50935", "@count": "45", "@label": "cabozantinib"}, {"@id": "23624", "@count": "44", "@label": "clofarabine"}, {"@id": "4119", "@count": "43", "@label": "tadalafil"}, {"@id": "31977", "@count": "43", "@label": "CP 526555-18"}, {"@id": "11155", "@count": "43", "@label": "Gardasil"}, {"@id": "26552", "@count": "43", "@label": "arsenic trioxide, Cell Therapeutics"}, {"@id": "8023", "@count": "43", "@label": "romidepsin"}]}, {"@total": "19", "@label": "Trial Patient Selection", "@name": "trialTermsPatientSelection", "FilterOption": [{"@id": "EAYAD", "@count": "42404", "@label": "Young Adults"}, {"@id": "EAMAA", "@count": "42358", "@label": "Middle-aged Adults"}, {"@id": "EAAAD", "@count": "40643", "@label": "Aged Adults"}, {"@id": "EAELD", "@count": "32585", "@label": "Elderly Adults"}, {"@id": "EGFEM", "@count": "6180", "@label": "Female"}, {"@id": "EAADL", "@count": "3997", "@label": "Adolescents"}, {"@id": "EGMAL", "@count": "3148", "@label": "Male"}, {"@id": "EACHI", "@count": "2797", "@label": "Children"}, {"@id": "EAPRE", "@count": "2309", "@label": "Preschool Children"}, {"@id": "EAINF", "@count": "1752", "@label": "Infants"}, {"@id": "EVHVA", "@count": "1700", "@label": "Healthy volunteers accepted"}, {"@id": "EVHVO", "@count": "1261", "@label": "Healthy volunteers only"}, {"@id": "EANEW", "@count": "1125", "@label": "Newborn Infants"}, {"@id": "ECJAP", "@count": "613", "@label": "Japanese Ancestry"}, {"@id": "ECASI", "@count": "544", "@label": "Asian Ancestry"}, {"@id": "ECEUR", "@count": "140", "@label": "European Ancestry"}, {"@id": "ECAFR", "@count": "69", "@label": "African Ancestry"}, {"@id": "ECNAM", "@count": "16", "@label": "Native American Ancestry"}, {"@id": "ECOCE", "@count": "6", "@label": "Oceanic Ancestry"}]}, {"@total": "100", "@label": "Trial Company Sponsor", "@name": "trialCompaniesSponsor", "FilterOption": [{"@id": "20519", "@count": "1894", "@label": "National Cancer Institute"}, {"@id": "23382", "@count": "1051", "@label": "MD Anderson Cancer Center"}, {"@id": "28355", "@count": "943", "@label": "GlaxoSmithKline plc"}, {"@id": "23137", "@count": "941", "@label": "Novartis AG"}, {"@id": "22122", "@count": "730", "@label": "Memorial Sloan-Kettering Cancer Center"}, {"@id": "17810", "@count": "700", "@label": "Eli Lilly & Co"}, {"@id": "18767", "@count": "689", "@label": "Pfizer Inc"}, {"@id": "1009547", "@count": "614", "@label": "Sanofi"}, {"@id": "14190", "@count": "605", "@label": "AstraZeneca plc"}, {"@id": "19446", "@count": "565", "@label": "Roche Holding AG"}, {"@id": "15065", "@count": "562", "@label": "Bristol-Myers Squibb Co"}, {"@id": "15615", "@count": "383", "@label": "Dana-Farber Cancer Institute Inc"}, {"@id": "18077", "@count": "373", "@label": "Merck & Co Inc"}, {"@id": "20520", "@count": "367", "@label": "National Institute of Allergy and Infectious Diseases"}, {"@id": "14109", "@count": "343", "@label": "Amgen Inc"}, {"@id": "19453", "@count": "287", "@label": "Genentech Inc"}, {"@id": "14455", "@count": "285", "@label": "Bayer AG"}, {"@id": "21111", "@count": "271", "@label": "Mayo Foundation"}, {"@id": "1042135", "@count": "250", "@label": "Sidney Kimmel Comprehensive Cancer Center"}, {"@id": "24771", "@count": "239", "@label": "Eastern Cooperative Oncology Group"}, {"@id": "1028858", "@count": "239", "@label": "SWOG"}, {"@id": "16218", "@count": "234", "@label": "Fred Hutchinson Cancer Research Center"}, {"@id": "20567", "@count": "229", "@label": "Duke University"}, {"@id": "15331", "@count": "224", "@label": "Celgene Corp"}, {"@id": "1041378", "@count": "224", "@label": "Children's Oncology Group"}, {"@id": "23119", "@count": "217", "@label": "European Organisation for Research and Treatment of Cancer (EORTC)"}, {"@id": "21569", "@count": "211", "@label": "Massachusetts General Hospital"}, {"@id": "29603", "@count": "189", "@label": "H Lee Moffitt Cancer Center and Research Institute"}, {"@id": "1037951", "@count": "188", "@label": "North Central Cancer Treatment Group"}, {"@id": "1041702", "@count": "185", "@label": "Gynecologic Oncology Group"}, {"@id": "1039242", "@count": "184", "@label": "Case Comprehensive Cancer Center"}, {"@id": "20679", "@count": "183", "@label": "Stanford University"}, {"@id": "21099", "@count": "180", "@label": "Roswell Park Cancer Institute"}, {"@id": "13601", "@count": "176", "@label": "Abbott Laboratories"}, {"@id": "26109", "@count": "162", "@label": "Jonsson Comprehensive Cancer Center"}, {"@id": "26013", "@count": "162", "@label": "University of Chicago"}, {"@id": "24773", "@count": "161", "@label": "University of California San Francisco"}, {"@id": "DOL1000375", "@count": "159", "@label": "Fudan University"}, {"@id": "18720", "@count": "157", "@label": "Taiho Pharmaceutical Co Ltd"}, {"@id": "26113", "@count": "155", "@label": "Washington University in St Louis"}, {"@id": "1032972", "@count": "154", "@label": "Sarah Cannon Research Institute"}, {"@id": "1051922", "@count": "154", "@label": "City of Hope Medical Center"}, {"@id": "20659", "@count": "153", "@label": "University of Pittsburgh"}, {"@id": "21991", "@count": "150", "@label": "Millennium Pharmaceuticals Inc"}, {"@id": "29469", "@count": "146", "@label": "Cancer Research UK"}, {"@id": "1004360", "@count": "145", "@label": "Sun Yat-Sen University"}, {"@id": "20645", "@count": "144", "@label": "Northwestern University"}, {"@id": "19461", "@count": "141", "@label": "Hoffmann-La Roche Inc"}, {"@id": "1040381", "@count": "141", "@label": "Cancer and Leukemia Group B"}, {"@id": "29481", "@count": "141", "@label": "Johnson & Johnson Pharmaceutical Research & Development LLC"}, {"@id": "28443", "@count": "135", "@label": "The University Health Network"}, {"@id": "1013295", "@count": "134", "@label": "Astellas Pharma Inc"}, {"@id": "1039398", "@count": "132", "@label": "Radiation Therapy Oncology Group"}, {"@id": "18101", "@count": "129", "@label": "Merck KGaA"}, {"@id": "1059823", "@count": "127", "@label": "Merck Sharp & Dohme Corp"}, {"@id": "20534", "@count": "127", "@label": "Baylor College of Medicine"}, {"@id": "1004334", "@count": "127", "@label": "Samsung Medical Center (SMC)"}, {"@id": "14881", "@count": "125", "@label": "Boehringer Ingelheim Corp"}, {"@id": "20701", "@count": "124", "@label": "University of Washington"}, {"@id": "1036320", "@count": "123", "@label": "Asan Medical Center"}, {"@id": "20573", "@count": "123", "@label": "Emory University"}, {"@id": "20300", "@count": "123", "@label": "Takeda Pharmaceutical Co Ltd"}, {"@id": "1042263", "@count": "122", "@label": "Ohio State University Comprehensive Cancer Center"}, {"@id": "20658", "@count": "120", "@label": "University of Pennsylvania"}, {"@id": "DOL1000742", "@count": "119", "@label": "University of Wisconsin-Madison"}, {"@id": "1040998", "@count": "115", "@label": "Masonic Cancer Center"}, {"@id": "16450", "@count": "110", "@label": "Gilead Sciences Inc"}, {"@id": "14383", "@count": "108", "@label": "Barbara Ann Karmanos Cancer Institute"}, {"@id": "1035000", "@count": "107", "@label": "Takeda Global Research & Development Center Inc"}, {"@id": "1003240", "@count": "106", "@label": "National Heart Lung and Blood Institute"}, {"@id": "1038961", "@count": "105", "@label": "National Taiwan University Hospital"}, {"@id": "20518", "@count": "105", "@label": "National Institutes of Health"}, {"@id": "1060642", "@count": "104", "@label": "National Cancer Center Hospital"}, {"@id": "20699", "@count": "101", "@label": "Wake Forest University"}, {"@id": "16299", "@count": "100", "@label": "Genzyme Corp"}, {"@id": "18438", "@count": "100", "@label": "Medical Research Council (MRC)"}, {"@id": "17332", "@count": "99", "@label": "Johnson & Johnson"}, {"@id": "20524", "@count": "97", "@label": "University of Alabama at Birmingham"}, {"@id": "1040917", "@count": "97", "@label": "Weill Medical College of Cornell University"}, {"@id": "1040374", "@count": "96", "@label": "Vanderbilt-Ingram Cancer Center"}, {"@id": "21814", "@count": "96", "@label": "St Jude Children's Research Hospital"}, {"@id": "1005775", "@count": "95", "@label": "National Cancer Center of Korea"}, {"@id": "1041077", "@count": "92", "@label": "UNC Lineberger Comprehensive Cancer Center"}, {"@id": "1003017", "@count": "91", "@label": "Seoul National University Hospital"}, {"@id": "21081", "@count": "90", "@label": "Institut Gustave Roussy"}, {"@id": "1003379", "@count": "90", "@label": "Sichuan University"}, {"@id": "21112", "@count": "89", "@label": "Fox Chase Cancer Center"}, {"@id": "19620", "@count": "88", "@label": "Eisai Inc"}, {"@id": "17193", "@count": "87", "@label": "ImClone Systems Inc"}, {"@id": "14112", "@count": "87", "@label": "Wyeth"}, {"@id": "1010270", "@count": "86", "@label": "The Royal Marsden NHS Trust"}, {"@id": "1041700", "@count": "86", "@label": "Japan Clinical Oncology Group"}, {"@id": "20653", "@count": "84", "@label": "Osaka University"}, {"@id": "18008", "@count": "82", "@label": "MedImmune LLC"}, {"@id": "22182", "@count": "81", "@label": "University of Oxford"}, {"@id": "1039386", "@count": "81", "@label": "National Cancer Institute of Canada"}, {"@id": "20559", "@count": "80", "@label": "Columbia University"}, {"@id": "19087", "@count": "80", "@label": "Pierre Fabre SA"}, {"@id": "18614", "@count": "79", "@label": "Novo Nordisk A/S"}, {"@id": "1053899", "@count": "78", "@label": "Abramson Cancer Center of the University of Pennsylvania"}]}, {"@total": "14", "@label": "Trial Phase", "@name": "trialPhase", "FilterOption": [{"@id": "C2", "@count": "19566", "@label": "Phase 2 Clinical"}, {"@id": "C1", "@count": "9743", "@label": "Phase 1 Clinical"}, {"@id": "NS", "@count": "9001", "@label": "Phase not specified"}, {"@id": "C3", "@count": "7058", "@label": "Phase 3 Clinical"}, {"@id": "C12", "@count": "4614", "@label": "Phase 1/Phase 2 Clinical"}, {"@id": "C4", "@count": "2654", "@label": "Phase 4 Clinical"}, {"@id": "C23", "@count": "792", "@label": "Phase 2/Phase 3 Clinical"}, {"@id": "C1B", "@count": "623", "@label": "Phase 1b Clinical"}, {"@id": "C2A", "@count": "385", "@label": "Phase 2a Clinical"}, {"@id": "C2B", "@count": "331", "@label": "Phase 2b Clinical"}, {"@id": "C0", "@count": "222", "@label": "Phase 0 Clinical"}, {"@id": "C3B", "@count": "187", "@label": "Phase 3b Clinical"}, {"@id": "C1A", "@count": "67", "@label": "Phase 1a Clinical"}, {"@id": "C3A", "@count": "16", "@label": "Phase 3a Clinical"}]}, {"@total": "11", "@label": "Trial Region", "@name": "trialRegions", "FilterOption": [{"@id": "USCA", "@count": "23616", "@label": "US & Canada"}, {"@id": "NSWE", "@count": "13292", "@label": "Northern, Southern & Western Europe"}, {"@id": "EAPO", "@count": "9858", "@label": "East Asia & Pacific Ocean"}, {"@id": "EEUR", "@count": "2843", "@label": "Eastern Europe"}, {"@id": "AUNZ", "@count": "2383", "@label": "Australia & New Zealand"}, {"@id": "SOAM", "@count": "1604", "@label": "South America"}, {"@id": "MENA", "@count": "1383", "@label": "Middle East & North Africa"}, {"@id": "SOCA", "@count": "1041", "@label": "Southern & Central Asia"}, {"@id": "CSAF", "@count": "737", "@label": "Central & Southern Africa"}, {"@id": "CAAC", "@count": "728", "@label": "Central America & Caribbean"}, {"@id": "INDO", "@count": "1", "@label": "Indian Ocean"}]}, {"@total": "7", "@label": "Trial Recruitment Status", "@name": "trialRecruitmentStatus", "FilterOption": [{"@id": "4", "@count": "19065", "@label": "Completed"}, {"@id": "2", "@count": "14339", "@label": "Recruiting"}, {"@id": "12", "@count": "7910", "@label": "Status not specified"}, {"@id": "3", "@count": "6850", "@label": "No longer recruiting"}, {"@id": "6", "@count": "4276", "@label": "Terminated"}, {"@id": "1", "@count": "2492", "@label": "Not yet recruiting"}, {"@id": "5", "@count": "327", "@label": "Suspended"}]}, {"@total": "34", "@label": "Registry Id", "@name": "trialRegistries", "FilterOption": [{"@id": "1000", "@count": "36283", "@label": "CT.gov"}, {"@id": "1001", "@count": "6386", "@label": "EudraCT"}, {"@id": "1003", "@count": "3768", "@label": "UMIN"}, {"@id": "1002", "@count": "1093", "@label": "ISRCTN"}, {"@id": "1007", "@count": "829", "@label": "ChiCTR"}, {"@id": "1006", "@count": "829", "@label": "JapicCTI"}, {"@id": "1011", "@count": "690", "@label": "ANZCTR"}, {"@id": "1030", "@count": "537", "@label": "RSRM CTR"}, {"@id": "1012", "@count": "477", "@label": "CTRI"}, {"@id": "1004", "@count": "475", "@label": "WHO ICTRP"}, {"@id": "1023", "@count": "438", "@label": "UKCRN"}, {"@id": "1019", "@count": "373", "@label": "DRKS"}, {"@id": "1015", "@count": "326", "@label": "NTR"}, {"@id": "1035", "@count": "216", "@label": "Singapore HSA CTR"}, {"@id": "1014", "@count": "144", "@label": "IRCT"}, {"@id": "1021", "@count": "143", "@label": "NMRR"}, {"@id": "1010", "@count": "129", "@label": "CRiS"}, {"@id": "1009", "@count": "111", "@label": "HKClinicalTrials.com"}, {"@id": "1039", "@count": "73", "@label": "CDE"}, {"@id": "1013", "@count": "64", "@label": "RPCEC"}, {"@id": "1033", "@count": "51", "@label": "Mexico CTR"}, {"@id": "1038", "@count": "41", "@label": "PHRR"}, {"@id": "1008", "@count": "22", "@label": "Hong Kong CCTCTR"}, {"@id": "1005", "@count": "19", "@label": "JMACCT CTR"}, {"@id": "1020", "@count": "17", "@label": "ReBec"}, {"@id": "1016", "@count": "9", "@label": "PACTR"}, {"@id": "1017", "@count": "8", "@label": "CTR Freiburg"}, {"@id": "1018", "@count": "4", "@label": "SLCTR"}, {"@id": "1037", "@count": "4", "@label": "TCTR"}, {"@id": "1036", "@count": "3", "@label": "JAZMP CTR"}, {"@id": "1027", "@count": "2", "@label": "SUKL CTR"}, {"@id": "1031", "@count": "2", "@label": "Estonia CTR"}, {"@id": "1024", "@count": "1", "@label": "TzCTR"}, {"@id": "1034", "@count": "1", "@label": "INFARMA CTR"}]}, {"@total": "3", "@label": "Trial Source", "@name": "trialSources", "FilterOption": [{"@id": "CTGOV", "@count": "22976", "@label": "ClinicalTrials.gov only"}, {"@id": "OTHERS", "@count": "17889", "@label": "Others only"}, {"@id": "CTGOVOTHERS", "@count": "13258", "@label": "ClinicalTrials.gov and others"}]}, {"@total": "3", "@label": "Funder Type", "@name": "trialFunderType", "FilterOption": [{"@id": "ACA", "@count": "14", "@label": "Academic"}, {"@id": "GOV", "@count": "5", "@label": "Government"}, {"@id": "CMP", "@count": "4", "@label": "Company"}]}, {"@total": "6", "@label": "Trial Terms Endpoint", "@name": "trialTermsEndpoint", "FilterOption": [{"@id": "SIEEFC", "@count": "48830", "@label": "Efficacy"}, {"@id": "SIESFT", "@count": "44336", "@label": "Safety"}, {"@id": "SIEPCK", "@count": "10147", "@label": "Pharmacokinetics"}, {"@id": "SIEPCD", "@count": "4629", "@label": "Pharmacodynamics"}, {"@id": "SIEBAV", "@count": "354", "@label": "Bioavailability"}, {"@id": "SIEBEQ", "@count": "226", "@label": "Bioequivalence"}]}, {"@total": "2", "@label": "Trial Outcome Available", "@name": "trialOutcomesAvailable", "FilterOption": [{"@id": "NO", "@count": "33411", "@label": "No"}, {"@id": "YES", "@count": "21848", "@label": "Yes"}]}, {"@total": "2", "@label": "Trial Commercially Significant", "@name": "trialIsCommerciallySignificant", "FilterOption": [{"@id": "NO", "@count": "35999", "@label": "No"}, {"@id": "YES", "@count": "19260", "@label": "Yes"}]}, {"@total": "3", "@label": "Trial Endpoint Achieved", "@name": "trialEndpointsAchieved", "FilterOption": [{"@id": "UNSPECIFIED", "@count": "19316", "@label": "Unspecified"}, {"@id": "YES", "@count": "834", "@label": "Yes"}, {"@id": "NO", "@count": "387", "@label": "No"}]}]}, "SearchResults": {"Trial": [{"ActionsSecondaryInterventionsPrimary": {"Action": ["Analgesic", "Anti-inflammatory"]}, "DateChangeLast": "2013-12-04T00:00:00Z", "Identifiers": {"Identifier": ["102-240-02", "EudraCT 2012-001769-34"]}, "Countries": {"Country": "Sweden"}, "PatientSegmentTerms": {"PatientSegment": ["Osteoarthritis - Subjects with Osteoarthritis of Hand", "Osteoarthritis - Subjects with Osteoarthritis of Knee", "Pain - Subjects with Moderate to Severe Pain", "Pain - Subjects with Somatic Pain - Subjects with arthritic pain"]}, "ActionsPrimaryInterventionsPrimary": {"Action": "5-HT 2 receptor antagonist"}, "TitleDisplay": "A Double-blind, Placebo-Controlled, Parallel-group, Randomised Study of Safety, Tolerability and Efficacy of AMAP102 in Patients With Osteoarthritis", "Indications": {"Indication": "Osteoarthritis"}, "PrimaryCompletionDate": "", "TermsDesign": {"Term": ["Interventional", "Treatment", "Randomized", "Multiple Blind", "Placebo Control", "Parallel Assignment"]}, "RecruitmentStatus": "Recruiting", "Teaser": "...failure in the opinion of the investigator, uncontrolled hypertension in the opinion of the investigator, history of stroke or transient ischemic attack within 6 months of enrollment, significant active hepatic disease, history of <b>malignant</b> <b>neoplastic</b> <b>disease</b> (other than basal cell carcinoma of the skin) within the past five years, or a current severe infectious disease with or without fever Is a woman of childbearing potential who has a positive serum pregnancy test or is a nursing mother...", "CompaniesSponsor": {"Company": "AnaMar Medical AB"}, "PatientCountEnrollment": 120, "Phase": "Phase 2 Clinical", "InterventionsPrimaryDisplay": {"Intervention": "AMAP-102 alone"}, "DateStart": "2012-10-02T00:00:00Z", "TermsPatientSelection": {"Term": ["Middle-aged Adults", "Aged Adults", "Elderly Adults"]}, "@Id": "132754", "BiomarkerNames": {"BiomarkerName": ["C-reactive protein ", " Cartilage oligomeric matrix protein ", " Interleukin-6 ", " Tumor necrosis factor"]}, "TermsEndpoint": {"Term": ["Safety", "Efficacy"]}}, {"DateStart": "2008-04-14T00:00:00Z", "DateChangeLast": "2014-04-17T00:00:00Z", "Countries": {"Country": "UK"}, "PatientSegmentTerms": {"PatientSegment": "Restless legs syndrome - Subjects with Idiopathic Restless Legs Syndrome"}, "Identifiers": {"Identifier": ["EudraCT 2007-006558-24", "SP935"]}, "TitleDisplay": "Phase IIIB, Open-Label, Multicenter Trial To Assess the Practicability and Tolerability Of Switching Subjects Overnight From Pramipexole Or Ropinirole To Rotigotine Transdermal Patch And its Effect On Symptoms In Subjects With Idiopathic Restless Legs Syndrome", "Indications": {"Indication": "Restless legs syndrome"}, "PrimaryCompletionDate": "", "TermsDesign": {"Term": ["Interventional", "Treatment", "Open Label", "Dose Comparison"]}, "RecruitmentStatus": "Terminated", "Teaser": "...creatinine> 2.0 mg/dl)Subject has clinically relevant hepatic dysfunction (total bilirubin> 2.0 mg/dl or alanine aminotransferase [ALT] and/or aspartate aminotransferase [AST] > 2 x the upper limit of the reference range)Subject has a <b>malignant</b> <b>neoplastic</b> <b>disease</b> requiring therapy within 12 months prior to Screening Visit (SCR)Subject is currently receiving treatment with any of the following drug classes: neuroleptics, hypnotics, anxiolytic drugs, anticonvulsive therapy, opioids, benzodiazepines...", "CompaniesSponsor": {"Company": "UCB SA"}, "PatientCountEnrollment": 120, "Phase": "Phase 3b Clinical", "InterventionsPrimaryDisplay": {"Intervention": "rotigotine alone"}, "TermsPatientSelection": {"Term": ["Young Adults", "Middle-aged Adults", "Aged Adults", "Elderly Adults"]}, "@Id": "132344", "TermsEndpoint": {"Term": ["Safety", "Efficacy"]}}, {"ActionsSecondaryInterventionsPrimary": {"Action": ["Anti-inflammatory", "Anticancer", "Bone resorption inhibitor"]}, "DateChangeLast": "2014-07-09T00:00:00Z", "Identifiers": {"Identifier": ["0822-066", "EudraCT 2012-003414-14", "MK-0822-066", "NCT01630616", "PK Study in Adolescents and Young Adults Treated with Glucocorticoids"]}, "Countries": {"Country": ["Canada", "Moldova, Republic of", "South Korea", "UK", "US"]}, "PatientSegmentTerms": {"PatientSegment": "Osteoporosis - Subjects at Risk of Developing Osteoporosis"}, "ActionsPrimaryInterventionsPrimary": {"Action": "Cathepsin K inhibitor"}, "TitleDisplay": "PK Study in Adolescents and Young Adults Treated with Glucocorticoids: A Study of Odanacatib When Administered to Adolescents and Young Adults Treated With Glucocorticoids", "Indications": {"Indication": "Osteoporosis"}, "PrimaryCompletionDate": "", "TermsDesign": {"Term": ["Interventional", "Treatment", "Randomized", "Multiple Blind", "Placebo Control", "Parallel Assignment"]}, "RecruitmentStatus": "Recruiting", "Teaser": "Subjects will receive single-dose of odanacatib (10 or 50 mg, po) along with placebo.Pregnant or unwilling to undergo pregnancy testHistory of stroke, chronic seizures, or major neurological disorderHistory of <b>malignant</b> <b>neoplastic</b> <b>disease</b> (<b>cancer</b>)Breast-feedingPrimary growth disorderAny disease affecting the stomach or proximal small intestine resulting in malabsorptionReceived treatment which might have influenced bone turnover, including anabolic steroids, testosterone...", "DateEnd": "2016-05-31T00:00:00Z", "CompaniesSponsor": {"Company": "Merck Sharp & Dohme Corp"}, "PatientCountEnrollment": 24, "Phase": "Phase 1 Clinical", "InterventionsPrimaryDisplay": {"Intervention": "odanacatib alone"}, "DateStart": "2013-03-31T00:00:00Z", "TermsPatientSelection": {"Term": ["Children", "Adolescents", "Young Adults"]}, "@Id": "88788", "TermsEndpoint": {"Term": ["Safety", "Pharmacokinetics", "Pharmacodynamics"]}}, {"ActionsSecondaryInterventionsPrimary": {"Action": ["Analgesic", "Antiparkinsonian"]}, "DateChangeLast": "2013-12-02T00:00:00Z", "Identifiers": {"Identifier": ["243-08-001", "JapicCTI-090888", "NCT01628926"]}, "Countries": {"Country": "Japan"}, "PatientSegmentTerms": {"PatientSegment": ["Parkinsons disease - Parkinson's Subjects with ON-OFF Episodes", "Parkinsons disease - Subjects with Advanced/Late Stage Parkinson's Disease", "Parkinsons disease - Subjects with History of Parkinson's Disease Therapy", "Parkinsons disease - Subjects with Levodopa-Induced Dyskinesia"]}, "ActionsPrimaryInterventionsPrimary": {"Action": ["5-HT receptor agonist", "Adrenoceptor agonist", "Dopamine D1 receptor agonist", "Dopamine D2 receptor agonist", "Dopamine D3 receptor agonist", "Dopamine D4 receptor agonist", "Dopamine D5 receptor agonist"]}, "TitleDisplay": "A Placebo- and Ropinirole-Controlled Study for SPM-962 in Advanced Parkinson's Disease Patients", "Indications": {"Indication": "Parkinsons disease"}, "PrimaryCompletionDate": "", "TermsDesign": {"Term": ["Interventional", "Treatment", "Randomized", "Multiple Blind", "Placebo Control", "Parallel Assignment"]}, "RecruitmentStatus": "Completed", "Teaser": "...study protocolSubject has a history of pallidotomy, thalamotomy, deep brain stimulation or fetal tissue transplantSubject has dementia, including DLB and PDD (MMSE score</= 24 at screening)Subject who has a complication or history of <b>malignant</b> <b>neoplastic</b> <b>disease</b>, or received treatment for the disease within 12 months prior to the screening testSubject is unable to give consentSubject who is unable to properly record information in a diarySubject is participating in another trial of IPs or received...", "DateEnd": "2011-05-31T00:00:00Z", "CompaniesSponsor": {"Company": "Otsuka Pharmaceutical Co Ltd"}, "PatientCountEnrollment": 420, "Phase": "Phase 3 Clinical", "InterventionsPrimaryDisplay": {"Intervention": ["ropinirole alone", "rotigotine (transdermal patch, Parkinson's/restless legs syndrome), UCB alone"]}, "DateStart": "2009-06-30T00:00:00Z", "TermsPatientSelection": {"Term": ["Young Adults", "Middle-aged Adults", "Aged Adults"]}, "@Id": "88752", "TermsEndpoint": {"Term": ["Safety", "Efficacy"]}}, {"ActionsSecondaryInterventionsPrimary": {"Action": ["Analgesic", "Antiparkinsonian"]}, "DateChangeLast": "2013-09-11T00:00:00Z", "Identifiers": {"Identifier": ["NCT01569464", "RESTORE", "RL0003"]}, "Countries": {"Country": "US"}, "PatientSegmentTerms": {"PatientSegment": ["Restless legs syndrome - Subjects with Moderate to Severe Restless Legs Syndrome", "Restless legs syndrome - Subjects with Idiopathic Restless Legs Syndrome"]}, "ActionsPrimaryInterventionsPrimary": {"Action": ["5-HT receptor agonist", "Adrenoceptor agonist", "Dopamine D1 receptor agonist", "Dopamine D2 receptor agonist", "Dopamine D3 receptor agonist", "Dopamine D4 receptor agonist", "Dopamine D5 receptor agonist"]}, "TitleDisplay": "RESTORE: Rotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs Syndrome (RLS)", "Indications": {"Indication": "Restless legs syndrome"}, "PrimaryCompletionDate": "", "TermsDesign": {"Term": ["Interventional", "Treatment", "Randomized", "Multiple Blind", "Placebo Control", "Parallel Assignment"]}, "RecruitmentStatus": "Completed", "Teaser": "...in the opinion of the investigator, could jeopardize or would compromise the subject's well being or ability to participate in this study Subject has a clinically relevant venous or arterial peripheral vascular diseaseSubject has a <b>malignant</b> <b>neoplastic</b> <b>disease</b> requiring therapy within 12 months prior to screening (visit 1)Subject is currently receiving treatment with any of the following drug classes: neuroleptics, hypnotics, antidepressants, anxiolytic drugs, anticonvulsive therapy, budipine...", "DateEnd": "2013-04-01T00:00:00Z", "CompaniesSponsor": {"Company": "UCB Pharma Inc"}, "PatientCountEnrollment": 150, "Phase": "Phase 3b Clinical", "InterventionsPrimaryDisplay": {"Intervention": "rotigotine (transdermal patch, Parkinson's/restless legs syndrome), UCB alone"}, "DateStart": "2012-03-31T00:00:00Z", "TermsPatientSelection": {"Term": ["Young Adults", "Middle-aged Adults", "Aged Adults"]}, "@Id": "86208", "TermsEndpoint": {"Term": ["Safety", "Efficacy"]}}, {"PrimaryCompletionDate": "", "PatientCountEnrollment": 81, "PatientSegmentTerms": {"PatientSegment": ["Hypertension - Subjects on Hypertensive Treatment", "Hypertension - Subjects with Co-morbid Conditions", "Restless legs syndrome - RLS Subjects with Motor Symptoms", "Restless legs syndrome - Specific Treatment Na\u00efve Restless Legs Syndrome Subjects", "Restless legs syndrome - Subjects with Moderate to Severe Restless Legs Syndrome", "Restless legs syndrome - Subjects with Idiopathic Restless Legs Syndrome", "Restless legs syndrome - Subjects with Severe to Very Severe Restless Legs Syndrome"]}, "InterventionsPrimaryDisplay": {"Intervention": "rotigotine (transdermal patch, Parkinson's/restless legs syndrome), UCB alone"}, "IndicationsAdverse": {"Indication": ["Dizziness", "Drowsiness", "Fatigue", "Headache", "Nausea", "Pruritus", "Rhinopharyngitis"]}, "Teaser": "...York Heart Association class III or IV congestive heart failure, or had a myocardial infarction within 12 months prior to screening [visit 1])Subject has clinically relevant venous or arterial peripheral vascular diseaseSubject has a <b>malignant</b> <b>neoplastic</b> <b>disease</b> requiring therapy within 12 months prior to screening (visit 1)Subject is currently receiving treatment with any of the following drug classes: neuroleptics, hypnotics, antidepressants, anxiolytic drugs, anticonvulsive therapy, budipine...", "Phase": "Phase 4 Clinical", "@Id": "81707", "DateStart": "2011-09-30T00:00:00Z", "ActionsPrimaryInterventionsPrimary": {"Action": ["5-HT receptor agonist", "Adrenoceptor agonist", "Dopamine D1 receptor agonist", "Dopamine D2 receptor agonist", "Dopamine D3 receptor agonist", "Dopamine D4 receptor agonist", "Dopamine D5 receptor agonist"]}, "Countries": {"Country": "Germany"}, "Identifiers": {"Identifier": ["2011-000053-23", "ENCORE", "NCT01455012", "SP0977"]}, "Indications": {"Indication": "Restless legs syndrome"}, "TitleDisplay": "ENCORE: Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome", "RecruitmentStatus": "Completed", "DateEnd": "2012-06-01T00:00:00Z", "CompaniesSponsor": {"Company": "UCB SA"}, "TermsPatientSelection": {"Term": ["Young Adults", "Middle-aged Adults", "Aged Adults"]}, "TermsEndpoint": {"Term": ["Safety", "Efficacy"]}, "ActionsSecondaryInterventionsPrimary": {"Action": ["Analgesic", "Antiparkinsonian"]}, "DateChangeLast": "2014-04-04T00:00:00Z", "TermsDesign": {"Term": ["Interventional", "Treatment", "Randomized", "Multiple Blind", "Placebo Control", "Parallel Assignment"]}}, {"ActionsSecondaryInterventionsPrimary": {"Action": ["Antiarrhythmic agent", "Coagulation inhibitor"]}, "DateChangeLast": "2013-10-30T00:00:00Z", "Identifiers": {"Identifier": ["MK-0000-216", "NCT01379300"]}, "DateStart": "2011-05-31T00:00:00Z", "PatientSegmentTerms": {"PatientSegment": "Hemophilia - Subjects with Hemophilia B"}, "ActionsPrimaryInterventionsPrimary": {"Action": ["Factor IIa antagonist", "Factor Xa antagonist", "Protease-activated receptor-1 antagonist"]}, "TitleDisplay": "A Study to Investigate Biomarkers After Single Doses of Anticoagulants in Healthy Young Male and Healthy Elderly Participants", "PrimaryCompletionDate": "", "TermsDesign": {"Term": ["Interventional", "Treatment", "Randomized", "Open Label", "Crossover Assignment"]}, "RecruitmentStatus": "Completed", "Teaser": "...hematological, hepatic, immunological, renal, respiratory, or genitourinary abnormalities or diseases History of <b>malignant</b> <b>neoplastic</b> <b>disease</b>, with the exception of adequately treated non-melanomatous skin carcinoma or other malignancies that have been successfully...deficiency), immunological, renal, respiratory, neurological or genitourinary abnormalities or diseases History of <b>malignant</b> <b>neoplastic</b> <b>disease</b>, with the exception of adequately treated non-melanomatous skin carcinoma or other malignancies that have been successfully...", "DateEnd": "2011-12-31T00:00:00Z", "CompaniesSponsor": {"Company": "Merck & Co Inc"}, "PatientCountEnrollment": 42, "Phase": "Phase 1 Clinical", "InterventionsPrimaryDisplay": {"Intervention": ["dabigatran etexilate alone", "rivaroxaban alone"]}, "BiomarkerNames": {"BiomarkerName": ["D-dimer ", " Prothrombin"]}, "TermsPatientSelection": {"Term": ["Healthy volunteers only", "Young Adults", "Middle-aged Adults", "Aged Adults", "Elderly Adults"]}, "@Id": "78767", "TermsEndpoint": {"Term": ["Pharmacokinetics", "Pharmacodynamics"]}}, {"ActionsSecondaryInterventionsPrimary": {"Action": ["Antihypertensive", "Diuretic agent", "Sodium metabolism modulator", "Unspecified drug target"]}, "DateChangeLast": "2014-05-12T00:00:00Z", "DateStart": "2011-06-30T00:00:00Z", "PatientSegmentTerms": {"PatientSegment": ["Hypertension - Hypertension Treatment Naive Subjects", "Hypertension - Subjects on Hypertensive Treatment", "Hypertension - Subjects with Co-morbid Conditions - Subjects with obesity"]}, "Identifiers": {"Identifier": ["MK-7145-009", "MK-7145-009 AM1", "NCT01370655"]}, "TitleDisplay": "A Study of MK-7145 Compared to Placebo and Hydrochlorothiazide for Lowering Blood Pressure in Male Participants With Hypertension", "Indications": {"Indication": "Hypertension"}, "PrimaryCompletionDate": "", "TermsDesign": {"Term": ["Interventional", "Treatment", "Randomized", "Multiple Blind", "Placebo Control", "Crossover Assignment"]}, "RecruitmentStatus": "Completed", "Teaser": "...change in vital sign measurements while going from a semi-recumbent to standing position accompanied by symptomsFunctional disability that can interfere with rising from a semi-recumbent position to the standing positionHistory of <b>malignant</b> <b>neoplastic</b> <b>disease</b>. Exceptions: adequately treated non-melanomatous skin carcinoma, other malignancies which have been successfully treated more than ten years prior to the prestudy (screening) visit, unlikely to sustain a recurrenceParticipant is unable...", "DateEnd": "2012-01-31T00:00:00Z", "CompaniesSponsor": {"Company": "Merck & Co Inc"}, "PatientCountEnrollment": 46, "Phase": "Phase 1b Clinical", "InterventionsPrimaryDisplay": {"Intervention": ["MK-7145 alone", "hydrochlorothiazide alone"]}, "TermsPatientSelection": {"Term": ["Male", "Young Adults", "Middle-aged Adults", "Aged Adults"]}, "@Id": "78068", "TermsEndpoint": {"Term": ["Safety", "Efficacy"]}}, {"ActionsSecondaryInterventionsControl": {"Action": ["5-HT uptake inhibitor", "Antidepressant", "Anxiolytic"]}, "PrimaryCompletionDate": "", "PatientCountEnrollment": 555, "PatientSegmentTerms": {"PatientSegment": ["Depression - Subjects Based on Severity of Depression - Subjects with moderate depression", "Depression - Subjects Based on Severity of Depression - Subjects with severe depression", "Depression - Subjects with Major Depressive Disorder"]}, "InterventionsControlDisplay": {"Intervention": ["citalopram hydrobromide alone", "pipamperone alone"]}, "InterventionsPrimaryDisplay": {"Intervention": "pipamperone + citalopram (depression), PharmaNeuroBoost alone"}, "Teaser": "...dysfunction (eg, GFR< 60 ml/min)Subject has clinically relevant hepatic dysfunction (total bilirubin> 2.0 mg/dl or alanine aminotransferase [ALT] and/or aspartate aminotransferase [AST] > 2 x the upper limit of the reference range) Subject has a <b>malignant</b> <b>neoplastic</b> <b>disease</b> or a documented history of epilepsy (juvenile convulsions excepted) or a documented, in the opinion of the investigator, clinically relevant risk of bleeding (eg, severe bleeding disorder, treatment with warfarin)Subject with a documented...", "Phase": "Phase 3 Clinical", "@Id": "75446", "DateStart": "2011-09-30T00:00:00Z", "ActionsPrimaryInterventionsPrimary": {"Action": ["5-HT 2a receptor antagonist", "Dopamine D4 receptor antagonist"]}, "Countries": {"Country": ["Canada", "Germany", "US"]}, "Identifiers": {"Identifier": ["2011-001190-11", "NCT01312922", "PNB01-C301"]}, "Indications": {"Indication": "Depression"}, "TitleDisplay": "Pipamperone/Citalopram (PNB-01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)", "RecruitmentStatus": "No longer recruiting", "DateEnd": "2012-11-30T00:00:00Z", "CompaniesSponsor": {"Company": "PharmaNeuroBoost NV"}, "TermsPatientSelection": {"Term": ["Young Adults", "Middle-aged Adults", "Aged Adults", "Elderly Adults"]}, "TermsEndpoint": {"Term": ["Efficacy", "Pharmacokinetics"]}, "ActionsSecondaryInterventionsPrimary": {"Action": ["5-HT uptake inhibitor", "Antidepressant"]}, "DateChangeLast": "2013-12-02T00:00:00Z", "TermsDesign": {"Term": ["Interventional", "Treatment", "Randomized", "Multiple Blind", "Active Control", "Parallel Assignment"]}}, {"ActionsSecondaryInterventionsPrimary": {"Action": ["5-HT uptake inhibitor", "Antidepressant", "Muscle relaxant", "Norepinephrine uptake inhibitor"]}, "DateChangeLast": "2013-09-14T00:00:00Z", "CompaniesCollaborator": {"Company": "Forest Laboratories Inc"}, "Countries": {"Country": "US"}, "PatientSegmentTerms": {"PatientSegment": ["Pain - Subjects with Chronic Pain", "Pain - Subjects with Somatic Pain"]}, "Identifiers": {"Identifier": ["NCT01289236", "SAV-MD-02"]}, "TitleDisplay": "Milnacipran in Subjects With Chronic Shoulder Pain", "Indications": {"Indication": "Pain"}, "PrimaryCompletionDate": "", "TermsDesign": {"Term": ["Interventional", "Treatment", "Randomized", "Single Blind", "Placebo Control", "Parallel Assignment"]}, "RecruitmentStatus": "Completed", "Teaser": "...3 x ULN) or significant renal impairment (defined as a serum creatinine level greater than twice the ULNUncontrolled hypertension, history of stroke or transient ischemic attack within 6 months of enrollment, epilepsy, history of <b>malignant</b> <b>neoplastic</b> <b>disease</b> that is active (basal cell carcinoma of the skin is permitted), active infectious diseaseSubjects who have a history of uncontrolled narrow angle glaucomaSubjects who test positive for illegal or prohibited substances at screening...", "DateEnd": "2011-06-01T00:00:00Z", "CompaniesSponsor": {"Company": "Delray Research Associates"}, "PatientCountEnrollment": 40, "Phase": "Phase 4 Clinical", "InterventionsPrimaryDisplay": {"Intervention": "milnacipran alone"}, "DateStart": "2009-10-31T00:00:00Z", "TermsPatientSelection": {"Term": ["Young Adults", "Middle-aged Adults", "Aged Adults", "Elderly Adults"]}, "@Id": "74460", "TermsEndpoint": {"Term": ["Safety", "Efficacy"]}}, {"ActionsSecondaryInterventionsPrimary": {"Action": ["Antibacterial", "Bacterial cell wall synthesis inhibitor", "Beta lactam antibiotic", "Carbapenem", "Synergist", "Systemic dermatological antibacterial product"]}, "DateChangeLast": "2013-09-11T00:00:00Z", "Identifiers": {"Identifier": ["MK-7655-005", "MK-7655-005 AM1", "NCT01275170"]}, "DateStart": "2011-01-31T00:00:00Z", "PatientSegmentTerms": {"PatientSegment": ["End stage renal disease - Subjects with Dialysis Dependant Chronic Kidney Disease(DD-CKD) - Subjects with stage 5 CKD/end stage renal disease(ESRD)", "End stage renal disease - Subjects with Non-Dialysis Dependant Chronic Kidney Disease(NDD-CKD) - Subjects with stage 2 CKD", "End stage renal disease - Subjects with Non-Dialysis Dependant Chronic Kidney Disease(NDD-CKD) - Subjects with stage 3 CKD", "End stage renal disease - Subjects with Non-Dialysis Dependant Chronic Kidney Disease(NDD-CKD) - Subjects with stage 4 CKD"]}, "ActionsPrimaryInterventionsPrimary": {"Action": ["Beta lactamase inhibitor", "Dehydropeptidase-1 inhibitor"]}, "TitleDisplay": "MK-7655-005 AM1: A Single-Dose Study to Investigate the Pharmacokinetics of MK-7655 in Participants With Impaired Renal Function (MK-7655-005)", "Indications": {"Indication": "Bacterial infection"}, "PrimaryCompletionDate": "", "TermsDesign": {"Term": ["Interventional", "Treatment", "Non-Randomized", "Open Label", "Parallel Assignment"]}, "RecruitmentStatus": "Completed", "Teaser": "...seizures, or major neurological disorderHistory of clinically significant endocrine, gastrointestinal, cardiovascular, hematological, hepatic, immunological, renal, respiratory, or genitourinary abnormalities or diseasesHistory of <b>malignant</b> <b>neoplastic</b> <b>disease</b>. Exceptions:Adequately treated non-melanomatous skin carcinoma or carcinoma in situ of the cervixOther malignancies which have been successfully treated >/= 10 years prior to the screening visitUse of any medication (prescription or...", "DateEnd": "2012-03-01T00:00:00Z", "CompaniesSponsor": {"Company": "Merck & Co Inc"}, "PatientCountEnrollment": 49, "Phase": "Phase 1 Clinical", "InterventionsPrimaryDisplay": {"Intervention": "MK-7655 plus imipenem + cilastatin"}, "TermsPatientSelection": {"Term": ["Healthy volunteers accepted", "Young Adults", "Middle-aged Adults", "Aged Adults"]}, "@Id": "73743", "TermsEndpoint": {"Term": ["Safety", "Pharmacokinetics"]}}, {"PrimaryCompletionDate": "", "PatientCountEnrollment": 240, "PatientSegmentTerms": {"PatientSegment": ["Restless legs syndrome - Specific Treatment Na\u00efve Restless Legs Syndrome Subjects", "Restless legs syndrome - Subjects with Moderate to Severe Restless Legs Syndrome", "Restless legs syndrome - Subjects with Severe to Very Severe Restless Legs Syndrome"]}, "InterventionsPrimaryDisplay": {"Intervention": "rotigotine (transdermal patch, Parkinson's/restless legs syndrome), UCB alone"}, "IndicationsAdverse": {"Indication": "Erythema"}, "Teaser": "...engage in hazardous work such as driving a vehicle, operating machinery, or working in a high locationPatients with autoimmune disease, chronic active hepatitis, or immune deficiency disorderPatients who have a complication or history of <b>malignant</b> <b>neoplastic</b> <b>disease</b>, or received treatment for the disease within 12 months prior to the screening testPatients who are unable to properly record information in a patient diaryPatients who received other IPs within 12 weeks prior to commencement of study...", "Phase": "Phase 3 Clinical", "@Id": "64749", "DateStart": "2010-02-28T00:00:00Z", "ActionsPrimaryInterventionsPrimary": {"Action": ["5-HT receptor agonist", "Adrenoceptor agonist", "Dopamine D1 receptor agonist", "Dopamine D2 receptor agonist", "Dopamine D3 receptor agonist", "Dopamine D4 receptor agonist", "Dopamine D5 receptor agonist"]}, "Countries": {"Country": "Japan"}, "Identifiers": {"Identifier": ["243-09-001", "JapicCTI-101053", "NCT01084551"]}, "Indications": {"Indication": "Restless legs syndrome"}, "TitleDisplay": "Study of SPM-962 in Patients With Restless Legs Syndrome (RLS)", "RecruitmentStatus": "Completed", "DateEnd": "2011-09-01T00:00:00Z", "CompaniesSponsor": {"Company": "Otsuka Pharmaceutical Co Ltd"}, "TermsPatientSelection": {"Term": ["Young Adults", "Middle-aged Adults", "Aged Adults"]}, "TermsEndpoint": {"Term": ["Safety", "Efficacy"]}, "ActionsSecondaryInterventionsPrimary": {"Action": ["Analgesic", "Antiparkinsonian"]}, "DateChangeLast": "2013-12-02T00:00:00Z", "TermsDesign": {"Term": ["Interventional", "Treatment", "Randomized", "Multiple Blind", "Placebo Control", "Parallel Assignment"]}}, {"ActionsSecondaryInterventionsControl": {"Action": ["Anti-inflammatory", "Gastrointestinal system agent", "Unspecified drug target"]}, "PrimaryCompletionDate": "", "PatientCountEnrollment": 120, "PatientSegmentTerms": {"PatientSegment": "Ulcerative colitis - Subjects with Mild to Moderate Ulcerative Colitis"}, "InterventionsControlDisplay": {"Intervention": "mesalazine (delayed-release tablets, ulcerative colitis), Procter & Gamble alone"}, "InterventionsPrimaryDisplay": {"Intervention": "GSK-1399686 alone"}, "Teaser": "...pulmonary, metabolic or infectious disease or mental disorder that, in the opinion of the investigator, represents an unacceptable safety risk for participation in this trialHistory of <b>malignant</b> <b>neoplastic</b> <b>disease</b> within the past five years other than localized basal cell skin <b>cancer</b>, squamous cell skin <b>cancer</b> or <b>cancer</b> in situ that has been resectedHistory of regular alcohol consumption within 6 months of the study or presence of recreational drug abuse or dependencePresence of infectious colitis...", "Phase": "Phase 2 Clinical", "BiomarkerNames": {"BiomarkerName": ["Calprotectin ", " Hydrocortisone"]}, "@Id": "62856", "DateStart": "2009-09-30T00:00:00Z", "Countries": {"Country": ["Belgium", "Canada", "Germany", "Norway", "Sweden"]}, "Identifiers": {"Identifier": [111407, "2009-011608-51", "NCT01036022"]}, "Indications": {"Indication": "Ulcerative colitis"}, "TitleDisplay": "Effect of GSK-1399686 in Patients With Mild to Moderately Active Ulcerative Colitis", "RecruitmentStatus": "Completed", "DateEnd": "2012-07-31T00:00:00Z", "CompaniesSponsor": {"Company": "GlaxoSmithKline plc"}, "TermsPatientSelection": {"Term": ["Young Adults", "Middle-aged Adults", "Aged Adults"]}, "TermsEndpoint": {"Term": ["Safety", "Efficacy", "Pharmacokinetics"]}, "ActionsSecondaryInterventionsPrimary": {"Action": ["Anti-inflammatory", "Unspecified drug target"]}, "DateChangeLast": "2014-02-11T00:00:00Z", "TermsDesign": {"Term": ["Interventional", "Treatment", "Randomized", "Multiple Blind", "Placebo Control", "Parallel Assignment"]}}, {"ActionsSecondaryInterventionsPrimary": {"Action": ["Anti-inflammatory", "Anticancer chemosensitizer", "Cardioprotectant", "HIV fusion inhibitor"]}, "DateChangeLast": "2014-03-17T00:00:00Z", "Identifiers": {"Identifier": ["AMD31001101", "NCT00445302"]}, "Countries": {"Country": "US"}, "PatientSegmentTerms": {"PatientSegment": ["End stage renal disease - Subjects with Non-Dialysis Dependant Chronic Kidney Disease(NDD-CKD) - Subjects with stage 2 CKD", "End stage renal disease - Subjects with Non-Dialysis Dependant Chronic Kidney Disease(NDD-CKD) - Subjects with stage 3 CKD", "End stage renal disease - Subjects with Non-Dialysis Dependant Chronic Kidney Disease(NDD-CKD) - Subjects with stage 4 CKD"]}, "ActionsPrimaryInterventionsPrimary": {"Action": "CXCR4 chemokine antagonist"}, "TitleDisplay": "Safety, PK, And Hematological Activity Of AMD-3100 In Subjects With Renal Impairment", "PrimaryCompletionDate": "", "TermsDesign": {"Term": ["Interventional", "Treatment", "Non-Randomized", "Open Label", "Active Control", "Single Group Assignment"]}, "RecruitmentStatus": "Completed", "Teaser": "...thrombocytopeniaReceived blood transfusions within 30 days prior to trial entryAny subject who requires therapeutic intervention within the 30 days prior to administration of study medication in order to meet the inclusion/exclusion criteriaActive <b>malignant</b>/<b>neoplastic</b> <b>disease</b> requiring treatment of any kindActive infection requiring antibioticsRenal impairment requiring any method of dialysisHistory of kidney transplantSubjects having clinical status or laboratory parameter deterioration between the time of...", "DateEnd": "2007-08-31T00:00:00Z", "CompaniesSponsor": {"Company": "Genzyme Corp"}, "PatientCountEnrollment": 23, "Phase": "Phase 1 Clinical", "InterventionsPrimaryDisplay": {"Intervention": "plerixafor alone"}, "DateStart": "2006-01-31T00:00:00Z", "TermsPatientSelection": {"Term": ["Healthy volunteers only", "Young Adults", "Middle-aged Adults", "Aged Adults"]}, "@Id": "33406", "TermsEndpoint": {"Term": ["Safety", "Efficacy", "Pharmacokinetics"]}}, {"ActionsSecondaryInterventionsPrimary": {"Action": ["Anticancer", "Anticancer alkylating agent", "DNA synthesis inhibitor"]}, "DateChangeLast": "2013-12-02T00:00:00Z", "IndicationsAdverse": {"Indication": "Death"}, "Countries": {"Country": "Mexico"}, "PatientSegmentTerms": {"PatientSegment": ["Esophagus tumor - Subjects with Gastro-esophageal Junction Cancer", "Stomach tumor - Others - Subjects with Adenocarcinoma of the Gastroesophageal Junction", "Stomach tumor - Subjects with Advanced/Metastatic Gastric Cancer", "Stomach tumor - Subjects with Relapsed/Recurrent Gastric Cancer", "Stomach tumor - Subjects with Unresectable Gastric Cancer"]}, "Identifiers": {"Identifier": ["L_8915", "NCT00263354"]}, "TitleDisplay": "Oxaliplatin in Gastric Cancer", "Indications": {"Indication": ["Metastatic stomach cancer", "Stomach tumor"]}, "PrimaryCompletionDate": "", "TermsDesign": {"Term": ["Interventional", "Treatment", "Non-Randomized", "Open Label", "No Control", "Single Group Assignment"]}, "RecruitmentStatus": "Completed", "Teaser": "...1248361]. Symptomatic sensorial peripheral neuropathyUncontrolled concomitant diseaseAnother <b>malignant</b> <b>neoplastic</b> <b>disease</b> diagnosed within the previous five years to the diagnosis of advanced or metastatic gastric <b>cancer</b>, with the exception of in situ cervix carcinoma or non-melonoma skin cancerConcomitant...confirmationFirst line locally unresectable or metastatic gastric cancerRelapsing gastric <b>cancer</b> after local and/or systemic treatment with a post-surgical period of at least 4 weeks...", "DateEnd": "2006-07-01T00:00:00Z", "CompaniesSponsor": {"Company": "Sanofi"}, "PatientCountEnrollment": 20, "Phase": "Phase 2 Clinical", "InterventionsPrimaryDisplay": {"Intervention": "Variable regimens including 5-FU , folinic acid , leucovorin , oxaliplatin"}, "DateStart": "2003-10-31T00:00:00Z", "TermsPatientSelection": {"Term": ["Young Adults", "Middle-aged Adults", "Aged Adults", "Elderly Adults"]}, "@Id": "25470", "TermsEndpoint": {"Term": ["Safety", "Efficacy"]}}, {"ActionsSecondaryInterventionsControl": {"Action": ["Analgesic", "Antiparkinsonian"]}, "ActionsPrimaryInterventionsControl": {"Action": ["Dopamine D2 receptor agonist", "Dopamine D3 receptor agonist"]}, "PrimaryCompletionDate": "", "PatientCountEnrollment": 124, "PatientSegmentTerms": {"PatientSegment": ["Parkinsons disease - Subjects with History of Parkinson's Disease Therapy", "Parkinsons disease - Subjects with Motor Symptoms of Parkinson's Disease", "Parkinsons disease - Subjects with Motor Symptoms of Parkinson's Disease - Subjects with bradykinesia", "Parkinsons disease - Subjects with Motor Symptoms of Parkinson's Disease - Subjects with rigidity", "Parkinsons disease - Subjects with Motor Symptoms of Parkinson's Disease - Subjects with tremors", "Parkinsons disease - Treatment Refractory Parkinson's Disease Subjects"]}, "InterventionsControlDisplay": {"Intervention": "ropinirole alone"}, "InterventionsPrimaryDisplay": {"Intervention": "rotigotine (transdermal patch, Parkinson's/restless legs syndrome), UCB alone"}, "IndicationsAdverse": {"Indication": ["Dizziness", "Movement disorder", "Pruritus", "Tremor"]}, "Teaser": "...of symptomatic (not asymptomatic) orthostatic hypotension in the 6 months prior to baselineSubject has a history of significant skin hypersensitivity to adhesive or other transdermals or recent unresolved contact dermatitisSubject has <b>malignant</b> <b>neoplastic</b> <b>disease</b> requiring therapy within 12 months prior to enrollmentSubject has a history of chronic alcohol or drug abuse within the last 6 monthsSubject has taken herbal medicine therapy within the last 2 weeks prior to the baseline visitSubject has...", "Phase": "Phase 3b Clinical", "BiomarkerNames": {"BiomarkerName": ["Alanine transaminase ", " Albumin ", " Alkaline phosphatase ", " Aspartate aminotransferase ", " Bilirubin ", " Creatinine ", " Hematocrit ", " Hemoglobin ", " Total protein ", " Urea nitrogen ", " Uric acid ", " gamma-Glutamyltransferase"]}, "@Id": "7119", "DateStart": "2007-07-31T00:00:00Z", "ActionsPrimaryInterventionsPrimary": {"Action": ["5-HT receptor agonist", "Adrenoceptor agonist", "Dopamine D1 receptor agonist", "Dopamine D2 receptor agonist", "Dopamine D3 receptor agonist", "Dopamine D4 receptor agonist", "Dopamine D5 receptor agonist"]}, "Identifiers": {"Identifier": ["NCT00593606", "SP908"]}, "Indications": {"Indication": "Parkinsons disease"}, "TitleDisplay": "Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine", "RecruitmentStatus": "Completed", "DateEnd": "2007-12-31T00:00:00Z", "CompaniesSponsor": {"Company": "UCB SA"}, "TermsPatientSelection": {"Term": ["Healthy volunteers accepted", "Young Adults", "Middle-aged Adults", "Aged Adults", "Elderly Adults", "Asian Ancestry"]}, "TermsEndpoint": {"Term": ["Safety", "Efficacy", "Pharmacokinetics"]}, "ActionsSecondaryInterventionsPrimary": {"Action": ["Analgesic", "Antiparkinsonian"]}, "DateChangeLast": "2013-12-02T00:00:00Z", "TermsDesign": {"Term": ["Interventional", "Treatment", "Non-Randomized", "Open Label", "Active Control", "Single Group Assignment"]}}, {"PrimaryCompletionDate": "", "PatientCountEnrollment": 11248, "PatientSegmentTerms": {"PatientSegment": ["Breast tumor - Others - Subjects with Node Negative Breast Cancer", "Breast tumor - Subjects at Risk of Developing Invasive Breast Cancer - Ductal carcinoma in situ/Intraductal carcinoma (DCIS)", "Breast tumor - Subjects at Risk of Developing Invasive Breast Cancer - Lobular carcinoma in situ (LCIS)", "Breast tumor - Subjects with Early Stage Breast Cancer", "Breast tumor - Subjects with HER-2 Negative Breast Cancer", "Breast tumor - Subjects with Hormone Receptor Positive Breast Cancer - Estrogen receptor positive (ER+) breast cancer", "Breast tumor - Subjects with Hormone Receptor Positive Breast Cancer - Progesterone receptor positive (PR+) breast cancer", "Breast tumor - Subjects with Locally Advanced Breast Cancer", "Breast tumor - Subjects with Stage I Breast Cancer", "Breast tumor - Subjects with Stage II Breast Cancer", "Breast tumor - Subjects with Stage III Breast Cancer - TNM stage IIIA Breast cancer"]}, "InterventionsPrimaryDisplay": {"Intervention": "Variable regimens including anastrozole , exemestane , letrozole , tamoxifen"}, "Teaser": "...both, and as defined by the Sixth Edition of the American Joint Committee on <b>Cancer</b> (AJCC) staging criteriaPatients with histologically confirmed adenocarcinoma...or an aromatase inhibitor (eg, anastrazole, letrozole, exemestane) for breast <b>cancer</b> prevention or a SERM for other indications (eg, raloxifene for osteoporosis...individual therapy for women who have node-negative, estrogen-receptor positive breast <b>cancer</b> by using a special test (Oncotype DX), and whether hormone therapy alone or hormone...", "Phase": "Phase 3 Clinical", "BiomarkerNames": {"BiomarkerName": "HER2"}, "@Id": "58168", "DateStart": "2006-04-30T00:00:00Z", "ActionsPrimaryInterventionsPrimary": {"Action": ["Aromatase inhibitor", "Estrogen receptor antagonist"]}, "Countries": {"Country": ["Australia", "Canada", "Ireland", "New Zealand", "Peru", "Puerto Rico", "US"]}, "Identifiers": {"Identifier": ["CDR0000472066", "ECOG-PACCT-1", "NCI-2009-00707", "NCT00310180", "NCT00554931", "PACCT-1", "TAILORx", "U10CA021115"]}, "Indications": {"Indication": "Breast tumor"}, "TitleDisplay": "TAILORx: Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer", "RecruitmentStatus": "No longer recruiting", "CompaniesSponsor": {"Company": "National Cancer Institute"}, "TermsPatientSelection": {"Term": ["Female", "Young Adults", "Middle-aged Adults", "Aged Adults"]}, "TermsEndpoint": {"Term": ["Safety", "Efficacy"]}, "ActionsSecondaryInterventionsPrimary": {"Action": ["Anticancer", "Anticancer hormone antagonist", "Reproductive system modulator"]}, "DateChangeLast": "2014-05-08T00:00:00Z", "CompaniesCollaborator": {"Company": ["American College of Surgeons", "Cancer and Leukemia Group B", "NCIC Clinical Trials Group", "NSABP Foundation Inc", "North Central Cancer Treatment Group", "SWOG"]}, "TermsDesign": {"Term": ["Interventional", "Treatment", "Randomized", "Open Label", "Parallel Assignment"]}}, {"DateStart": "2000-10-31T00:00:00Z", "DateChangeLast": "2014-04-24T00:00:00Z", "CompaniesCollaborator": {"Company": ["Cancer and Leukemia Group B", "NCIC Clinical Trials Group", "National Cancer Institute", "North Central Cancer Treatment Group", "SWOG"]}, "Countries": {"Country": ["Canada", "US"]}, "PatientSegmentTerms": {"PatientSegment": ["Lung tumor - Subjects with Early Stage Lung Cancer", "Lung tumor - Subjects with Early Stage Lung Cancer - Subjects with stage I lung cancer", "Lung tumor - Subjects with Non Small Cell Lung Cancer (NSCLC)", "Lung tumor - Subjects with Resectable/Operable Lung Cancer", "Lung tumor - Treatment Naive Subjects"]}, "Identifiers": {"Identifier": ["CALGB-79803", "CAN-NCIC-BR16", "CDR0000068402", "ECOG-5597", "NCCTG-E5597", "NCI-P00-0176", "NCT00008385", "SWOG-E5597"]}, "TitleDisplay": "Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer", "Indications": {"Indication": "Non-small-cell lung cancer"}, "PrimaryCompletionDate": "", "TermsDesign": {"Term": ["Interventional", "Prevention", "Randomized", "Multiple Blind", "Placebo Control", "Parallel Assignment"]}, "RecruitmentStatus": "No longer recruiting", "Teaser": "...transaminase (SGPT) no > ULNRenal:Not specifiedOther:No concurrent or other prior <b>cancer</b> within the past five years except localized non-melanoma skin cancerPrior concurrent...endpoints included. SPTS were developed in 216 patients, in which 38.9% had lung <b>cancer</b>. Placebo and selenium arms showed STP incidence of 1.36/3.66/100 person-years versus...in patients who have undergone surgery to remove stage I non-small cell lung <b>cancer</b> (NSCLC).Completely resected stage I NSCLC patients (n = 1960) were randomized...", "DateEnd": "2014-11-30T00:00:00Z", "CompaniesSponsor": {"Company": "Eastern Cooperative Oncology Group"}, "PatientCountEnrollment": 1960, "Phase": "Phase 3 Clinical", "InterventionsPrimaryDisplay": {"Intervention": "selenium alone"}, "TermsPatientSelection": {"Term": ["Young Adults", "Middle-aged Adults", "Aged Adults", "Elderly Adults"]}, "@Id": "181738", "TermsEndpoint": {"Term": ["Safety", "Efficacy"]}}, {"DateStart": "2008-10-31T00:00:00Z", "DateChangeLast": "2014-03-11T00:00:00Z", "CompaniesCollaborator": {"Company": "National Cancer Institute"}, "Countries": {"Country": "US"}, "PatientSegmentTerms": {"PatientSegment": ["Cancer supportive care - Cancer-related Fatigue", "Cancer supportive care - Others - Subjects with General cancers", "Multiple myeloma - Subjects with Symptomatic Multiple Myeloma"]}, "Identifiers": {"Identifier": ["CDR0000597665", "NCCTG-N07C2", "NCT00719563"]}, "TitleDisplay": "American Ginseng in Treating Patients With Fatigue Caused by Cancer", "Indications": {"Indication": "Fatigue"}, "PrimaryCompletionDate": "", "TermsDesign": {"Term": ["Interventional", "Treatment", "Randomized", "Multiple Blind", "Placebo Control"]}, "RecruitmentStatus": "No longer recruiting", "Teaser": "...doxorubicin hydrochloride, vincristine, and prednisolone [CHOP] therapy or any regular <b>cancer</b> treatment) except as prophylaxis for nausea and vomitingLow-dose dexamethasone...completed treatment, greater benefit was reported in patients receiving active <b>cancer</b> treatment. Statistically significant differences were not reported between the...ginseng to see how well it worked in treating patients with fatigue caused by <b>cancer</b>.Patients were treated with either placebo or Wisconsin Ginseng 2000 mg for 2...", "DateEnd": "2011-09-30T00:00:00Z", "CompaniesSponsor": {"Company": "North Central Cancer Treatment Group"}, "PatientCountEnrollment": 360, "Phase": "Phase 3 Clinical", "InterventionsPrimaryDisplay": {"Intervention": "American ginseng alone"}, "BiomarkerNames": {"BiomarkerName": ["Cytokines ", " Hydrocortisone"]}, "TermsPatientSelection": {"Term": ["Young Adults", "Middle-aged Adults", "Aged Adults", "Elderly Adults"]}, "@Id": "151868", "TermsEndpoint": {"Term": ["Safety", "Efficacy"]}}, {"PrimaryCompletionDate": "", "PatientCountEnrollment": 56, "PatientSegmentTerms": {"PatientSegment": ["Breast tumor - Subjects with Advanced/Metastatic Breast Cancer/Stage IV Breast Cancer", "Breast tumor - Subjects with HER-2 Negative Breast Cancer"]}, "InterventionsPrimaryDisplay": {"Intervention": "pixantrone alone"}, "IndicationsAdverse": {"Indication": ["Anemia", "Fatigue", "Hyponatremia", "Neutropenia"]}, "Teaser": "...of confirmed tumor responses in patients with HER2-negative metastatic breast <b>cancer</b> treated with pixantrone dimaleate. The secondary objectives of the study were...and EKG normal within the past 22 daysNo other prior stage III or IV invasive <b>cancer</b> within the past three years except curatively treated non-melanoma skin cancerNo...efficacy of pixantrone in treating patients with HER2-negative metastatic breast <b>cancer</b>.Patients (n = 47) were randomized to two dose schedules: In group A, patients...", "Phase": "Phase 2 Clinical", "BiomarkerNames": {"BiomarkerName": ["Alanine transaminase ", " Aspartate aminotransferase ", " HER2"]}, "@Id": "64843", "DateStart": "2010-05-31T00:00:00Z", "ActionsPrimaryInterventionsPrimary": {"Action": "DNA gyrase inhibitor"}, "Countries": {"Country": "US"}, "Identifiers": {"Identifier": ["CDR0000667253", "N1031", "NCCTG-N1031", "NCT01086605"]}, "Indications": {"Indication": "Metastatic breast cancer"}, "TitleDisplay": "Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer", "RecruitmentStatus": "Completed", "DateEnd": "2012-01-01T00:00:00Z", "CompaniesSponsor": {"Company": "North Central Cancer Treatment Group"}, "TermsPatientSelection": {"Term": ["Young Adults", "Middle-aged Adults", "Aged Adults", "Elderly Adults"]}, "TermsEndpoint": {"Term": ["Safety", "Efficacy", "Pharmacodynamics"]}, "ActionsSecondaryInterventionsPrimary": {"Action": ["Anticancer alkylating agent", "Immunomodulator"]}, "DateChangeLast": "2014-04-15T00:00:00Z", "CompaniesCollaborator": {"Company": "National Cancer Institute"}, "TermsDesign": {"Term": ["Interventional", "Treatment", "Randomized", "Open Label"]}}]}, "@hits": "20", "@totalResults": "55259", "@offset": "0"}}